AXT INC, 10-K filed on 3/14/2025
Annual Report
v3.25.0.1
Document and Entity Information - USD ($)
 12 Months Ended
Dec. 31, 2024
Mar. 01, 2025
Jun. 28, 2024
Document And Entity Information      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2024    
Document Transition Report false    
Securities Act File Number 000-24085    
Entity Registrant Name AXT INC    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 94-3031310    
Entity Address, Address Line One 4281 Technology Drive    
Entity Address, City or Town Fremont    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 94538    
City Area Code 510    
Local Phone Number 438-4700    
Title of 12(b) Security Common Stock, $0.001 par value    
Trading Symbol AXTI    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 119,813,368
Entity Common Stock, Shares Outstanding   45,597,995  
Document Incorporated by Reference

Portions of the registrant’s definitive proxy statement relating to our annual meeting of stockholders to be held on May 15, 2025 (the “Proxy Statement”) are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such Proxy Statement will be filed with the Securities and Exchange Commission (the “SEC”) pursuant to Regulation 14A not later than 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K.

    
Auditor Name BPM LLP    
Auditor Firm ID 207    
Auditor Location San Jose, California    
Entity Central Index Key 0001051627    
Current Fiscal Year End Date --12-31    
Document Fiscal Year Focus 2024    
Document Fiscal Period Focus FY    
Amendment Flag false    
v3.25.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 22,833,000 $ 37,752,000
Restricted cash 10,978,000 12,362,000
Short-term investments   2,140,000
Accounts receivable, net of allowances for credit losses of $147 and $579 as of December 31, 2024 and December 31, 2023 25,640,000 19,256,000
Inventories 85,077,000 86,503,000
Prepaid expenses and other current assets 13,744,000 12,643,000
Total current assets 158,272,000 170,656,000
Property, plant and equipment, net 159,721,000 166,348,000
Operating lease right-of-use assets 2,479,000 2,799,000
Other assets 18,842,000 18,898,000
Total assets 339,314,000 358,701,000
Current liabilities:    
Accounts payable 12,356,000 9,617,000
Accrued liabilities 14,556,000 19,019,000
Short-term loans 47,264,000 52,921,000
Total current liabilities 74,176,000 81,557,000
Noncurrent operating lease liabilities 1,977,000 2,351,000
Other long-term liabilities 8,253,000 5,647,000
Total liabilities 84,406,000 89,555,000
Commitments and contingencies (Note 16)
Redeemable noncontrolling interests (Note 18) 38,577,000 41,663,000
Stockholders' equity:    
Preferred stock Series A, $0.001 par value; 2,000 shares authorized; 883 shares issued and outstanding as of December 31, 2024 and December 31, 2023 (Liquidation preference of $8,052 and $7,875 as of December 31, 2024 and December 31, 2023) 3,532,000 3,532,000
Common stock, $0.001 par value; 70,000 shares authorized; 45,358 and 44,239 shares issued and outstanding as of December 31, 2024 and December 31, 2023 45,000 44,000
Additional paid-in capital 241,514,000 238,452,000
Accumulated deficit (43,664,000) (32,040,000)
Accumulated other comprehensive loss (8,657,000) (5,999,000)
Total AXT, Inc. stockholders' equity 192,770,000 203,989,000
Noncontrolling interests 23,561,000 23,494,000
Total stockholders' equity 216,331,000 227,483,000
Total liabilities, redeemable noncontrolling interests and stockholders' equity $ 339,314,000 $ 358,701,000
v3.25.0.1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Accounts receivable, allowances for doubtful accounts $ 147 $ 579
Stockholders' equity:    
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 2,000,000 2,000,000
Preferred stock, shares issued (in shares) 883,000 883,000
Preferred stock, shares outstanding (in shares) 883,000 883,000
Preferred stock, liquidation preference $ 8,052 $ 7,875
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 70,000,000 70,000,000
Common stock, shares issued (in shares) 45,358,000 44,239,000
Common stock, shares outstanding (in shares) 45,358,000 44,239,000
v3.25.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
CONSOLIDATED STATEMENTS OF OPERATIONS      
Revenue $ 99,361 $ 75,795 $ 141,118
Cost of revenue 75,525 62,477 88,997
Gross profit 23,836 13,318 52,121
Operating expenses:      
Selling, general and administrative 24,096 22,806 25,654
Research and development 14,543 12,081 13,913
Total operating expenses 38,639 34,887 39,567
Income (loss) from operations (14,803) (21,569) 12,554
Interest expense, net (1,340) (1,527) (1,071)
Equity in income of unconsolidated joint ventures 3,439 1,884 5,957
Other income, net 2,047 2,179 3,487
Income (loss) before provision for income taxes (10,657) (19,033) 20,927
Provision for income taxes 1,134 160 2,185
Net income (loss) (11,791) (19,193) 18,742
Less: Net (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests 167 1,312 (2,931)
Net income (loss) attributable to AXT, Inc. $ (11,624) $ (17,881) $ 15,811
Net income (loss) attributable to AXT, Inc. per common share:      
Basic $ (0.27) $ (0.42) $ 0.37
Diluted $ (0.27) $ (0.42) $ 0.37
Weighted-average number of common shares outstanding:      
Basic 43,154 42,643 42,104
Diluted 43,154 42,643 42,715
v3.25.0.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)      
Net income (loss) $ (11,791) $ (19,193) $ 18,742
Other comprehensive loss, net of tax:      
Change in foreign currency translation loss, net of tax (3,292) (3,818) (10,994)
Change in unrealized gain (loss) on available-for-sale debt investments, net of tax 20 283 (238)
Total other comprehensive loss, net of tax (3,272) (3,535) (11,232)
Comprehensive income (loss) attributable to AXT, Inc. (15,063) (22,728) 7,510
Less: Comprehensive (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests 781 1,965 (1,117)
Comprehensive income (loss) attributable to AXT, Inc. $ (14,282) $ (20,763) $ 6,393
v3.25.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
AXT, Inc. Stockholders' Equity
Noncontrolling Interests
Total
Balance, beginning of period at Dec. 31, 2021 $ 3,532 $ 43 $ 231,622 $ (29,970) $ 6,302 $ 211,529 $ 18,317 $ 229,846
Balance (in shares) at Dec. 31, 2021 883 42,886            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock options exercised   $ 1 517     518   518
Common stock options exercised (in shares)   172            
Investment in subsidiary with noncontrolling interest     (466)     (466) 2,699 2,233
Investment in subsidiary with redeemable noncontrolling interest     471     471   471
Restricted stock awards canceled (in shares)   (91)            
Stock-based compensation     3,273     3,273   3,273
Issuance of common stock in the form of restricted stock (in shares)   587            
Tongmei stock-based compensation     733     733   733
Noncontrolling interest portion of Tongmei stock-based compensation     100     100 (42) 58
Investment in subsidiary from noncontrolling interest             1,887 1,887
Net income (loss)       15,811   15,811 1,333 17,144
Other comprehensive loss         (9,420) (9,420) (901) (10,321)
Balance, end of period at Dec. 31, 2022 $ 3,532 $ 44 235,308 (14,159) (3,118) 221,607 23,293 244,900
Balance (in shares) at Dec. 31, 2022 883 43,554            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock options exercised     10     10   10
Common stock options exercised (in shares)   4            
Investment in subsidiary with noncontrolling interest     (153)     (153) 861 708
Investment in subsidiary with redeemable noncontrolling interest     155     155   155
Restricted stock awards canceled (in shares)   (23)            
Stock-based compensation     2,779     2,779   2,779
Issuance of common stock in the form of restricted stock (in shares)   704            
Tongmei stock-based compensation     761     761   761
Noncontrolling interest portion of Tongmei stock-based compensation     (98)     (98) 55 (43)
Net income (loss)       (17,881)   (17,881) (391) (18,272)
Other comprehensive loss         (2,881) (2,881) (324) (3,205)
Balance, end of period at Dec. 31, 2023 $ 3,532 $ 44 238,452 (32,040) (5,999) 203,989 23,494 227,483
Balance (in shares) at Dec. 31, 2023 883 44,239            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock options exercised   $ 1 27     28   28
Common stock options exercised (in shares)   12            
Restricted stock awards canceled (in shares)   (6)            
Stock-based compensation     2,647     2,647   2,647
Issuance of common stock in the form of restricted stock (in shares)   1,113            
Tongmei stock-based compensation     450     450   450
Noncontrolling interest portion of Tongmei stock-based compensation     (62)     (62) 31 (31)
Net income (loss)       (11,624)   (11,624) 342 (11,282)
Other comprehensive loss         (2,658) (2,658) (306) (2,964)
Balance, end of period at Dec. 31, 2024 $ 3,532 $ 45 $ 241,514 $ (43,664) $ (8,657) $ 192,770 $ 23,561 $ 216,331
Balance (in shares) at Dec. 31, 2024 883 45,358            
v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Net income (loss) $ (11,791) $ (19,193) $ 18,742
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:      
Depreciation and amortization 8,979 8,722 8,119
Amortization of marketable securities premium   18 58
Stock-based compensation 3,097 3,540 4,006
Provision for credit losses   272 (177)
Loss on sale of equity investment   166  
(Gain) loss on disposal of equipment 118 21 (85)
Return of equity method investments as dividends 2,396 4,316 1,608
Equity in income of unconsolidated joint ventures (3,439) (2,050) (5,957)
Deferred tax assets 265 553 104
Changes in operating assets and liabilities:      
Accounts receivable (6,896) 9,306 4,535
Inventories (737) 1,073 (31,412)
Prepaid expenses and other current assets (6,002) (652) (3,486)
Other assets 1,261 419 (471)
Accounts payable 3,038 (162) (5,519)
Accrued liabilities 1,004 (1,897) (2,127)
Other long-term liabilities (3,405) (1,049) 3,297
Net cash provided by (used in) operating activities (12,112) 3,403 (8,765)
Cash flows from investing activities:      
Purchases of property, plant and equipment (5,771) (10,475) (28,465)
Purchases of available-for-sale debt securities     (2,158)
Proceeds from sales and maturities of available-for-sale debt securities 2,160 9,582 5,400
Proceeds from sales of equity securities - 15% Jia Mei   827  
Investments in non-marketable equity investments (834) (2,538)  
Net cash used in investing activities (4,445) (2,604) (25,223)
Cash flows from financing activities:      
Proceeds from common stock options exercised 28 10 518
Proceeds from short-term bank loans 54,501 56,470 53,078
Payments on short-term bank loans (60,092) (49,210) (17,798)
Proceeds from capital increase in subsidiary shares from noncontrolling interests   708 2,233
Proceeds from long-term loan 5,831 635  
Payments on long-term loan (804)    
Net cash provided by (used in) financing activities (536) 8,613 38,031
Effect of exchange rate changes on cash, restricted cash and cash equivalents 790 (646) 542
Net increase (decrease) in cash, restricted cash and cash equivalents (16,303) 8,766 4,585
Cash, restricted cash and cash equivalents at the beginning of the year 50,114 41,348 36,763
Cash, restricted cash and cash equivalents at the end of the period 33,811 50,114 41,348
Supplemental disclosures:      
Income taxes paid, net of refunds 962 686 1,692
Interest expense paid 2,069 1,564  
Supplemental disclosure of non-cash flow information:      
Loan proceeds received by notes receivable   1,481  
Notes receivables paid to purchase fixed assets 4,572 4,170 6,835
Non-cash consideration received from sale of DongFang   585  
Conversion of related party borrowings to Additional Paid-in Capital     1,887
Investment in subsidiary shares from noncontrolling interest   308 937
Bank loan proceeds paid directly to a third-party vendor, included in accounts payable     474
Sales of land and building to unconsolidated joint venture     976
Consideration payable in connection with construction in progress, included in accrued liabilities $ 857 $ 6,574 $ 4,135
v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)
 12 Months Ended
Dec. 31, 2024
CONSOLIDATED STATEMENTS OF CASH FLOWS  
Percentage of equity interest sold 15.00%
v3.25.0.1
The Company and Summary of Significant Accounting Policies
 12 Months Ended
Dec. 31, 2024
The Company and Summary of Significant Accounting Policies  
The Company and Summary of Significant Accounting Policies

Note 1. The Company and Summary of Significant Accounting Policies

The Company

AXT, Inc. (“AXT”, “the Company”, “we,” “us,” and “our” refer to AXT, Inc. and its consolidated subsidiaries) is a worldwide materials science company that develops and produces high-performance compound and single element semiconductor substrates, also known as wafers. Our consolidated subsidiaries produce and sell certain raw materials some of which are used in our substrate manufacturing process and some of which are sold to other companies.

​

Our substrate wafers are used when a typical silicon substrate wafer cannot meet the conductive requirements of a semiconductor or optoelectronic device. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. However, certain chips may become too hot or perform their function too slowly if silicon is used as the base material. In addition, optoelectronic applications, such as LED lighting and chip-based lasers, do not use silicon substrates because they require a wave form frequency that cannot be achieved using silicon. Alternative or specialty materials are used to replace silicon as the preferred base in these situations. Our wafers provide such alternative or specialty materials. We do not design or manufacture the chips. We add value by researching, developing and producing the specialty material wafers. We have two product lines: specialty material substrates and raw materials integral to these substrates. In 2024, our substrate product group generated 68% of our revenue and raw materials product group generated 32%. Our compound substrates combine indium with phosphorous (indium phosphide: InP) or gallium with arsenic (gallium arsenide: GaAs). Our single element substrates are made from germanium (Ge).

Our raw materials include purified gallium, InP based material and pBN crucibles. We use purified gallium in producing our GaAs substrates and also sell purified gallium in the open market to other companies for use in magnetic materials, high temperature thermometers and growing single crystal ingots including gallium arsenide, gallium nitride, gallium antimonite, gallium phosphide and other materials and alloys. Pyrolytic boron nitride (pBN) crucibles are used in the high temperature (typically in the range 500 C to 1,500 C) growth process of single crystal ingots and epitaxial layer growth in MBE reactors. We use these pBN crucibles in our own ingot growth processes and also sell them in the open market to other companies.

Principles of Consolidation

The consolidated financial statements include the accounts of AXT, and our consolidated subsidiaries, Beijing Tongmei Xtal Technology Co., Ltd. (“Tongmei”), AXT-Tongmei, Inc. (“AXT-Tongmei”), Baoding Tongmei Xtal Technology Co., Ltd. (“Baoding Tongmei”), ChaoYang Tongmei Xtal Technology Co., Ltd. (“ChaoYang Tongmei”), ChaoYang LiMei Semiconductor Technology Co., Ltd. (“ChaoYang LiMei”), ChaoYang XinMei High Purity Semiconductor Materials Co., Ltd. (“ChaoYang XinMei”), Nanjing JinMei Gallium Co., Ltd. (“JinMei”), ChaoYang JinMei Gallium Ltd. (“ChaoYang JinMei”), ChaoYang ShuoMei High Purity Semiconductor Materials Co., Ltd. (“ChaoYang ShuoMei”), MaAnShan JinMei Gallium Ltd., (“MaAnShan JinMei”) and Beijing BoYu Semiconductor Vessel Craftwork Technology Co., Ltd. (“BoYu”). Baoding Tongmei is located in the city of Dingxing, China. Each of ChaoYang Tongmei and ChaoYang LiMei is located in the city of Kazuo, China. All significant inter-company accounts and transactions have been eliminated. Investments in business entities in which we do not have controlling interests, but have the ability to exercise significant influence over operating and financial policies (generally 20-50% ownership), are accounted for by the equity method. For the years ended 2024 and 2023, we have three companies accounted for by the equity method. For the majority-owned subsidiaries that we consolidate, we reflect the portion we do not own as either noncontrolling interests in stockholder’s equity or as redeemable noncontrolling interests in temporary equity on our consolidated balance sheets and in our consolidated statements of operations.

​

When market conditions are warranted, we intend to construct facilities at the ChaoYang LiMei location to provide us with additional production capacity. For the years ended 2024 and 2023, expenses associated with ChaoYang LiMei had a de minimis impact on our consolidated financial statements.

​

In February 2021, Tongmei signed a joint venture agreement with certain investors to fund a new company, ChaoYang XinMei. The agreement called for a total investment of approximately $3.0 million, of which Tongmei would fund approximately $1.8 million for a 58.5 percent ownership of ChaoYang XinMei. In February 2021, the investors completed the initial funding of approximately $1.5 million. Tongmei’s portion of the investment was approximately $0.9 million. In May 2021, the investors completed the funding of the remaining balance of approximately $1.5 million. Tongmei’s portion of the final investment was approximately $0.9 million, for a total investment of approximately $1.8 million for a 58.5 percent ownership of ChaoYang XinMei. In September 2021 and October 2021, ChaoYang XinMei received funding from a minority investor of $0.9 million and $1.0 million, respectively. In December 2021 and January 2022, ChaoYang XinMei received funding from Tongmei of $1.4 million and $1.4 million, respectively. In January 2022, the China local government certified this additional funding in ChaoYang XinMei as an equity investment. Tongmei’s ownership remained at 58.5% after these equity investments. In April 2022, Tongmei entered into a capital increase agreement (the “Capital Increase Agreement”) with minority investors to further invest $4.5 million in ChaoYang XinMei. Tongmei’s portion of the investment was approximately $2.6 million, of which $1.1 million was invested in April 2022 and $0.8 million was invested in May 2022. The minority investors’ portion of the investment was approximately $1.9 million, of which $0.7 million was invested in April 2022 and $0.6 million was invested in May 2022. As a result, noncontrolling interests increased $1.4 million and redeemable noncontrolling interests increased $0.1 million. Tongmei’s ownership remained at 58.5% after the April 2022 and May 2022 equity investments. In July 2022, Tongmei and the minority investors further invested $0.8 million and $0.6 million in ChaoYang XinMei, respectively. This completed the investment obligations under the Capital Increase Agreement. As a result, noncontrolling interests increased $610,000 and redeemable noncontrolling interests increased $57,000. Tongmei’s ownership remained at 58.5% after the July 2022 equity investment.

​

In April 2022, ChaoYang JinMei signed a joint venture agreement with a certain investor to fund a new company, ChaoYang ShuoMei, our consolidated subsidiary. The agreement calls for a total investment of approximately $4.4 million, of which ChaoYang JinMei will fund approximately $3.3 million for a 75 percent ownership of ChaoYang ShuoMei. In July and August 2022, ChaoYang JinMei completed the initial funding of $1.0 million in ChaoYang ShuoMei. In August 2022, the investor invested $334,000 in ChaoYang ShuoMei. As a result, noncontrolling interests increased $406,000 and redeemable noncontrolling interests increased $73,000. In January 2023, ChaoYang ShuoMei received $0.5 million in funding from ChaoYang JinMei and $0.2 million in funding from one of the minority investors. As a result, noncontrolling interests increased $0.2 million and redeemable noncontrolling interests increased $36,000. In May 2023, ChaoYang ShuoMei received $1.0 million in funding from ChaoYang JinMei and $0.3 million in funding from one of the minority investors. As a result, noncontrolling interests increased $0.4 million and redeemable noncontrolling interests increased $75,000. In August 2023, ChaoYang ShuoMei received $0.6 million in funding from ChaoYang JinMei and $0.2 million in funding from one of the minority investors. As a result, noncontrolling interests increased $0.2 million and redeemable noncontrolling interests increased $44,000. ChaoYang JinMei has completed its investment obligations under the ChaoYang ShuoMei Joint Venture Agreement. ChaoYang JinMei’s ownership of ChaoYang ShuoMei remained at 75% after these equity investments.

​

In April 2022, Tongmei signed a joint venture agreement with certain investors to fund a new company, ChaoYang KaiMei. The agreement called for a total investment of approximately $7.6 million, of which Tongmei would fund approximately $3.0 million for a 40.0 percent ownership of ChaoYang KaiMei. In July 2022, the investors completed the initial funding of approximately $2.2 million. Tongmei’s portion of the investment was approximately $0.9 million. In January 2023, Tongmei made an investment of $0.9 million to ChaoYang KaiMei. In each of July 2023 and August 2023, Tongmei made an investment of approximately $0.6 million in ChaoYang KaiMei. These contributions culminated in the fulfillment of all of Tongmei’s financial obligations under the April 2022 ChaoYang KaiMei Joint Venture Agreement. In September 2023, Tongmei entered into another joint venture agreement with the same group of investors. This new agreement called for additional investment of approximately $5.6 million, with Tongmei committing to fund approximately $2.3 million. In December 2023, Tongmei made its initial additional investment of approximately $0.6 million in ChaoYang KaiMei, followed by additional investments of approximately $0.3 million each in June, July and November 2024. Tongmei’s ownership of ChaoYang KaiMei remained at 40% after these equity investments.

​

All activities for MaAnShan JinMei ceased during the first half of 2022 and the subsidiary was subsequently dissolved in May 2022. The dissolution of MaAnShan JinMei had a de minimis impact on the consolidated results.

​

During the quarter ended December 31, 2020, Tongmei entered into two sets of definitive transaction documents, each consisting of a capital increase agreement along with certain supplemental agreements in substantially the same form (collectively, the “Capital Increase Agreements”), with several private equity investors in China.

​

In preparation for Tongmei’s application for a listing of shares in an initial public offering (the “IPO”) on the Shanghai Stock Exchange’s Sci-Tech innovAtion boaRd (the “STAR Market”), in late December 2020, we reorganized our entity structures in China. JinMei and BoYu and its subsidiaries were assigned to Tongmei and effectively merged with Tongmei although they retained their own respective legal entity status and are wholly owned subsidiaries of Tongmei. The 33% minority interest stakeholders of BoYu converted their ownership to a 7.59% minority interest in Tongmei. The 8.5% minority interest stakeholders, employees of JinMei, converted their ownership to a 0.38% minority interest in Tongmei. Further, a number of employees, key managers and contributors purchased a 0.4% minority interest in Tongmei. Additionally, Baoding Tongmei and ChaoYang Tongmei, were assigned to Tongmei as wholly owned subsidiaries. In 2020, the private equity funds (the “Investors”) had transferred approximately $48.1 million of new capital to Tongmei. An additional investment of approximately $1.5 million of new capital was funded in January 2021. Under China regulations these investments must be formally approved by the appropriate government agency and are not deemed to be dilutive until such approval is granted. The government approved the approximately $49 million investment in its entirety on January 25, 2021, at which time the Investors owned a redeemable noncontrolling interest in Tongmei of 7.28%. As of September 30, 2022, Tongmei’s noncontrolling interests and redeemable noncontrolling interests totaled approximately 14.5%. AXT remains the controlling stakeholder of Tongmei and holds a majority of the board of director positions of Tongmei. In June 2021, AXT sold AXT-Tongmei to Tongmei for $1. Since Tongmei is 85.5% owned by AXT, and the transaction was between common interest holders, the transaction was accounted for at net book value and resulted in an increase of $1.2 million to noncontrolling interests and $1.2 million to redeemable noncontrolling interests.

​

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates, judgments and assumptions. We believe that the estimates, judgments, and assumptions upon which management relies are reasonable based on information available at the time that these estimates, judgments, and assumptions are made. These estimates, judgments, and assumptions can affect the reported amounts of assets and liabilities as of the date of the consolidated financial statements as well as the reported amounts of revenues and expenses during the periods presented. To the extent there are material differences between these estimates and actual results, our consolidated financial statements would be affected.

Fair Value of Financial Instruments

The carrying amounts of certain of our financial instruments including cash and cash equivalents, restricted cash, short-term investments and long-term investments, accounts receivable, accounts payable, accrued liabilities and bank loans approximate fair value due to their short maturities. Certain cash equivalents and investments are required to be adjusted to fair value on a recurring basis. See Note 2.

Fair Value of Investments

ASC Topic 820, Fair value measurement (“ASC 820”) establishes three levels of inputs that may be used to measure fair value.

Level 1 instruments represent quoted prices in active markets. Therefore, determining fair value for Level 1 instruments does not require significant management judgment, and the estimation is not difficult.

Level 2 instruments include observable inputs other than Level 1 prices, such as quoted prices for similar instruments in markets with insufficient volume or infrequent transactions (less active markets), issuer bank statements, credit ratings, non-binding market consensus prices that can be corroborated with observable market data, model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated with observable market data for substantially the full term of the assets or liabilities, or quoted prices for similar assets or liabilities. These Level 2 instruments require more management judgment and subjectivity compared to Level 1 instruments, including:

●Determining which instruments are most comparable to the instrument being priced requires management to identify a sample of similar securities based on the coupon rates, maturity, issuer, credit rating, and instrument type, and subjectively select an individual security or multiple securities that are deemed most similar to the security being priced.
●Determining which model-derived valuations to use in determining fair value requires management judgment. When observable market prices for similar securities or comparable securities are not available, we price our marketable debt instruments using non-binding market consensus prices that are corroborated with observable market data or pricing models, such as discounted cash flow models, with all significant inputs derived from or corroborated with observable market data.

Level 3 instruments include unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities. The determination of fair value for Level 3 instruments requires the most management judgment and subjectivity.

We place short-term foreign currency hedges that are intended to offset the potential cash exposure related to fluctuations in the exchange rate between the United States dollar and Japanese yen. We measure the fair value of these foreign currency hedges at each month end and quarter end using current exchange rates and in accordance with generally accepted accounting principles. At quarter end any foreign currency hedges not settled are netted in “Accrued liabilities” on the consolidated balance sheets and classified as Level 3 assets and liabilities. As of December 31, 2024 and 2023, the net change in fair value from the placement of the hedge to settlement had a de minimis impact to the consolidated results.

Foreign Currency Translation

The functional currency of our Chinese subsidiaries is the renminbi, the local currency of China. Transaction gains and losses resulting from transactions denominated in currencies other than the U.S. dollar or in the functional currencies of our subsidiaries are included in “Other income, net” for the years presented. The transaction gain totaled $0.1 million, $0.2 million and $1.6 million for the years ended December 31, 2024, 2023 and 2022, respectively. The assets and liabilities of the subsidiaries are translated at the rates of exchange on the balance sheet date. Revenue and expense items are translated at the average rate of exchange for the period. Gains and losses from foreign currency translation are included in “Other comprehensive income (loss)”, net of tax in the consolidated statements of comprehensive income (loss).

Revenue Recognition

We manufacture and sell high-performance compound semiconductor substrates including indium phosphide, gallium arsenide and germanium wafers, and our consolidated subsidiaries sell certain raw materials, including high purity gallium (6N and 7N Ga), pyrolytic boron nitride (pBN) crucibles and boron oxide (B2O3). After we ship our products, there are no remaining obligations or customer acceptance requirements that would preclude revenue recognition. Our products are typically sold pursuant to purchase orders placed by our customers, and our terms and conditions of sale do not require customer acceptance. We account for a contract with a customer when there is a legally enforceable contract, which could be the customer’s purchase order, the rights of the parties are identified, the contract has commercial terms, and collectibility of the contract consideration is probable. The majority of our contracts have a single performance obligation to transfer products and are short term in nature, usually less than six months. Our revenue is measured based on the consideration specified in the contract with each customer in exchange for transferring products that are generally based upon a negotiated formula, list or fixed price. Revenue is recognized when control of the promised goods is transferred to our customer, which is either upon shipment from our dock, receipt at the customer’s dock, or removal from consignment inventory at the customer’s location, in an amount that reflects the consideration we expect to be entitled to receive in exchange for those goods.

​

We have elected to account for shipping and handling as activities to fulfill the promise to transfer the goods. Shipping and handling fees billed to customers in a sales transaction are recorded as an offset to shipping and handling expenses. Sales taxes and value added taxes in foreign jurisdictions that are collected from customers and remitted to governmental authorities are accounted for on a net basis and, therefore, are excluded from revenue.

​

We do not provide training, installation or commissioning services. We provide for future returns based on historical data, prior experience, current economic trends and changes in customer demand at the time revenue is recognized. We do not recognize any asset associated with the incremental cost of obtaining revenue generating customer contracts. As such, sales commissions are expensed as incurred, given that the expected period of benefit is less than one year.

 

Contract Balances

 

We receive payments from customers based on a billing schedule as established in our contracts. Contract assets are recorded when we have a conditional right to consideration for our completed performance under the contracts. Accounts receivables are recorded when the right to this consideration becomes unconditional. We do not have any material contract assets as of December 31, 2024, or 2023.

​

​

​

​

​

​

​

​

​

​

​

December 31, 

​

December 31,

​

​

​

2024

​

2023

​

Contract liabilities

​

$

1,590

​

$

305

​

During the three and twelve months ended December 31, 2024, the Company recognized $0 and $156,000, respectively, of revenue that was included in the contract balances as of December 31, 2023. During the three and twelve months ended December 31, 2023, the Company recognized $9,000 and $278,000, respectively, of revenue that was included in the contract balances as of December 31, 2022.

​

​

​

​

​

​

​

​

Disaggregated Revenue

 

In general, revenue disaggregated by product types and geography (See Note 14) is aligned according to the nature and economic characteristics of our business and provides meaningful disaggregation of our results of operations. Since we operate in one segment, all financial segment and product line information can be found in the consolidated financial statements.

 

Practical Expedients and Exemptions

 

We elected to use the following practical expedients: (i) not to adjust the promised amount of consideration for the effects of a significant financing component when we expect, at contract inception, that the period between our transfer of a promised product or service to a customer and when the customer pays for that product or service will be one year or less; (ii) to expense costs as incurred for costs to obtain a contract when the amortization period would have been one year or less; (iii) not to assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer.

 

In addition, we do not disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less.

​

Accounting for Sales and Use Taxes

We record sales taxes collected on sales of our products and for amounts not yet remitted to tax authorities as accrued liabilities on our consolidated balance sheets.

Risks and Concentration of Credit Risk

Our business is very dependent on the semiconductor, lasers and optical industries which can be highly cyclical and experience downturns as a result of economic changes, overcapacity, and technological advancements. Significant technological changes in the industry or customer requirements, or the emergence of competitive products with new capabilities or technologies, could adversely affect our operating results. In addition, a significant portion of our revenues and net income is derived from international sales. Fluctuations of the United States dollar against foreign currencies and changes in local regulatory or economic conditions, particularly in an emerging market such as China, could adversely affect operating results.

We depend on a limited number of suppliers for certain raw materials, components and equipment used in manufacturing our products, including quartz tubing and polishing solutions. We generally purchase these materials through standard purchase orders and not pursuant to long-term supply contracts.

Financial instruments that potentially subject us to concentration of credit risk consist primarily of cash, restricted cash, cash equivalents, investments, and accounts receivable. We invest primarily in money market accounts, certificates of deposit and corporate bonds. The composition and maturities are regularly monitored by management. Such deposits are in excess of the amount of the insurance provided by the federal government on such deposits. We are exposed to credit risks in the event of default by the issuers to the extent of the amount recorded on the consolidated balance sheets.

​

We perform ongoing credit evaluations of our customers’ financial condition, and limit the amount of credit extended when deemed necessary, but generally do not require collateral. The credit risk in our accounts receivable is mitigated by our credit evaluation process and the geographical dispersion of sales transactions. One customer accounted for more than 10% of our accounts receivable as of December 31, 2024 and no customer accounted for more than 10% of our accounts receivable as of December 31, 2023.

No customer represented 10% of our revenue for the year ended December 31, 2024 and 2023. One customer represented 15% of our revenue for the year ended December 31, 2022. Our top five customers, although not the same five customers for each period, represented 30% of our revenue for the year 2024, 25% of our revenue for the year 2023, and 34% of our revenue for the year 2022.

For the years ended December 31, 2024 and 2023, two third-party customers for the raw materials products from our consolidated subsidiaries accounted for over 10% of the revenue from raw materials sales. For the year ended December 31, 2022, one third-party customer for the raw materials products from our consolidated subsidiaries accounted for over 10% of the revenue from raw materials sales. Our subsidiaries and raw material joint ventures are a key strategic benefit for us as they further diversify our sources of revenue.

Cash and Cash Equivalents

We consider investments in highly liquid instruments purchased with an original maturity of three months or less to be cash equivalents. Cash equivalents consist primarily of certificate of deposits. Cash and cash equivalents are stated at cost, which approximates fair value.

Restricted Cash

​

We maintain restricted cash in connection with cash balances temporarily restricted for regular business operations. These balances have been excluded from the Company’s cash and cash equivalents balance. As of December 31, 2024, $11.0 million was included in restricted cash in our consolidated balance sheets.

Short-Term and Long-Term Investments

We classify our investments in marketable securities as available-for-sale debt securities. Short-term and long-term investments are comprised of available-for-sale marketable securities, which consist primarily of certificates of deposit and corporate bonds. These investments are reported at fair value as of the respective balance sheet dates with unrealized gains and losses included in accumulated other comprehensive income (loss) within stockholders’ equity on the consolidated balance sheets. The amortized cost of securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization is included in “Other income, net” in the consolidated statements of operations. Realized gains and losses and declines in value judged to be other than temporary on available-for-sale securities are also included in “Other income, net” in the consolidated statements of operations. The cost of securities sold is based upon the specific identification method.

Accounts Receivable and Allowance for Credit Losses and Sales Returns

Accounts receivable are recorded at the invoiced amount and are not interest bearing. We review at least quarterly, or when there are changes in credit risks, the likelihood of collection on our accounts receivable balances and provide an allowance for credit losses. We measure the expected credit losses on a collective (pool) basis when similar delinquency status exist. We evaluate receivables from U.S. customers with an emphasis on balances in excess of 90

days and for receivables from customers located outside the U.S. with an emphasis on balances in excess of 120 days and establish a reserve allowance on the receivable balances if needed. The reason for the difference in the evaluation of receivables between foreign and U.S. customers is that U.S. customers have historically made payments in a shorter period of time than foreign customers. Foreign business practices generally require us to allow customer payment terms that are longer than those accepted in the United States.

In accordance with ASC Topic 326, Financial Instruments – Credit Losses current expected credit loss impairment model, we exercise judgment when determining the adequacy of these reserves as we evaluate historical bad debt trends, general economic conditions in the United States and internationally, and reasonable and supportable forecasts of future economic conditions. Uncollectible receivables are recorded as provision for credit losses when a credit loss is expected through the establishment of an allowance, which would then be written off when all efforts to collect have been exhausted and recoveries are recognized when they are received. As of December 31, 2024 and 2023, our accounts receivable, net balance was $25.6 million and $19.3 million, respectively, which was net of an allowance of $147,000 and $579,000, respectively. During 2024, we decreased the allowance by $432,000. During 2023, we increased the allowance by $272,000. If actual uncollectible accounts differ substantially from our estimates, revisions to the estimated allowance for credit losses would be required, which could have a material impact on our financial results for the future periods.

As of December 31, 2024 and 2023, the sales returns reserve (included in accrued liabilities) balance was $28,000 and $39,000, respectively. During 2024, we utilized $28,000 and reserved an additional $17,000 and during 2023, we utilized $39,000 and reduced an additional $34,000.

​

Warranty Reserve

We maintain a warranty reserve based upon our claims experience during the prior twelve months and any pending claims and returns of which we are aware. Warranty costs are accrued at the time revenue is recognized. As of December 31, 2024 and 2023, accrued product warranties totaled $451,000 and $703,000, respectively. The increase in accrued product warranties is primarily attributable to increased claims for quality issues experienced by some of our customers. If actual warranty costs or pending new claims differ substantially from our estimates, revisions to the estimated warranty liability would be required, which could have a material impact on our financial condition and results of operations for future periods.

Inventories

Inventories are stated at the lower of cost (approximated by standard cost) or net realizable value. Cost is determined using the weighted average cost method. Our inventory consists of raw materials as well as finished goods and work-in-process that include material, labor and manufacturing overhead costs. We routinely evaluate the levels of our inventory in light of current market conditions in order to identify excess and obsolete inventory, and we provide a reserve for certain inventories to their estimated net realizable value based upon the age and quality of the product and the projections for sale of the completed products. When a reserve is recorded, a new lower cost basis for that inventory is established and subsequent changes in facts and circumstances do not result in the restoration or increase in the new cost basis.

Property, Plant and Equipment

Property, plant and equipment are stated at cost less accumulated depreciation computed using the straight-line method over the estimated economic lives of the assets, which vary from 1 to 39.5 years. Leasehold improvements are amortized using the straight-line method over the shorter of the estimated useful life or the term of the lease. We generally depreciate computer, software, office equipment, furniture and fixtures over 3 to 5 years, machinery and equipment over 1 to 20 years, automobiles over 5 to 10 years, leasehold and building improvements over 10 years, or the lease term if shorter, and buildings over 39.5 years. Repairs and maintenance costs are expensed as incurred.

Impairment of Long-Lived Assets

We evaluate property, plant and equipment and intangible assets for impairment. When events and circumstances indicate that long-lived assets may be impaired, we compare the carrying value of the long-lived assets to the projection of future undiscounted cash flows attributable to these assets. In the event that the carrying value exceeds the future undiscounted cash flows, we record an impairment charge against income equal to the excess of the carrying value over the assets’ fair value. Fair values are determined based on quoted market values, discounted cash flows or internal and external appraisals, as applicable. We did not recognize any impairment charges of long-lived assets in 2024, 2023 and 2022.

Impairment of Investments

All available-for-sale debt securities are periodically reviewed for impairment. An investment is considered to be impaired when its fair value is less than its amortized cost basis and it is more likely than not that we will be required to sell the impaired security before recovery of its amortized cost basis. Factors considered in determining whether a loss is temporary include the magnitude of the decline in market value, the length of time the market value has been below cost (or adjusted cost), credit quality, and our ability and intent to hold the securities for a period of time sufficient to allow for any anticipated recovery in market value.

We also invest in equity instruments of privately held companies in China for business and strategic purposes. Investments in our unconsolidated joint venture companies are classified as other assets and accounted for under either the equity or fair value method, depending on whether we have the ability to exercise significant influence over their operations or financial decisions. We monitor our investments for impairment and record reductions in carrying value when events or changes in circumstances indicate that the carrying value may not be recoverable. Determination of impairment is highly subjective and is based on a number of factors, including an assessment of the strength of each company’s management, the length of time and extent to which the fair value has been less than our cost basis, the financial condition and near-term prospects of the subsidiary, fundamental changes to the business prospects of the Company, share prices of subsequent offerings, and our intent and ability to hold the investment for a period of time sufficient to allow for any anticipated recovery in our carrying value. We estimate fair value of our fair value method investments considering available information such as pricing in recent rounds of financing, current cash positions, earnings (loss) and cash flow forecasts, recent operational performance, and any other readily available market data.

For the year ended December 31, 2023, one of our PRC joint ventures assessed one of its equity investments was fully impaired. For the year ended December 31, 2023, we divested our equity investment in a PRC joint venture. The impairment and divestiture resulted in a total of $1.9 million in impairment charges in our consolidated financial results. There were no impairment charges during the year ended December 31, 2022 and 2024.

Segment Reporting

We operate in one segment for the design, development, manufacture and distribution of high-performance compound and single element semiconductor substrates and sale of raw materials integral to these substrates. Our chief operating decision-maker (“CODM”) has been identified as our Chief Executive Officer, who reviews operating results to make decisions about allocating resources and assessing our performance for the Company. We discuss revenue and capacity for both AXT and our joint ventures collectively, when determining capacity constraints and need for raw materials in our business, and consider their capacity when determining our strategic and product marketing and advertising strategies. While we consolidate our majority-owned or significantly controlled joint ventures, we do not allocate any portion of overhead, interest and other income, interest expense or taxes to them. We therefore have determined that our joint venture operations do not constitute an operating segment. Since we operate in one segment, all financial segment and product line information can be found in the consolidated financial statements. The CODM regularly evaluates consolidated net income (loss) and functional expenses, including cost of revenue, selling, general and administrative and research and development, to manage Company operations.

Stock-Based Compensation

We have employee stock option plans, which are described more fully in Note 10-“Employee Benefit Plans and Stock-based Compensation”. We account for stock-based compensation in accordance with the provisions of ASC Topic 718, Compensation-Stock Compensation (“ASC 718”). We utilize the Black-Scholes option pricing model to estimate the grant date fair value of stock options, which requires the input of highly subjective assumptions, including estimating stock price volatility and expected term. Stock-based compensation cost is measured at each grant date, based on the fair value of the award, and is recognized as expense and as an increase in additional paid-in capital over the requisite service period of the award.

Research and Development

Research and development costs consist primarily of salaries, including stock-based compensation expense and related personnel costs, depreciation, materials and product testing which are expensed as incurred. Tangible assets acquired for research and development purposes are capitalized if they have alternative future use.

​

Advertising Costs

Advertising costs, included in selling, general and administrative expenses, are expensed as incurred. Advertising costs for the years ended December 31, 2024, 2023 and 2022 were insignificant.

Income Taxes

We account for income taxes in accordance with ASC Topic 740, Income Taxes (“ASC 740”), which requires that deferred tax assets and liabilities be recognized using enacted tax rates for the effect of temporary differences between the book and tax bases of recorded assets and liabilities. ASC 740 also requires that deferred tax assets be reduced by a valuation allowance if it is more likely than not that a portion of the deferred tax asset will not be realized. The impact of ASC 740 is more fully described in Note 12.

Comprehensive Income (loss)

The components of other comprehensive income (loss) include unrealized gains and losses on marketable securities and foreign currency translation adjustments. Comprehensive income (loss) is presented in the consolidated statements of comprehensive income (loss). The balance of accumulated other comprehensive income (loss) is as follows (in thousands):

​

​

​

​

​

​

​

​

​

​

As of December 31, 

​

    

2024

​

2023

Accumulated other comprehensive loss:

​

​

​

​

​

​

Unrealized loss on investments, net

​

$

—

​

$

(20)

Cumulative translation adjustment

​

 

(9,514)

​

​

(6,530)

​

​

 

(9,514)

​

​

(6,550)

Less: Cumulative translation adjustment attributable to noncontrolling interests and redeemable noncontrolling interests

​

​

(857)

​

​

(551)

Accumulated other comprehensive loss attributable to AXT, Inc.

​

$

(8,657)

​

$

(5,999)

​

Net Income (Loss) Per Share

Basic net income (loss) per share is computed using the weighted-average number of common shares outstanding during the periods less shares of common stock subject to repurchase and non-vested stock awards. Diluted net income (loss) per share is computed using the weighted-average number of common shares outstanding and potentially dilutive common shares outstanding during the periods. The dilutive effect of outstanding stock options and restricted stock awards is reflected in diluted earnings per share by application of the treasury stock method. Potentially dilutive common shares consist of common shares issuable upon the exercise of stock options and vesting of restricted

stock awards. Potentially dilutive common shares are excluded from the computation of weighted-average number of common shares outstanding in net loss years, as their effect would be anti-dilutive to the computation.

Recent Accounting Pronouncements

In November 2023, the Financial Accounting Standards Board (“FASB”) released ASU 2023-07— Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, aiming to enhance the transparency and relevance of segment information provided in financial statements. The amendments in this Update require that a public entity disclose significant segment expenses, profit or loss and assets, etc. for each reportable segment, on an annual and interim basis. The Update is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Adoption of the new standard had an immaterial effect on our consolidated financial statements.

In December 2023, FASB issued ASU 2023-09— Income Taxes (Topic 740): Improvements to Income Tax Disclosures, to help investors better understand an entity’s exposure to potential changes in jurisdictional tax legislation and the ensuing risks and opportunities. Furthermore, the Update improves to assess income tax information that affects cash flow forecasts and capital allocation decisions. The Update is effective for public business entities for annual periods beginning after December 15, 2024, on a prospective basis. Adoption of the new standard will have an immaterial effect on our consolidated financial statements.

In March 2024, FASB released ASU 2024-01— Compensation—Stock Compensation (Topic 718). The update adds an illustrative example aimed at clarifying the scope application of a profit interest award in accordance with Topic 718. The update is effective for annual periods beginning after December 15, 2024, and interim periods within those annual periods. Adoption of the new standard will have an immaterial effect on our consolidated financial statements.

In November 2024, FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40), which requires public business entities to disclose additional information on specific expense categories in the notes to the financial statements. The Update is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Adoption is expected to have an immaterial effect on our consolidated financial statements.
v3.25.0.1
Cash, Restricted Cash, Cash Equivalents and Investments
 12 Months Ended
Dec. 31, 2024
Cash, Restricted Cash, Cash Equivalents and Investments  
Cash, Restricted Cash, Cash Equivalents and Investments

​

​

Note 2. Cash, Restricted Cash, Cash Equivalents and Investments

Our cash, restricted cash and cash equivalents consist of cash and instruments with original maturities of less than three months. Our investments consist of instruments with original maturities of more than three months. As of December 31, 2024 and 2023, our cash, restricted cash, cash equivalents and debt investments are classified as follows (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

December 31, 2024

​

December 31, 2023

 

​

    

​

​

    

Gross

    

Gross

    

​

​

    

​

​

    

Gross

    

Gross

    

​

​

 

​

​

Amortized

​

Unrealized

​

Unrealized

​

Fair

​

Amortized

​

Unrealized

​

Unrealized

​

Fair

 

​

    

Cost

    

Gain

    

(Loss)

    

Value

    

Cost

    

Gain

    

(Loss)

    

Value

 

Classified as:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Cash, restricted cash and cash equivalents

​

$

33,811

​

$

—

​

$

—

​

$

33,811

​

$

50,114

​

$

—

​

$

—

​

$

50,114

​

Investments (available-for-sale):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Certificates of deposit 1

​

 

—

​

 

—

​

​

—

​

 

—

​

 

2,160

​

 

—

​

​

(20)

​

 

2,140

​

Total cash, restricted cash, cash equivalents and investments

​

$

33,811

​

$

—

​

$

—

​

$

33,811

​

$

52,274

​

$

—

​

$

(20)

​

$

52,254

​

Contractual maturities on investments:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Due within 1 year 2

​

$

—

​

​

​

​

​

​

​

$

—

​

$

2,160

​

​

​

​

​

​

​

$

2,140

​

​

​

$

—

​

​

​

​

​

​

​

$

—

​

$

2,160

​

​

​

​

​

​

​

$

2,140

​

1.Certificate of deposit with original maturities of less than three months.
2.Certificate of deposit with original maturities of more than three months.
3.Classified as “Short-term investments” in our consolidated balance sheets.
4.Classified as “Long-term investments” in our consolidated balance sheets.

​

We manage our debt investments as a single portfolio of highly marketable securities that is intended to be available to meet our current cash requirements. Certificates of deposit and corporate bonds are typically held until maturity.

Historically, the gross unrealized losses related to our portfolio of available-for-sale debt securities were immaterial, and primarily due to normal market fluctuations and not due to increased credit risk or other valuation concerns. Gross unrealized losses on our available-for-sale debt securities as of December 31, 2023 was $20,000, and historically, such gross unrealized losses have been temporary in nature and we believe that it is probable the principal and interest will be collected in accordance with the contractual terms. We review our debt investment portfolio at least quarterly, or when there are changes in credit risks or other potential valuation concerns, to identify and evaluate whether an allowance for credit losses or impairment would be necessary. Factors considered in determining whether a loss is temporary include the magnitude of the decline in market value, the length of time the market value has been below cost (or adjusted cost), credit quality, and our ability and intent to hold the securities for a period of time sufficient to allow for any anticipated recovery in market value.

The following table summarizes the fair value and gross unrealized losses related to available-for-sale debt securities, aggregated by investment category and length of time that individual debt securities have been in a continuous unrealized loss position as of December 31, 2023 (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

In Loss Position

​

In Loss Position

​

Total In

 

​

​

< 12 months

​

> 12 months

​

Loss Position

 

​

    

    

​

    

Gross

    

    

​

    

Gross

    

    

​

    

Gross

 

​

​

Fair

​

Unrealized

​

Fair

​

Unrealized

​

Fair

​

Unrealized

 

As of December 31, 2023

​

Value

​

(Loss)

​

Value

​

(Loss)

​

Value

​

(Loss)

 

Investments:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Certificates of deposit

​

$

—

​

$

—

​

$

2,140

​

$

(20)

​

$

2,140

​

$

(20)

​

Total in loss position

​

$

—

​

$

—

​

$

2,140

​

$

(20)

​

$

2,140

​

$

(20)

​

​

Investments in Privately Held Raw Material Companies

We have made strategic investments in private companies located in China in order to gain access at a competitive cost to raw materials that are critical to our substrate business (see Note 6). The investment balances for the non-consolidated companies, are accounted for under the equity method and included in “Other assets” in the consolidated balance sheets and totaled $14.1 million and $12.5 million as of December 31, 2024 and 2023, respectively. As of December 31, 2024 and 2023, there were three companies accounted for under the equity method, respectively.

Fair Value Measurements

We invest primarily in money market accounts, certificates of deposit, corporate bonds and notes, and government securities. ASC Topic 820, Fair Value Measurements and Disclosures (“ASC 820”), establishes three levels of inputs that may be used to measure fair value. Level 1 instrument valuations are obtained from real-time quotes for transactions in active exchange markets of the asset or identical assets. Level 2 instrument valuations are obtained from readily available, observable pricing sources for comparable instruments. Level 3 instrument valuations are obtained from unobservable inputs in which there is little or no market data, which require us to develop our own assumptions. On a recurring basis, we measure certain financial assets and liabilities at fair value, primarily consisting of our short-term and long-term debt investments.

The type of instrument valued based on quoted market prices in active markets include our money market funds, which are generally classified within Level 1 of the fair value hierarchy. We classify our available-for-sale debt securities including certificates of deposit and corporate bonds as having Level 2 inputs. The valuation techniques used to measure the fair value of these financial instruments having Level 2 inputs were derived from bank statements, quoted market prices, broker or dealer statements or quotations, or alternative pricing sources with reasonable levels of price transparency. There were no changes in valuation techniques or related inputs in the year ended December 31, 2024. There have been no transfers between fair value measurement levels during the years ended December 31, 2024 and 2023.

We place short-term foreign currency hedges that are intended to offset the potential cash exposure related to fluctuations in the exchange rate between the United States dollar and Japanese yen. We measure the fair value of these foreign currency hedges at each month end and quarter end using current exchange rates and in accordance with generally accepted accounting principles. At quarter end any foreign currency hedges not settled are netted in “Accrued liabilities” on the consolidated balance sheets and classified as Level 3 assets and liabilities. As of December 31, 2024, the net change in fair value from the placement of the hedge to settlement at each month end during the quarter had a de minimis impact to the consolidated results.

The following table summarizes our financial assets and liabilities measured at fair value on a recurring basis in accordance with ASC 820 as of December 31, 2023 (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

​

    

Quoted Prices in

    

​

​

​

Significant

 

​

​

​

​

​

Active Markets of

​

Significant Other

​

Unobservable

 

​

​

Balance as of

​

Identical Assets

​

Observable Inputs

​

Inputs

 

​

    

December 31, 2023

    

(Level 1)

    

(Level 2)

    

(Level 3)

 

Assets:

​

​

​

​

​

​

​

​

​

​

​

​

​

Investments:

​

​

​

​

​

​

​

​

​

​

​

​

​

Certificates of deposit

​

$

2,140

​

$

—

​

$

2,140

​

$

—

​

Total

​

$

2,140

​

$

—

​

$

2,140

​

$

—

​

​

Items Measured at Fair Value on a Nonrecurring Basis

Certain assets that are subject to nonrecurring fair value measurements are not included in the table above. These assets include investments in privately held companies accounted for by equity and fair value method (See Note 6). For the year ended December 31, 2023, one of our PRC joint ventures assessed one of its equity investments was fully impaired. For the year ended December 31, 2023, we divested our equity investment in a PRC joint venture. The impairment and divestiture resulted in a total of $1.9 million in impairment charges in our financial results. We had no impairment charges for 2024 and 2022.

v3.25.0.1
Inventories
 12 Months Ended
Dec. 31, 2024
Inventories  
Inventories

Note 3. Inventories

The components of inventory are summarized below (in thousands):

​

​

​

​

​

​

​

​

​

​

December 31, 

​

December 31, 

​

​

    

2024

    

2023

 

Inventories:

​

​

​

​

​

​

​

Raw materials

​

$

31,743

​

$

32,910

​

Work in process

​

 

50,779

​

 

50,008

​

Finished goods

​

 

2,555

​

 

3,585

​

​

​

$

85,077

​

$

86,503

​

​

As of December 31, 2024 and 2023, carrying values of inventories were net of inventory reserves of $24.1 million and $21.9 million, respectively, for excess and obsolete inventory and $73,000 and $78,000, respectively, for lower of cost or net realizable value reserves.
v3.25.0.1
Related Party Transactions
 12 Months Ended
Dec. 31, 2024
Related Party Transactions  
Related Party Transactions

Note 4. Related Party Transactions

ChaoYang Tongmei purchases raw materials from one of PRC joint ventures, Donghai County Dongfang High Purity Electronic Materials Co., Ltd. (“Dongfang”) for production in the ordinary course of business. In November 2023, the Company completed the sale of Dongfang to a third party. As of December 31, 2024 and 2023, amounts payable of $0 and $0, respectively, were included in “Accounts payable” in our consolidated balance sheets.

In September 2021 and October 2021, our consolidated subsidiary, ChaoYang XinMei received funding from a minority investor of $0.9 million and $1.0 million, respectively. As of December 31, 2021, $1.9 million was included in short-term loan from noncontrolling interest in our consolidated balance sheets. In December 2021 and January 2022, the same subsidiary received funding from Tongmei of $1.4 million and $1.4 million, respectively. In January 2022, the China local government certified this additional funding in ChaoYang XinMei as an equity investment. As a result, noncontrolling interests increased $2.2 million and redeemable noncontrolling interests increased $0.2 million. Short-term loan from noncontrolling interest decreased to $0. In April 2022, Tongmei entered into the Capital Increase Agreement with minority investors to further invest approximately $4.5 million in ChaoYang XinMei. In April 2022 and May 2022, ChaoYang XinMei received funding from Tongmei of $1.1 million and $0.8 million, respectively, as equity investments. In April 2022 and May 2022, the minority investors invested $0.7 million and $0.6 million, respectively. As a result, noncontrolling interests increased $1.4 million and redeemable noncontrolling interests increased $0.1 million.

Tongmei’s ownership remained at 58.5% after these equity investments. In July 2022, Tongmei and the minority investors further invested $0.8 million and $0.6 million in ChaoYang XinMei, respectively. This completed the investment obligations under the Capital Increase Agreement. As a result, noncontrolling interests increased $610,000 and redeemable noncontrolling interests increased $57,000. Tongmei’s ownership remained at 58.5% after the July 2022 equity investment.

​

In September 2022, our consolidated subsidiary, ChaoYang LiMei completed the sale of land and its attached buildings to our equity investment entity, ChaoYang KaiMei, for a total consideration of $1.5 million. In January 2023, ChaoYang KaiMei paid to ChaoYang LiMei $1.5 million. As of December 31, 2024, $0 million was included in “Prepaid expenses and other current assets” in our consolidated balance sheets.

​

Our Related Party Transactions Policy seeks to prohibit all conflicts of interest in transactions between related parties and us, unless they have been approved by our Board of Directors. This policy applies to all of our employees, directors, and our consolidated subsidiaries. Our executive officers retain board seats on the Board of Directors of the companies in which we have invested in our PRC joint ventures. See Note 6 for further details.
v3.25.0.1
Property, Plant and Equipment, Net
 12 Months Ended
Dec. 31, 2024
Property, Plant and Equipment, Net.  
Property, Plant and Equipment, Net

Note 5. Property, Plant and Equipment, Net

The components of our property, plant and equipment are summarized below (in thousands):

​

​

​

​

​

​

​

​

​

​

December 31, 

​

December 31, 

​

​

​

2024

​

2023

​

Property, plant and equipment:

​

​

​

​

​

​

​

Machinery and equipment, at cost

​

$

67,917

​

$

65,918

​

Less: accumulated depreciation and amortization

​

​

(44,065)

​

​

(42,112)

​

Building, at cost

​

​

137,420

​

​

125,786

​

Less: accumulated depreciation and amortization

​

​

(26,310)

​

​

(23,339)

​

Leasehold improvements, at cost

​

 

7,575

​

 

7,596

​

Less: accumulated depreciation and amortization

​

​

(6,347)

​

​

(5,984)

​

Construction in progress

​

 

23,531

​

 

38,483

​

​

​

$

159,721

​

$

166,348

​

​

As of December 31, 2024, the balance of construction in progress was $23.5 million, of which $17.9 million was related to our buildings in our Dingxing and Kazuo locations, $1.4 million was for manufacturing equipment purchases not yet placed in service and $4.3 million was from our construction in progress for our other consolidated subsidiaries. As of December 31, 2023, the balance of construction in progress was $38.5 million, of which $31.2 million was related to our buildings in our Dingxing and Kazuo locations, $3.1 million was for manufacturing equipment purchases not yet placed in service and $4.2 million was from our construction in progress for our other consolidated subsidiaries. 

Depreciation and amortization expense was $9.0 million, $8.7 million and $8.1 million for the years ended December 31, 2024, 2023 and 2022, respectively.
v3.25.0.1
Investments in Privately Held Raw Material Companies
 12 Months Ended
Dec. 31, 2024
Investments in Privately Held Raw Material Companies  
Investments in Privately Held Raw Material Companies

Note 6. Investments in Privately Held Raw Material Companies

We have made strategic investments in private companies located in China in order to gain access at a competitive cost to raw materials that are critical to our substrate business. These companies form part of our overall supply chain.

The investments are summarized below (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Investment Balance as of

​

​

​

​

​

​

​

December 31, 

​

December 31, 

​

Accounting

​

Ownership

*

Company

    

2024

    

2023

    

Method

    

Percentage

​

Nanjing JinMei Gallium Co., Ltd.

​

$

592

​

$

592

 

Consolidated

 

** 85.5

%

ChaoYang JinMei Gallium Co., Ltd.

​

​

1,820

​

​

1,820

​

Consolidated

​

** 85.5

%

Beijing BoYu Semiconductor Vessel Craftwork Technology Co., Ltd.

​

 

1,346

​

 

1,346

 

Consolidated

 

** 85.5

%

ChaoYang ShuoMei High Purity Semiconductor Materials Co., Ltd.

​

​

3,122

​

​

3,122

​

Consolidated

​

**** 75.0

%

ChaoYang XinMei High Purity Semiconductor Materials Co., Ltd.

​

​

7,331

​

​

7,331

​

Consolidated

 

*** 58.5

%

​

​

$

14,211

​

$

14,211

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Beijing JiYa Semiconductor Material Co., Ltd.

​

$

4,867

​

​

3,806

​

Equity

​

39

%

Xiaoyi XingAn Gallium Co., Ltd.

​

​

5,304

​

​

5,516

​

Equity

​

** 25

%

ChaoYang KaiMei Quartz Co., Ltd.

​

​

3,895

​

​

3,154

​

Equity

​

***** 40

%

​

​

$

14,066

​

$

12,476

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Emeishan Jia Mei High Purity Metals Co., Ltd.

​

 

551

​

 

551

 

Fair value

 

****** 10

%

​

​

$

551

​

$

551

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

* These percentages reflect the ownership currently in effect upon the completion of the reorganization in China and the ownership in effect upon the completion of the new capital funding by private equity investors in January 2021.

​

** In preparation for Tongmei’s application for a listing of shares in an IPO on the STAR Market, in late December 2020 we reorganized our entity structures in China. JinMei and BoYu and their subsidiaries, previously organized under AXT, Inc., were assigned to Tongmei and effectively merged with Tongmei although they retained their own respective legal entity status and are wholly owned subsidiaries of Tongmei. The 33% minority interest stakeholders of BoYu converted their ownership to a 7.59% minority interest in Tongmei. The 8.5% minority interest stakeholders, employees of JinMei, converted their ownership to a 0.38% minority interest in Tongmei. Further, a number of employees, key managers and contributors, purchased a 0.4% minority interest in Tongmei. In 2020, the Investors transferred approximately $48.1 million of new capital to Tongmei. An additional investment of approximately $1.5 million of new capital was funded in early January 2021. Under China regulations these investments must be formally approved by the appropriate government agency and are not deemed to be dilutive until such approval is granted. The government approved the approximately $49 million investment in its entirety on January 25, 2021 at which time the Investors owned a redeemable noncontrolling interest in Tongmei of 7.28%. As of December 31, 2022, Tongmei’s noncontrolling interests and redeemable noncontrolling interests totaled approximately 14.5%. AXT remains the controlling stakeholder of Tongmei and holds a majority of the Board of Director positions of Tongmei.

​

*** In February 2021, Tongmei signed a joint venture agreement with certain investors to fund ChaoYang XinMei.

​

**** In April 2022, ChaoYang JinMei signed a joint venture agreement with certain investor to fund a new company, ChaoYang ShuoMei.

​

***** In April 2022, Tongmei signed a joint venture agreement with certain investors to fund a new company, ChaoYang KaiMei.

​

****** In May 2023, we sold 15% of our equity investments in Jia Mei to a third party. We now own 10% of the equity ownership of Jia Mei and account for it under the fair value method.

In May 2023, we reduced our ownership in Jia Mei from 25% to 10% by selling a portion of our Jia Mei shares to an unrelated third party for approximately $827,000. Considering our decreased ownership and that we no longer have

significant influence over its operations and financial policies, we adopted the fair value method of accounting to report on the investment in Jia Mei. As Jia Mei's equity interest is without a readily determinable fair value, we elected to use the measurement alternative to measure at cost, less any impairment, plus or minus fair value changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer. As a result of the share sale, we recognized a gain of $575,000. Additionally, in accordance with ASC Topic 321, Investments–Equity Securities, we adjusted the investment in Jia Mei to its fair value at the time of the sale. The gain resulting from the sale and the subsequent remeasurement was incorporated as a component of “Equity in income of unconsolidated joint ventures” in the consolidated statements of operations for the twelve months ended December 31, 2023. The gain from the sale and the subsequent remeasurement includes the following:

​

​

​

​

​

​

​

Amount

​

    

(in thousands)

Fair value of the consideration received

​

$

779

Foreign income tax withholding

​

​

48

Carrying value of 15% of Emeishan Jia Mei High Purity Metals Co., Ltd.

​

​

(252)

Gain recognized on sale of 15% of Emeishan Jia Mei High Purity Metals Co., Ltd.

​

$

575

​

​

​

​

​

​

​

​

​

​

Amount

​

​

(in thousands)

Fair value of the retained investment in Emeishan Jia Mei High Purity Metals Co., Ltd.

​

$

551

Carrying value of retained noncontrolling investment (10%)

​

​

(168)

Gain on retained noncontrolling investment due to remeasurement (10%)

​

$

383

​

The Jia Mei investment is reviewed for other-than-temporary declines in value on a quarterly basis. We did not record any other-than-temporary impairment charges for Jia Mei investment during the twelve months ended December 31, 2023.

​

In November 2023, our 46% equity ownership interest in Dongfang was sold to a third party for consideration valued at approximately $0.6 million, including raw materials, equipment, and vehicle. As a result, our equity ownership interest of Dongfang decreased from 46% to 0%. The loss resulting from the sale was incorporated as a component of “Equity in income of unconsolidated joint ventures” in the consolidated statements of operations for the twelve months ended December 31, 2023. The loss from the sale includes the following:

​

​

​

​

​

​

​

Amount

​

    

(in thousands)

Fair value of the consideration received

​

$

585

Carrying value of 46% of Donghai County Dongfang High Purity Electronic Materials Co., Ltd.

​

​

(1,710)

Loss recognized on sale of 46% of Donghai County Dongfang High Purity Electronic Materials Co., Ltd.

​

$

(1,125)

​

Although we have representation on the board of directors of each of the privately held raw material companies, the daily operations of each of these companies are managed by local management and not by us. Decisions concerning their respective short-term strategy and operations, ordinary course of business capital expenditures and sales of finished product, are made by local management with regular guidance and input from us.

For AXT’s minority investment entities that are not consolidated, the investment balances are included in “Other assets” in our consolidated balance sheets and totaled $14.1 million and $12.5 million as of December 31, 2024 and 2023, respectively. Our respective ownership interests in ChaoYang KaiMei, JiYa, Xiaoyi XingAn and Jia Mei was

40%, 39%, 25%, and 10%, respectively. These minority investment entities are not considered variable interest entities because:

●all minority investment entities have sustainable businesses of their own;
●our voting power is proportionate to our ownership interests;
●we only recognize our respective share of the losses and/or residual returns generated by the companies if they occur; and
●we do not have controlling financial interest in, do not maintain operational or management control of, do not control the board of directors of, and are not required to provide additional investment or financial support to any of these companies.

Occasionally, one of our PRC subsidiaries or PRC raw material joint ventures declares and pays a dividend. These dividends generally occur when the PRC joint venture declares a dividend for all of its shareholders. Dividends paid to the Company are subject to a 10% PRC withholding tax. The Company is required to obtain approval from the State Administration of Foreign Exchange (“SAFE”) to transfer funds in or out of the PRC. SAFE requires a valid agreement to approve the transfers, which are processed through a bank. Other than PRC foreign exchange restrictions, the Company is not subject to any PRC restrictions and limitations on its ability to distribute earnings from its businesses, including its PRC subsidiaries and PRC joint ventures, to the Company and its investors as well as the ability to settle amounts owed by the Company to its PRC subsidiaries and PRC joint ventures. If SAFE approval is denied the dividend payable to the Company would be owed but would not be paid.

For the years ended December 31, 2024, 2023 and 2022, the aggregate dividends paid to us, directly or to an intermediate entity within our corporate structure, by our PRC subsidiaries and PRC raw material joint ventures were approximately $2.4 million, $4.3 million and $2.9 million, respectively. In June 2022, July 2022 and August 2022, we received a dividend of $1.3 million from BoYu, $1.5 million from Xiaoyi XingAn and $0.1 million from JiYa, respectively. In April 2023, Xiaoyi XingAn distributed a dividend of $1.8 million to us. Additionally, in both April 2023 and November 2023, JiYa distributed dividends to us, totaling $2.0 million and $0.5 million, respectively. In May 2024 and November 2024, we received a dividend of $2.1 million from Xiaoyi XingAn and $0.3 million from JiYa, respectively. For the years ended December 31, 2024 and 2023, there were no dividends paid to minority shareholders by our PRC subsidiaries or PRC raw material joint ventures.

AXT’s minority investment entities are not consolidated and are accounted for under the equity method. The equity entities had the following summarized income information (in thousands) for the years ended December 31, 2024, 2023 and 2022, respectively: (The 2023 income information includes results of Jia Mei for Q1 and Q2.)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Our share for the

 

​

​

​

Year Ended

​

Year Ended

 

​

​

​

December 31, 

​

December 31, 

 

​

    

2024

    

2023

​

2022

    

2024

    

2023

    

2022

 

Net revenue

​

$

37,591

​

$

32,544

​

$

48,139

​

$

11,715

​

$

10,033

​

$

15,031

​

Gross profit

​

 

17,747

​

 

11,698

​

 

27,000

​

 

5,374

​

 

3,365

​

 

8,229

​

Operating income

​

 

13,780

​

 

10,115

​

 

24,987

​

 

3,889

​

 

2,724

​

 

7,532

​

Net income

​

​

11,944

​

​

8,681

​

​

19,104

​

​

3,439

​

​

1,884

​

​

5,957

​

​

These minority investment entities that are not consolidated, but rather are accounted for under the equity method, had the following summarized balance sheet information (in thousands) as of December 31, 2024 and 2023, respectively: (The 2023 balance sheet information excludes Jia Mei.)

​

​

​

​

​

​

​

​

​

​

As of December 31, 

 

​

    

2024

​

2023

 

Current assets

​

$

34,858

    

$

31,636

​

Noncurrent assets

​

 

20,975

​

 

19,751

​

Current liabilities

​

 

5,602

​

 

7,367

​

Noncurrent liabilities

​

 

6,165

​

 

—

​

​

Our portion of the income and losses, including impairment charges, from these minority investment entities that are not consolidated and are accounted for under the equity method was an income of $3.4 million, $1.9 million and $6.0 million for the years ended December 31, 2024, 2023 and 2022, respectively. Undistributed retained earnings relating to our investments in these minority investment entities amounted to $9.2 million and $8.1 million as of December 31, 2024 and 2023, respectively.

v3.25.0.1
Balance Sheets Details
 12 Months Ended
Dec. 31, 2024
Balance Sheets Details  
Balance Sheets Details

Note 7. Balance Sheets Details

Other Assets

The components of other assets are summarized below (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

As of December 31, 

​

    

 

2024

    

2023

​

Equity method investments

​

​

$

14,066

​

$

12,476

​

Value added tax receivable, long term

​

​

​

194

​

​

1,291

​

Other intangible assets

​

​

​

1,710

​

​

1,821

​

Deferred tax assets

​

​

​

1,418

​

​

1,683

​

Other assets

​

​

​

1,454

​

​

1,627

​

​

​

​

$

18,842

​

$

18,898

​

​

Accrued Liabilities

The components of accrued liabilities are summarized below (in thousands):

​

​

​

​

​

​

​

​

​

​

As of December 31, 

​

​

 

2024

    

2023

 

Preferred stock dividends payable

​

$

2,901

​

$

2,901

​

Accrued compensation and related charges

​

​

2,832

​

​

3,707

​

Payable in connection with construction in progress

​

​

1,985

​

​

7,249

​

Advances from customers

​

​

1,590

​

​

305

​

Accrued professional services

​

​

1,460

​

​

868

​

Current portion of operating lease liabilities

​

​

536

​

​

458

​

Accrued product warranty

​

​

451

​

​

703

​

Other tax payable

​

​

399

​

​

493

​

Other personnel-related costs

​

​

256

​

​

286

​

Accrued income taxes

​

​

127

​

​

—

​

Accrual for sales returns

​

​

28

​

​

39

​

Other accrued liabilities

​

​

1,991

​

​

2,010

​

​

​

$

14,556

​

$

19,019

​

​

​

​

​

​

​

​

​

​
v3.25.0.1
Bank Loans and Line of Credit
 12 Months Ended
Dec. 31, 2024
Bank Loans and Line of Credit  
Bank Loans and Line of Credit

Note 8. Bank Loans and Line of Credit

Our bank loans and credit facilities typically have a term of 12 months or less and are included in “Short-term loan” in our consolidated balance sheets. The following table represents short-term bank loans as of December 31, 2024 and 2023 (in thousands, except interest rate data):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Loan

Interest

​

​

​

​

​

December 31, 

​

December 31, 

Subsidiary

Bank

​

Detail

Rate

​

Start Date

​

Due Date

​

2024

​

2023

Tongmei

Bank of China (1)

$

1,848

3.5

%  

January-23

​

January-24

$

-

$

1,795

​

​

​

2,184

2.8

%  

March-23

​

March-24

​

-

​

2,118

​

​

​

376

2.7

%  

September-23

​

September-24

​

-

​

386

​

​

​

876

3.5

%  

November-23

​

November-24

​

-

​

876

​

​

​

1,003

3.5

%  

November-23

​

November-24

​

-

​

1,003

​

Bank of China (2)

​

2,911

3.5

%  

January-23

​

January-24

​

-

​

2,825

​

Bank of China (5)

​

1,426

2.4

%  

September-24

​

September-25

​

1,370

​

-

​

​

​

1,370

2.4

%  

November-24

​

November-25

​

1,370

​

-

​

​

​

685

2.7

%  

November-24

​

November-25

​

685

​

-

​

Bank of Communications (1)

​

1,455

3.3

%  

January-23

​

January-24

​

-

​

1,414

​

​

​

1,380

3.8

%  

May-23

​

May-24

​

-

​

1,414

​

​

​

1,373

3.8

%  

July-23

​

May-24

​

-

​

1,414

​

​

​

1,376

3.0

%  

May-24

​

May-25

​

1,370

​

-

​

​

​

2,480

3.0

%  

June-24

​

May-25

​

2,466

​

-

​

China Merchants Bank (1)

​

4,367

3.7

%  

January-23

​

January-24

​

-

​

4,235

​

​

​

1,386

3.5

%  

January-24

​

January-25

​

1,370

​

-

​

​

​

692

3.5

%  

February-24

​

February-25

​

685

​

-

​

​

​

692

3.5

%  

April-24

​

April-25

​

685

​

-

​

Bank of Beijing (3)

​

2,290

4.2

%  

January-23

​

January-24

​

-

​

2,220

​

​

​

3,541

3.2

%  

June-23

​

May-24

​

-

​

3,626

​

​

​

1,380

3.2

%  

June-23

​

February-24

​

-

​

1,414

​

​

​

1,414

3.0

%  

December-23

​

December-24

​

-

​

1,414

​

​

​

3,600

3.0

%  

March-24

​

February-25

​

3,565

​

-

​

​

​

3,580

3.0

%  

June-24

​

June-25

​

3,565

​

-

​

Industrial Bank (1)

​

2,757

4.3

%  

June-23

​

June-24

​

-

​

2,825

​

​

​

2,744

4.3

%  

July-23

​

July-24

​

-

​

2,825

​

​

​

2,744

4.3

%  

September-23

​

September-24

​

-

​

2,825

​

​

​

2,851

3.9

%  

September-24

​

September-25

​

2,740

​

-

​

​

​

2,679

3.9

%  

October-24

​

October-25

​

2,679

​

-

​

​

​

1,440

3.2

%  

November-24

​

November-25

​

1,440

​

-

​

NingBo Bank (1)

​

2,744

4.2

%  

August-23

​

September-24

​

-

​

2,820

​

​

​

1,271

4.3

%  

November-23

​

November-24

​

-

​

1,271

​

​

​

2,825

4.3

%  

December-23

​

December-24

​

-

​

2,825

​

​

​

1,647

4.3

%  

January-24

​

January-25

​

1,630

​

-

​

​

​

1,258

4.3

%  

May-24

​

March-25

​

1,255

​

-

​

​

​

1,822

3.9

%  

November-24

​

November-25

​

1,822

​

-

​

​

​

550

3.9

%  

December-24

​

December-25

​

550

​

-

​

Industrial and Commercial Bank of China (1)

​

2,744

3.3

%  

September-23

​

September-24

​

-

​

2,825

​

​

​

2,851

3.3

%  

September-24

​

September-25

​

2,740

​

-

​

NanJing Bank (1)

​

2,752

3.8

%  

October-23

​

October-24

​

-

​

2,752

​

China Citic Bank (1)

​

2,752

2.9

%  

June-24

​

June-25

​

2,740

​

-

​

​

​

2,851

2.9

%  

July-24

​

July-25

​

2,740

​

-

​

​

​

1,426

2.9

%  

September-24

​

September-25

​

1,370

​

-

​

Agricultural Bank of China (1)

​

1,235

2.6

%  

November-24

​

November-25

​

1,235

​

-

​

​

​

137

2.6

%  

December-24

​

December-25

​

137

​

-

BoYu

Industrial and Commercial Bank of China (4)

​

1,414

2.7

%  

December-23

​

December-24

​

-

​

1,414

​

Industrial and Commercial Bank of China (1)

​

1,426

2.8

%  

September-24

​

September-25

​

1,370

​

-

​

Bank of China (1)

​

1,204

2.4

%  

January-23

​

January-24

​

-

​

849

​

​

​

1,145

2.3

%  

September-24

​

September-25

​

1,096

​

-

​

​

​

274

2.4

%  

December-24

​

December-25

​

274

​

-

​

NingBo Bank (1)

​

1,414

3.3

%  

November-23

​

May-24

​

-

​

1,414

​

Industrial Bank (1)

​

688

3.6

%  

September-23

​

September-24

​

-

​

708

​

​

​

1,370

2.7

%  

November-24

​

November-25

​

1,370

​

-

​

Bank of Communications (1)

​

1,414

3.0

%  

November-23

​

May-24

​

-

​

1,414

​

​

​

274

3.0

%  

May-24

​

May-25

​

274

​

-

​

NanJing Bank (1)

​

1,370

2.8

%  

December-24

​

December-25

​

1,370

​

-

​

Loan Balance

​

​

​

​

​

​

​

$

45,963

$

52,921

Collateral for the above bank loans and line of credit

(1)Not collateralized.
(2)ChaoYang LiMei time deposit.
(3)AXT time deposit.
(4)BoYu’s land use rights and its building located at its facility in Tianjin, China. In addition, the December 2023 loan attracts a guarantee fee amounting to 0.7% of the loan amount.
(5)Baoding Tongmei’s land use rights and its building located at its facility in Dingxing, China. In addition, the loan attracts a guarantee fee amounting to 1.0% of the loan amount.

​

Long-term Loans

​

On January 30, 2024, the Company secured a new line of credit amounting to $9.7 million, structured as a five-year bank loan. The credit facility bears interest at a rate of 6.5% per annum on the amount drawn from the line of credit. The credit facility is collateralized by the real estate properties owned by ChaoYang Tongmei. In January 2024, the Company borrowed $5.8 million against the credit facility. The intended use of the credit facility is for construction projects. As of December 31, 2024, $5.2 million is included in “Other long-term liabilities” and $411,000 is included in “Short-term loans” in our consolidated balance sheets.

​

In December 2023, one of our consolidated subsidiaries, ChaoYang XinMei secured a loan of approximately $2.1 million from an unrelated financing company. According to the agreement, ChaoYang XinMei temporarily transferred ownership of its production line and related equipment to the financing company, while retaining the right to use the property for production. At the end of the 30-month contractual period, ChaoYang XinMei holds the option to repurchase the production line and related equipment for $14.00. As of December 31, 2024, $619,000 associated with this financing arrangement is included in “Other long-term liabilities” and $890,000 is included in “Short-term loans” in our consolidated balance sheets.

​

As of December 31, 2024, the maturities of our long-term loan liabilities in five years (including current portion) are as follows (in thousands):

​

​

​

​

Maturity of long-term loans

    

​

2025

$

1,301

2026

​

1,301

2027

​

959

2028

​

1,233

2029

​

2,347

​

In summary, short-term loans of $47.3 million included under “Short-term loans” in our consolidated balance sheet at December 31, 2024, consisted of $46.0 million of short-term bank loans and $1.3 million of the current portion of long-term debt. Long-term loans of $5.8 million included under “Other long-term liabilities” in our consolidated balance sheet at December 31, 2024 consisted of $5.2 million in a five-year bank loan and $0.6 million in a loan secured by ChaoYang XinMei.
v3.25.0.1
Stockholders' Equity and Stock Repurchase Program
 12 Months Ended
Dec. 31, 2024
Stockholders' Equity and Stock Repurchase Program  
Stockholders' Equity and Stock Repurchase Program

Note 9. Stockholders’ Equity and Stock Repurchase Program

Stockholders’ Equity

The 883,000 shares of $0.001 par value Series A preferred stock issued and outstanding as of December 31, 2024 and 2023, valued at $3,532,000 are non-voting and non-convertible preferred stock with a 5.0% cumulative annual dividend rate payable when declared by the Board of Directors and $4 per share liquidation preference over common stock, and must be paid before any distribution is made to common stockholders. These preferred shares were issued to Lyte Optronics, Inc. stockholders in connection with the completion of our acquisition of Lyte Optronics, Inc. on May 28, 1999.

Changes in AXT, Inc.’s ownership interests in consolidated subsidiaries

The effects of changes in the Company’s ownership interests in its less than 100% owned subsidiaries on the Company’s equity are as follows:

​

​

​

​

​

​

​

​

​

​

As of December 31, 

​

    

2024

​

2023

Net loss attributable to AXT, Inc.

​

$

(11,624)

    

$

(17,881)

Decrease in additional paid-in capital for:

​

 

​

​

 

​

Investment in subsidiary with noncontrolling interest

​

 

—

​

 

(308)

Change from net loss attributable to AXT, Inc., net of transfers to noncontrolling interests

​

$

(11,624)

​

$

(18,189)

​

Stock Repurchase Program

On October 27, 2014, our Board of Directors approved a stock repurchase program pursuant to which we may repurchase up to $5.0 million of our outstanding common stock. These repurchases can be made from time to time in the open market and are funded from our existing cash balances and cash generated from operations. During 2015, we repurchased approximately 908,000 shares at an average price of $2.52 per share for a total purchase price of approximately $2.3 million under the stock repurchase program. No shares were repurchased during 2024, 2023 and 2022 under this program. As of December 31, 2024, approximately $2.7 million remained available for future repurchases under this program. 

By the terms of the Series A preferred stock, so long as any shares of Series A preferred stock are outstanding, neither the Company nor any subsidiary of the Company shall redeem, repurchase or otherwise acquire any shares of common stock, unless all accrued dividends on the Series A preferred stock have been paid. During 2013 and 2015, we repurchased shares of our outstanding common stock. As of December 31, 2015, the Series A preferred stock had cumulative dividends of $2.9 million and we included this amount in “Accrued liabilities” in our consolidated balance sheets. In 2024, 2023 and 2022, we did not repurchase any of our outstanding common stock. If we are required to pay the cumulative dividends on the Series A preferred stock, our cash and cash equivalents would be reduced. We account for the cumulative year-to-date dividends on the Series A preferred stock when calculating our earnings per share.
v3.25.0.1
Employee Benefit Plans and Stock-based Compensation
 12 Months Ended
Dec. 31, 2024
Employee Benefit Plans and Stock-based Compensation  
Employee Benefit Plans and Stock-based Compensation

Note 10. Employee Benefit Plans and Stock-based Compensation

Stock Option Plans and Equity Incentive Plans

In May 2007, our stockholders approved our 2007 Equity Incentive Plan (the “2007 Plan”), which provides for the grant of incentive and non-qualified stock options to our employees, consultants and directors. The 2007 Plan is a restatement of the 1997 Stock Option Plan which expired in 2007. The 1,928,994 share reserve of the 1997 Stock Option Plan became the reserve of the 2007 Plan, together with 1,300,000 additional shares approved for issuance under the 2007 Plan. In May 2013, the stockholders approved an additional 2,000,000 shares to be issued under the 2007 plan. Awards may be made under the 2007 Plan are stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares, performance units, deferred compensation awards and other stock-based awards. Stock options and stock appreciation rights awarded under the 2007 Plan may not be repriced without stockholder approval. Stock options and stock appreciation rights may not be granted below fair market value. Stock options or stock appreciation rights generally shall not be fully vested over a period of less than three years from the date of grant and cannot be exercised more than 10 years from the date of grant. Restricted stock, restricted stock units, and performance awards generally shall not vest faster than over a three-year period (or a twelve-month period if vesting is based on a performance measure). In December 2008, the 2007 Plan was amended to comply with the applicable requirements under Section 409A of the Internal Revenue Code.

In May 2015, our stockholders approved our 2015 Equity Incentive Plan (the “2015 Plan”). The 2015 Plan is a replacement of the 2007 Plan. The 399,562 share reserve of the 2007 Plan became the reserve of the 2015 Plan, together with 3,000,000 additional shares approved for issuance under the 2015 Plan. In May 2019, our stockholders approved

1,600,000 of additional shares for issuance under the 2015 Plan. In May 2021, our stockholders approved 3,600,000 of additional shares for issuance under the 2015 Plan. In May 2024, our stockholders approved 3,600,000 of additional shares for issuance under the 2015 Plan. Awards that may be made under the 2015 Plan are stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares, performance units, deferred compensation awards and other stock-based awards. Stock options and stock appreciation rights awarded under the 2015 Plan may not be repriced without stockholder approval. Stock options and stock appreciation rights may not be granted below fair market value. Stock options or stock appreciation rights generally shall not be fully vested over a period of less than four years from the date of grant and cannot be exercised more than 10 years from the date of grant. Restricted stock, restricted stock units, and performance awards generally shall not vest faster than over a three-year period (or a twelve-month period if vesting is based on a performance measure). However, options granted to consultants and restricted stock awards granted to independent board members typically vest in one year and the 2015 Plan does allow for similar vesting to employees. As of December 31, 2024, approximately 3.7 million shares were available for grant under the 2015 Plan.

Stock Options

The following table summarizes the stock option transactions for each of the years ended December 31, 2022, 2023 and 2024 (in thousands, except per share data):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted-

​

​

​

​

​

    

​

    

​

​

    

average

    

​

​

 

​

​

​

​

Weighted-

​

Remaining

​

​

​

 

​

​

Number of

​

average

​

Contractual

​

Aggregate

 

​

​

Options

​

Exercise

​

Life

​

Intrinsic

 

Stock Options

    

Outstanding

    

Price

    

(in years)

    

Value

 

​

​

​

​

​

​

 

​

​

​

​

​

Balance as of January 1, 2022

 

1,378

​

$

4.83

 

5.60

​

$

5,573

​

Granted

 

—

​

 

—

​

​

​

​

​

​

Exercised

 

(172)

​

 

3.02

​

​

​

​

​

​

Canceled and expired

 

—

​

 

—

​

​

​

​

​

​

Balance as of December 31, 2022

 

1,206

​

$

5.09

 

5.08

​

$

630

​

Granted

 

—

​

 

—

​

​

​

​

​

​

Exercised

 

(4)

​

 

2.30

​

​

​

​

​

​

Canceled and expired

 

(4)

​

 

4.12

​

​

​

​

​

​

Balance as of December 31, 2023

​

1,198

​

$

5.10

 

4.09

​

$

14

​

Granted

 

—

​

 

—

​

​

​

​

​

​

Exercised

 

(12)

​

​

2.24

​

​

​

​

​

​

Canceled and expired

 

(11)

​

​

2.47

​

​

​

​

​

​

Balance as of December 31, 2024

 

1,175

​

$

5.16

 

3.16

​

$

—

​

Options exercisable as of December 31, 2024

 

1,175

​

$

5.16

 

3.16

​

$

—

​

​

The options outstanding and exercisable as of December 31, 2024 were in the following exercise price ranges (in thousands, except per share data):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Options Vested and

 

​

​

​

​

​

​

Options Outstanding as of

​

Exercisable as of

 

​

​

​

​

​

​

December 31, 2024

​

December 31, 2024

 

​

​

​

​

​

​

​

    

​

​

    

Weighted‑average

    

​

    

​

​

 

Range of

​

​

​

Weighted‑average

    

Remaining

​

​

​

Weighted‑Average

 

Exercise Price

​

Shares

​

Exercise Price

    

Contractual Life

​

Shares

​

Exercise Price

 

$

2.18

-

$

2.18

​

53

​

$

2.18

 

0.84

 

53

​

$

2.18

​

$

2.56

-

$

2.56

​

11

​

$

2.56

 

1.01

 

11

​

$

2.56

​

$

3.06

-

$

3.06

​

330

​

$

3.06

 

4.85

 

330

​

$

3.06

​

$

5.21

-

$

5.21

​

352

​

$

5.21

 

1.82

 

352

​

$

5.21

​

$

5.77

-

$

5.77

​

245

​

$

5.77

 

3.85

 

245

​

$

5.77

​

$

7.95

-

$

7.95

​

60

​

$

7.95

 

2.08

 

60

​

$

7.95

​

$

9.50

-

$

9.50

​

124

​

$

9.50

 

2.82

 

124

​

$

9.50

​

​

​

​

​

​

​

1,175

​

$

5.16

 

3.16

 

1,175

​

$

5.16

​

​

There were 12,000, 4,000 and 172,000 options exercised in the years ended December 31, 2024, 2023 and 2022, respectively. The total intrinsic value of options exercised for the years ended December 31, 2024, 2023 and 2022, was $29,000, $7,000 and $0.8 million, respectively.

As of December 31, 2024, the unamortized compensation costs related to unvested stock options granted to employees under our 2015 plan was $0. We did not capitalize any stock-based compensation to inventory as of December 31, 2024 and 2023, as the amount was insignificant.

Restricted Stock Awards

A summary of activity related to restricted stock awards for the years ended December 31, 2022, 2023 and 2024 is presented below (in thousands, except per share data):

​

​

​

​

​

​

​

​

    

​

    

Weighted-Average

 

​

​

​

​

Grant Date

 

Stock Awards

    

Shares

    

Share Value

 

Non-vested as of January 1, 2022

 

875

​

$

6.26

​

Granted

 

513

​

$

4.67

​

Vested

 

(387)

​

$

6.01

​

Forfeited

 

(17)

​

$

5.34

​

Non-vested as of December 31, 2022

 

984

​

$

5.55

​

Granted

 

692

​

$

2.20

​

Vested

 

(446)

​

$

5.25

​

Forfeited

 

(10)

​

$

6.37

​

Non-vested as of December 31, 2023

​

1,220

​

$

3.75

​

Granted

 

811

​

$

2.40

​

Vested

 

(485)

​

$

4.39

​

Forfeited

​

(5)

​

$

2.99

​

Non-vested as of December 31, 2024

 

1,541

​

$

2.84

​

​

Total fair value of stock awards vested during the years ended December 31, 2024, 2023 and 2022 was $2.1 million, $2.3 million and $2.3 million, respectively. As of December 31, 2024, we had $3.8 million of unrecognized compensation expense related to restricted stock awards, which will be recognized over the weighted average period of 1.5 years.

At-Risk, Performance Shares

​

In February 2021 and 2022 and March 2023, the Company issued at-risk, performance shares classified as equity awards. Expense is recognized quarterly on a straight-line method over the requisite service period, based on the probability of achieving the specified financial performance metric, with changes in expectations recognized as an adjustment to earnings in the period of change. Compensation cost is not recognized for at-risk, performance shares that do not vest because service or performance conditions are not satisfied and any previously recognized compensation cost is reversed. At-risk, performance shares are eligible to receive dividend equivalents under the Company's 2015 Equity Incentive Plan (the “Plan”), as determined by the Board of Directors. The Company will recognize forfeitures as they occur.

​

The Company's at-risk, performance shares are classified as equity and contain performance and service conditions that must be satisfied for an employee to receive the shares. The financial performance metric for the at-risk, performance shares issued in February 2021 is based upon year-end 2020 actual results as compared to the Company’s year-end actual results in 2021. The financial performance metric for the at-risk, performance shares issued in February 2022 is based upon year-end 2021 actual results as compared to the Company’s year-end actual results in 2022. The financial performance metrics for the at-risk, performance shares issued in March 2023 are based upon the Company’s year-end actual results in 2023. The financial performance metric for the at-risk, performance shares issued in February 2024 is based upon the Company’s year-end actual results in 2024. All performance shares, if earned, are still subject to annual vesting over a four-year period, except that no shares are vested on the first anniversary because the performance measurement is based on year-end results for the year 2021, 2022 and 2023, respectively.

​

The fair value of the at-risk, performance shares is determined based on the closing price of the Company’s common stock on the first day after the public issuance of the Company’s earnings release for the most recent fiscal quarter, following the Compensation Committee and Board of Directors approval, which is considered the grant date. The fair value per share of the at-risk, performance shares classified as equity awards granted in February 2021 and 2022 and March 2023 was $15.37, $7.83 and $3.71, respectively.

​

On February 17, 2021, the Compensation Committee recommended, and the Board approved, the grant to Dr. Morris Young, our Chief Executive Officer, of 113,130 at-risk, performance shares under the Plan. On February 17, 2021, the Compensation Committee approved the grant to Gary Fischer, our Chief Financial Officer and Corporate Secretary, of 38,475 at-risk, performance shares under the Plan. On March 14, 2022, the Compensation Committee met and certified that the year-over-year annual revenue growth rate achieved for fiscal year 2021, expressed as a percentage, was 44%. Therefore, all of the at-risk performance shares became eligible to vest.

​

On February 15, 2022, the Compensation Committee recommended, and the Board approved, the grant to Dr. Morris Young of 114,320 at-risk, performance shares under the Plan. On February 15, 2022, the Compensation Committee approved the grant to Gary Fischer of 32,100 at-risk, performance shares under the Plan. If the performance financial metric is less than 50% achieved these shares are forfeited. If the performance financial metric is between 50% and 200% achieved, then a corresponding pro rata portion of the 114,320 shares issued to Dr. Young would be eligible to vest and a corresponding pro rata portion of the 32,100 shares issued to Mr. Fischer would be eligible to vest. Any shares that are not eligible to vest are forfeited. If the target financial metric exceeds 200%, then the maximum number of at-risk performance shares that would be eligible to vest is 114,320 for Dr. Young and 32,100 for Mr. Fischer. On February 14, 2023, the Compensation Committee met and certified the year-over-year annual revenue growth rate achieved for fiscal year 2022, expressed as a percentage, was 2.7%. Therefore, none of the at-risk performance shares became eligible to vest.

​

On March 15, 2023, the Compensation Committee recommended, and the Board approved, the grant to Dr. Morris Young of 223,590 at-risk, performance shares under the Plan. On March 15, 2023, the Compensation Committee approved the grant to Gary Fischer of 77,600 at-risk, performance shares under the Plan. If the minimum financial metric for fiscal year 2023 is achieved, then based upon a performance formula, a corresponding portion of the 223,590 shares issued to Dr. Young would be eligible to vest and a corresponding portion of the 77,600 shares issued to Mr. Fischer would be eligible to vest. If the target financial metric is exceeded and an additional financial metric for fiscal year 2023 is achieved, then additional shares above the target number of shares are earned based on such performance formula and the maximum number of additional shares earned is capped at 100% of the target. If the minimum financial metric for fiscal year 2023

is not achieved, then these awards are forfeited. On February 20, 2024, the Compensation Committee met and certified that the minimum revenue metric for fiscal year 2023 was not achieved. Therefore, none of the at-risk performance shares became eligible to vest.

​

On February 20, 2024, the Compensation Committee recommended, and the Board approved, the grant to Dr. Morris Young of 223,590 at-risk, performance shares under the Plan. On February 20, 2024, the Compensation Committee approved the grant to Gary Fischer of 77,600 at-risk, performance shares under the Plan. If the minimum financial metric for fiscal year 2024 is achieved, then based upon a performance formula, a corresponding portion of the 223,590 shares issued to Dr. Young would be eligible to vest and a corresponding portion of the 77,600 shares issued to Mr. Fischer would be eligible to vest. If the target financial metric is exceeded, then additional shares above the target number of shares are earned based on such performance formula and the maximum number of additional shares earned is capped at 100% of the target. If the minimum financial metric for fiscal year 2024 is not achieved, then these awards are forfeited. On February 18, 2025, the Compensation Committee met and certified that the year-over-year annual revenue growth rate achieved for fiscal year 2024, expressed as a percentage, was 200%. Therefore, the maximum number of at-risk performance shares became eligible to vest.

​

A summary of the status of our unvested at-risk, performance shares as of December 31, 2024 is presented below (in thousands, except per share data):

​

​

​

​

​

​

​

    

​

    

Weighted-Average

​

​

​

​

Grant Date

Stock Awards

    

Shares

    

Share Value

Non-vested as of January 1, 2023

 

76

*

$

15.37

Granted

 

13

​

$

3.71

Vested

 

(38)

​

$

15.37

Forfeited

 

(13)

​

$

3.71

Non-vested as of December 31, 2023

​

38

​

$

15.37

Granted

 

301

**

$

2.28

Vested

 

(38)

​

$

15.37

Forfeited

​

—

​

$

—

Non-vested as of December 31, 2024

 

301

​

$

2.28

*The number of share presented is based on achieving 150% of the targeted financial performance metric as defined in the at-risk, performance shares agreement.

**The number of share presented is based on achieving 200% of the targeted financial performance metric as defined in the at-risk, performance shares agreement

​

As of December 31, 2024, there was $0.3 million of unrecognized compensation expense related to unvested at-risk, performance shares that is expected to be recognized over a weighted-average period of 1.9 years.

Common Stock

The following number of shares of common stock were reserved and available for future issuance as of December 31, 2024 (in thousands, except per share data):

​

​

​

​

Options outstanding

    

1,175

​

Restricted stock awards outstanding

 

1,842

​

Stock available for future grant: 2015 Equity Incentive Plan

 

3,733

​

Total

 

6,750

​

​

Stock-based Compensation

We recorded $3.1 million, $3.5 million and $4.0 million of stock-based compensation in our consolidated statements of operations for the years ended December 31, 2024, 2023 and 2022, respectively. The following table summarizes compensation costs related to our stock-based compensation awards (in thousands, except per share data):

​

​

​

​

​

​

​

​

​

​

​

​

​

Year Ended

​

​

​

December 31, 

​

​

    

2024

    

2023

​

2022

 

Cost of revenue

​

$

322

​

$

414

​

$

379

​

Selling, general and administrative

​

 

2,295

​

 

2,502

​

 

2,947

​

Research and development

​

 

480

​

 

624

​

 

680

​

Net effect on net loss

​

$

3,097

​

$

3,540

​

$

4,006

​

Shares used in computing basic net income (loss) per share

​

 

43,154

​

 

42,643

​

 

42,104

​

Shares used in computing diluted net income (loss) per share

​

 

43,154

​

 

42,643

​

 

42,715

​

Effect on basic net income (loss) per share

​

$

0.07

​

$

0.08

​

$

0.10

​

Effect on diluted net income (loss) per share

​

$

0.07

​

$

0.08

​

$

0.09

​

​

We estimate the fair value of stock options using a Black-Scholes option pricing model. There were no stock options granted during 2024, 2023 and 2022.

The expected term for stock options is based on the observed historical option exercise behavior and post-vesting forfeitures of options by our employees, and the contractual term, the vesting period and the expected term of the outstanding options. Expected volatility is based on the historical volatility of our common stock. The dividend yield of zero is based on the fact that we have never paid cash dividends and have no present intention to pay cash dividends. The risk-free interest rates are taken from the Daily Federal Yield Curve Rates as of the grant dates as published by the Federal Reserve and represent the yields on actively traded Treasury securities for terms equal to the expected term of the options.

Retirement Savings Plan

We have a 401(k) Savings Plan (“Savings Plan”) which qualifies as a thrift plan under Section 401(k) of the Internal Revenue Code. All full-time U.S. employees are eligible to participate in the Savings Plan after 90 days from the date of hire. Employees may elect to reduce their current compensation by up to the statutory prescribed annual limit and have the amount of such reduction contributed to the 401(k) Plan. We provide matching to employee contributions up to 4% of the employees’ base pay if employees contribute at least 6% of their base pay. If the contribution rate is less than 6% of the base pay, the matching percentage is prorated. Our contributions to the Savings Plan were $188,000, $186,000 and $191,000 for the years ended December 31, 2024, 2023 and 2022, respectively.
v3.25.0.1
Guarantees
 12 Months Ended
Dec. 31, 2024
Guarantees  
Guarantees

Note 11. Guarantees

Indemnification Agreements

We have entered into indemnification agreements with our directors and officers that require us to indemnify our directors and officers against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of a culpable nature; to advance their expenses incurred as a result of any proceeding against them as to which they could be indemnified; and to obtain directors’ and officers’ insurance if available on reasonable terms, which we currently have in place.

Product Warranty

We provide warranties for our products for a specific period of time, generally twelve months, against material defects. We provide for the estimated future costs of warranty obligations in cost of sales when the related revenue is recognized. The accrued warranty costs represent the best estimate at the time of sale of the total costs that we expect to

incur to repair or replace product parts that fail while still under warranty. The amount of accrued estimated warranty costs are primarily based on historical experience as to product failures as well as current information on repair costs. On a quarterly basis, we review the accrued balances and update the historical warranty cost trends. The following table reflects the change in our warranty accrual which is included in “Accrued liabilities” on the consolidated balance sheets, during 2024 and 2023 (in thousands):

​

​

​

​

​

​

​

​

​

​

Year Ended

 

​

​

December 31, 

 

​

    

2024

    

2023

 

Beginning accrued product warranty

​

$

703

​

$

669

​

Accruals for warranties issued

​

 

353

​

 

794

​

Adjustments related to pre-existing warranties including expirations and changes in estimates

​

 

(22)

​

 

(159)

​

Cost of warranty repair

​

 

(583)

​

 

(601)

​

Ending accrued product warranty

​

$

451

​

$

703

​

​
v3.25.0.1
Income Taxes
 12 Months Ended
Dec. 31, 2024
Income Taxes  
Income Taxes

Note 12. Income Taxes

Consolidated income (loss) before provision for income taxes was a loss of $10.7 and $19.0 million for the years ended December 31, 2024 and 2023, respectively, and income of $20.9 million for the year ended December 31, 2022. We recorded a current and deferred tax provision of $1.1 million, $0.2 million and $2.2 million for the years ended December 31, 2024, 2023 and 2022, respectively. The components of the provision for income taxes are summarized below (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

Year Ended December 31, 

 

​

    

2024

    

2023

    

2022

 

Current:

​

​

​

​

​

​

​

​

​

​

Federal

​

$

3

​

$

(317)

​

$

848

​

State

​

 

18

​

 

41

​

 

34

​

Foreign

​

 

910

​

 

(62)

​

 

918

​

Total current

​

 

931

​

 

(338)

​

 

1,800

​

Deferred:

​

​

​

​

​

​

​

​

​

​

Federal

​

 

144

​

 

(9)

​

 

(591)

​

State

​

​

6

​

​

(7)

​

​

(4)

​

Foreign

​

 

53

​

 

514

​

 

980

​

Total deferred

​

 

203

​

 

498

​

 

385

​

Total provision for income taxes

​

$

1,134

​

$

160

​

$

2,185

​

​

A reconciliation of the effective income tax rates and the U.S. statutory federal income tax rate is summarized below:

​

​

​

​

​

​

​

​

​

​

​

Year Ended December 31, 

 

​

    

2024

    

2023

    

2022

 

Statutory federal income tax rate

 

21.0

%  

21.0

%  

21.0

%  

State income taxes, net of federal tax benefits

 

(0.2)

​

1.6

​

0.1

​

Valuation allowance

 

(32.3)

​

(25.7)

​

(19.3)

​

Stock-based compensation

 

(2.4)

​

(1.7)

​

0.7

​

Foreign tax rate differential

​

(1.5)

​

6.1

​

(2.6)

​

Foreign tax incentives

​

1.9

​

0.1

​

(3.5)

​

Foreign income inclusion

​

—

​

—

​

18.9

​

Tax effect in equity method loss or gain from unconsolidated affiliates

​

2.8

​

0.4

​

(3.0)

​

Other

​

0.1

​

(2.6)

​

(1.8)

​

Effective tax rate

 

(10.6)

%  

(0.8)

%  

10.5

%  

​

Deferred tax assets and liabilities are summarized below (in thousands):

​

​

​

​

​

​

​

​

​

​

As of December 31, 

 

​

    

2024

    

2023

 

Deferred tax assets:

​

​

​

​

​

​

​

Net operating loss carryforwards

​

$

17,220

​

$

14,362

​

Accruals, reserves and other

​

 

4,542

​

 

4,349

​

Credit carryforwards

​

 

207

​

 

206

​

Operating lease liability

​

 

268

​

 

325

​

Gross deferred tax assets

​

​

22,237

​

​

19,242

​

Valuation allowance

​

 

(20,722)

​

 

(17,462)

​

Total deferred tax assets

​

 

1,515

​

 

1,780

​

Deferred tax liabilities:

​

 

​

​

 

​

​

Operating lease right-of-use assets

​

 

(261)

​

 

(323)

​

Total net deferred tax assets (included in other assets)

​

$

1,254

​

$

1,457

​

​

As of December 31, 2024 we have federal net operating loss (“NOL”) carryforwards of approximately $46.4 million, which will begin to expire in 2025. We have California net operating loss carryforwards of approximately $108,000 as of December 31, 2024.

The deferred tax assets valuation allowance as of December 31, 2024 is attributed to U.S. federal, and state deferred tax assets, which result primarily from future deductible accruals, reserves, NOL carryforwards, and tax credit carryforwards. We believe that, based on a number of factors, the available objective evidence creates sufficient uncertainty regarding the realizability of the deferred tax assets such that a full valuation allowance has been recorded. These factors include our history of losses related to domestic operations, and the lack of carryback capacity to realize deferred tax assets. The valuation allowance increased by $3.3 million and $5.6 million for the year ended December 31, 2024 and 2023, respectively.

The China Enterprise Income Tax Law (“EIT”) imposes a single uniform income tax rate of 25% on all Chinese enterprises. Our subsidiaries in China have qualified for a preferential 15% tax rate that is available for High and New Technology Enterprises (“HTE”). In order to retain the preferential tax rate, we must meet certain operating conditions, satisfy certain product requirements, meet certain headcount requirements and maintain certain levels of research expenditures. We realized benefits from this 10% reduction in tax rate of $348,000, $47,000 and $0.9 million for 2024, 2023 and 2022, respectively. As of December 31, 2024, the favorable tax rate is still valid for the Company and it will stay the same for next year if there is no change of the business nature. The preferential tax rate that we enjoy could be modified or discontinued altogether at any time, which could materially and adversely affect our financial condition and results of operations.

Our subsidiaries in China also qualify for reduction in their taxable income in China for research and development (“R&D”) expenditures. Government pre-approval is required to claim R&D tax benefits. Any R&D claim is then submitted with the annual corporate income tax for the taxing authorities’ approval. Historically, we didn’t record such benefit until we received the tax refund from the Chinese government. Beginning in 2019, we record the tax benefit in the year it incurs the cost rather than in the year the tax benefit is received. This will better align the costs with the tax benefit. Our consolidated subsidiaries in China have enjoyed various tax holidays since 2000. Benefits under the tax holidays vary by jurisdiction.

Utilization of the NOL and R&D credit carryforwards may be subject to a substantial annual limitation due to ownership changes that might have occurred previously or that could occur in the future, as provided by Section 382 of the Internal Revenue Code of 1986 (“Section 382”), as well as similar state provisions. Ownership changes may limit the amount of NOL and tax credit carryforwards that can be utilized to offset future taxable income and tax, respectively. In general, an ownership change, as defined by Section 382, results from transactions increasing the ownership of certain shareholders or public groups in the stock of a corporation by more than 50 percentage points over a three-year period. If there is a change of control, utilization of our NOL or tax credit carryforwards would be subject to an annual limitation under Section 382. Any limitation may result in expiration of a portion of the NOL or research and development credit

carryforwards before utilization. Subsequent ownership changes could further impact the limitation in future years. Until a Section 382 study for the year-ended December 31, 2024 is completed and any limitation known, no amounts are being presented as an uncertain tax position. A full valuation allowance has been provided against our NOL carryforwards and R&D credit carryforwards and, if an adjustment is required, this adjustment would be offset by an adjustment to the valuation allowance. Thus, there would be no net impact to the consolidated balance sheets or statements of operations if an adjustment were required.

During fiscal year 2024 and 2023, the amount of gross unrecognized tax benefits was $1.1 million as of December 31, 2024 and 2023. The Company recognizes interest and penalties related to uncertain tax positions as part of the provision for income taxes. To date, such interest and penalties have not been material. All of the unrecognized tax benefit would impact the effective tax rate in future periods if recognized.

We comply with the laws, regulations, and filing requirements of all jurisdictions in which we conduct business. We regularly engage in discussions and negotiations with tax authorities regarding tax matters in various jurisdictions.

We file income tax returns in the U.S. federal, various states and foreign jurisdictions. Currently, there is no tax audit in any of the jurisdictions and we do not expect there will be any significant change to this.

On August 9, 2022, Congress passed the Creating Helpful Incentives to Produce Semiconductors (CHIPS) Act to strengthen domestic semiconductor manufacturing, design and research, fortify the economy and national security, and reinforce America’s chip supply chains. The CHIPS Act provides for a new 25% advanced manufacturing investment credit for investments in semiconductor manufacturing and for the manufacture of certain equipment required in the semiconductor manufacturing process. Since the Company has all its manufacturing in China, the Company will not qualify for the investment credit.

On August 16, 2022, the Inflation Reduction Act (IRA) was signed into law. The law is intended to address inflation by paying down the national debt, lower consumer energy costs, provide incentives for the production of clean energy and reduce health care costs. The new law imposes a 1% excise tax on corporate buybacks, and a 15% minimum tax on the adjust financial statement income (AFSI) for corporations with average annual AFSI over a three-tax year period in excess of $1 billion. The Company does not anticipate the IRA to have a material impact on its financial statements.

v3.25.0.1
Net Income (Loss) per Share
 12 Months Ended
Dec. 31, 2024
Net Income (Loss) per Share  
Net Income (Loss) per Share

Note 13. Net Income (Loss) per Share

Basic net income (loss) per share is computed using the weighted average number of common shares outstanding during the periods less shares of common stock subject to repurchase and non-vested stock awards. Diluted net income (loss) per share is computed using the weighted-average number of common shares outstanding and potentially dilutive common shares outstanding during the periods. The dilutive effect of outstanding stock options and restricted stock awards is reflected in diluted earnings per share by application of the treasury stock method. Potentially dilutive common shares consist of common shares issuable upon the exercise of stock options. Potentially dilutive common shares are excluded in net loss periods, as their effect would be anti-dilutive.

A reconciliation of the numerators and denominators of the basic and diluted net income per share calculations is as follows (in thousands, except per share data):

​

​

​

​

​

​

​

​

​

​

​

​

​

Year ended

​

​

​

December 31, 

​

​

    

2024

    

2023

    

2022

 

Numerator:

​

​

​

​

​

​

​

​

​

​

Net income (loss) attributable to AXT, Inc.

​

$

(11,624)

​

$

(17,881)

​

$

15,811

​

Less: Preferred stock dividends

​

 

(177)

​

 

(177)

​

 

(177)

​

Net income (loss) available to common stockholders

​

$

(11,801)

​

$

(18,058)

​

$

15,634

​

Denominator:

​

​

​

​

​

​

​

​

​

​

Denominator for basic net income (loss) per share - weighted-average common shares

​

 

43,154

​

 

42,643

​

 

42,104

​

Effect of dilutive securities:

​

​

​

​

​

​

​

​

​

​

Common stock options

​

 

—

​

 

—

​

 

333

​

Restricted stock awards

​

 

—

​

 

—

​

 

278

​

Denominator for dilutive net income (loss) per common shares

​

 

43,154

​

 

42,643

​

 

42,715

​

Net income (loss) attributable to AXT, Inc. per common share:

​

​

​

​

​

​

​

​

​

​

Basic

​

$

(0.27)

​

$

(0.42)

​

$

0.37

​

Diluted

​

$

(0.27)

​

$

(0.42)

​

$

0.37

​

​

​

​

​

​

​

​

​

​

​

​

Options excluded from diluted net income (loss) per share as the impact is anti-dilutive

​

 

1,175

​

 

1,198

​

 

220

​

Restricted stock excluded from diluted net income (loss) per share as the impact is anti-dilutive

​

 

1,842

​

 

1,258

​

 

291

​

​
v3.25.0.1
Segment Information and Foreign Operations
 12 Months Ended
Dec. 31, 2024
Segment Information and Foreign Operations  
Segment Information and Foreign Operations

Note 14. Segment Information and Foreign Operations

Segment Information

We operate in one segment for the design, development, manufacture and distribution of high-performance compound and single element semiconductor substrates and sale of raw materials integral to these substrates. In accordance with ASC Topic 280, Segment Reporting, our chief operating decision-maker (“CODM”) has been identified as the Chief Executive Officer, who reviews operating results to make decisions about allocating resources and assessing performance for the Company. Since we operate in one segment, all financial segment and product line information can be found in the consolidated financial statements. The CODM regularly evaluates consolidated net income (loss) and functional expenses, including cost of revenue, selling, general and administrative and research and development, to manage Company operations. No additional disaggregated expense categories are presented beyond those already disclosed in the primary financial statements.

Product Information

The following table represents revenue amounts (in thousands) by product type:

​

​

​

​

​

​

​

​

​

​

​

​

​

Year Ended

​

​

​

December 31, 

​

 

​

2024

    

2023

    

2022

 

​

Product Type:

​

​

​

​

​

​

​

​

​

​

Substrates

$

67,748

​

$

47,466

​

$

111,094

​

​

Raw materials and others

 

31,613

​

 

28,329

​

 

30,024

​

​

Total

$

99,361

​

$

75,795

​

$

141,118

​

​

Geographical Information

The following table represents revenue amounts (in thousands) reported for products shipped to customers in the corresponding geographic region:

​

​

​

​

​

​

​

​

​

​

​

​

​

Year Ended

​

​

​

December 31, 

​

 

​

2024

    

2023

    

2022

 

​

Geographical region:

​

​

​

​

​

​

​

​

​

​

China

$

56,119

​

$

39,778

​

$

55,414

​

​

Taiwan

​

14,098

​

​

8,651

​

​

28,780

​

​

Japan

​

4,979

​

​

4,641

​

​

11,724

​

​

Asia Pacific (excluding China, Taiwan and Japan)

​

2,818

​

​

3,814

​

​

4,188

​

​

Europe (primarily Germany)

​

13,766

​

​

12,315

​

​

20,592

​

​

North America (primarily the United States)

 

7,581

​

 

6,596

​

 

20,420

​

​

Total

$

99,361

​

$

75,795

​

$

141,118

​

​

Long-lived assets consist primarily of property, plant and equipment, and operating lease right-of-use assets are attributed to the geographic location in which they are located. Long-lived assets, net of depreciation, by geographic region were as follows (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

As of December 31, 

​

​

 

2024

    

2023

 

Long-lived assets by geographic region, net of depreciation:

​

​

​

​

​

​

​

North America

​

$

1,353

​

$

1,631

​

China

​

 

160,847

​

 

167,516

​

​

​

$

162,200

​

$

169,147

​

​
v3.25.0.1
Other income (expense), net
 12 Months Ended
Dec. 31, 2024
Other income (expense), net  
Other income (expense), net

Note 15. Other income (expense), net

The components of other income (expense), net are summarized below (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

Year Ended

​

​

December 31, 

​

​

2024

    

2023

    

2022

Foreign exchange gain (loss)

​

$

91

​

$

169

​

$

1,573

Income from local China government subsidy

​

​

2,239

​

​

2,557

​

​

1,710

Other income (expense)

​

​

(283)

​

​

(547)

​

​

204

​

​

$

2,047

​

$

2,179

​

$

3,487

​

​

​

​

​

​

​

​

​

​

​
v3.25.0.1
Commitments and Contingencies
 12 Months Ended
Dec. 31, 2024
Commitments and Contingencies  
Commitments and Contingencies

Note 16. Commitments and Contingencies

Legal Proceedings

From time to time we may be involved in judicial or administrative proceedings concerning matters arising in the ordinary course of business. We do not expect that any of these matters, individually or in the aggregate, will have a material adverse effect on our business, financial condition, cash flows or results of operations.

On May 6, 2024, a putative shareholder class action complaint was filed in the U.S. District Court for the Eastern District of New York on behalf of persons or entities who purchased or acquired our publicly traded securities, against us, Morris S. Young, our Chief Executive Officer, and Gary L. Fischer, our Chief Financial Officer. The court transferred the case to the Northern District of California, where our headquarters are located. A lead plaintiff has been appointed and an amended complaint was filed. The amended complaint asserts a putative class period from March 24, 2021 and April 3, 2024, inclusive (the “Class Period”). The amended complaint alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Rule 10b-5 promulgated thereunder by the defendants, and seeks unspecified monetary relief, interest, and attorneys’ fees. Defendants ‘motion to dismiss is fully briefed and pending before the Court.

On August 22, 2024, a derivative lawsuit was filed in the Northern District of California by an alleged shareholder against Morris S. Young, our Chief Executive Officer, Gary L. Fischer, our Chief Financial Officer, current directors David C. Chang, Jesse Chen, and Christine Russell, and former director Leonard J. LeBlanc, with the Company named as a nominal defendant (together, “Defendants”). Defendants moved to dismiss on November 6, 2024, following which the plaintiff filed an amended complaint on November 20, 2024. The amended complaint asserts that the Defendants breached their fiduciary duties to the Company based on the allegations asserted in the original complaint in the putative shareholder class action. On November 27, 2024, Defendants again moved to dismiss. The motion to dismiss is fully briefed and pending before the Court.

It is not possible at this time to reasonably assess the final outcomes of these litigations or to reasonably estimate the possible loss or range of loss with respect to these litigations. We believe these claims to be meritless and intend to vigorously defend against them.

Leases

We lease certain equipment, office space, warehouse and facilities under long-term operating leases expiring at various dates through November 2029. The majority of our lease obligations relate to our lease agreement for our facility in Fremont, California with approximately 19,467 square feet, which was scheduled to expire in 2020. Under the terms of the facility lease agreement, in May 2020, we were granted an extension to the term of the lease for an additional three years. Furthermore, in September 2023, we entered into another agreement to extend the lease for an additional five years, commencing December 2023. There are no variable lease payments, residual value guarantees or any restrictions or covenants imposed by the facility lease. The remainder relate to our lease agreements for a nitrogen system and a facility. The nitrogen system is used during the manufacturing process for our facility in Dingxing, China. The equipment lease became effective in August 2019 and will expire in July 2029. The facility, located in Tongzhou, China, has a lease effective from December 2024 and expiring in November 2029. There are no variable lease payments, residual value guarantees or any restrictions or covenants imposed by these leases. All other operating leases have a term of 12 months or less.

​

Leases are classified as either finance leases or operating leases. A lease is classified as a finance lease if any one of the following criteria are met: the lease transfers ownership of the asset by the end of the lease term, the lease contains an option to purchase the asset that is reasonably certain to be exercised, the lease term is for a major part of the remaining useful life of the asset or the present value of the lease payments equals or exceeds substantially all of the fair value of the asset. A lease is classified as an operating lease if it does not meet any one of these criteria. All of our leases

are classified as operating leases and substantially all of our operating leases are comprised of equipment and office space leases. None of our leases are classified as, finance leases.

​

For all leases at the lease commencement date, a right-of-use asset and a lease liability are recognized. The right-of-use asset represents the right to use the leased asset for the lease term. The lease liability represents the present value of the lease payments under the lease.

​

The right-of-use asset is initially measured at cost, which primarily comprises the initial amount of the lease liability, plus any initial direct costs incurred, consisting mainly of brokerage commissions, less any lease incentives received. All right-of-use assets are reviewed for impairment. The lease liability is initially measured at the present value of the lease payments, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, our secured incremental borrowing rate for the same term as the underlying lease.

​

Lease payments included in the measurement of the lease liability comprise the following: the fixed noncancelable lease payments, payments for optional renewal periods where it is reasonably certain the renewal period will be exercised, and payments for early termination options unless it is reasonably certain the lease will not be terminated early.

​

Lease expense for operating leases consists of the lease payments plus any initial direct costs, primarily brokerage commissions, and is recognized on a straight-line basis over the lease term.

​

We have elected not to recognize right-of-use assets and lease liabilities for short-term leases that have a term of 12 months or less. The effect of short-term leases on our right-of-use asset and lease liability was not material.

​

As of December 31, 2024, the maturities of our operating lease liabilities (excluding short-term leases) are as follows (in thousands):

​

​

​

Maturity of Lease Liabilities

    

​

2025

$

630

2026

​

653

2027

​

670

2028

​

651

2029

​

191

Thereafter

​

-

Total minimum lease payments

​

2,795

Less: Interest

​

(282)

Present value of lease obligations

​

2,513

Less: Current portion, included in accrued liabilities

​

(536)

Long-term portion of lease obligations

$

1,977

​

The weighted average remaining lease term and the weighted-average discount rate for our operating leases are as follows:

​

​

​

​

​

​

​

​

​

December 31, 

​

December 31, 

​

​

​

2024

​

2023

​

Weighted-average remaining lease term (years)

​

4.27

​

5.22

​

Weighted-average discount rate

​

5.02

%

5.14

%

​

Supplemental cash flow information related to leases where we are the lessee is as follows (in thousands):

​

​

​

​

​

​

​

​

​

​

Year Ended

​

​

​

December 31, 

​

​

​

2024

​

2023

​

Cash paid for amounts included in the measurement of lease liabilities:

​

​

​

​

​

​

​

Operating cash flows from operating leases

​

$

603

​

$

578

​

​

The components of lease expense are as follows (in thousands) within our consolidated statements of operations:

​

​

​

​

​

​

​

Year Ended

​

December 31, 

​

2024

​

2023

Operating lease

$

615

​

$

548

Short-term lease expense

​

170

​

​

143

Total

$

785

​

$

691

​

Royalty Agreement

In 2020, we and a competitor entered into a cross license and covenant agreement (the “Cross License Agreement”), which has a term that began on January 1, 2020 and expires on December 31, 2029. The Cross License Agreement is a fixed-cost cross license and not a variable-cost cross license that is based on revenue or units. Under the Cross License Agreement, we are obligated to make annual payments over a 10-year period. For the years ended December 31, 2024 and 2023, the royalty expense under the Cross License Agreement was not considered material to our consolidated financial statements.

​

​

​

Land Purchase and Investment Agreement

 

We have established a wafer process production line in Dingxing, China. In addition to a land rights and building purchase agreement that we entered into with a private real estate development company to acquire our new manufacturing facility, we also entered into a cooperation agreement with the Dingxing local government. In addition to pledging its full support and cooperation, the Dingxing local government will issue certain credits or rebates to us as we achieve certain milestones. We, in turn, agreed to hire local workers over time, pay taxes when due and eventually demonstrate a total investment of approximately $90 million in value, assets and capital. The investment will include cash paid for the land and buildings, cash on deposit in our name at local banks, the gross value of new and used equipment (including future equipment that might be used for indium phosphide and germanium substrates production), the deemed value for our customer list or the end user of our substrates, for example, the end users of 3-D sensing VCSELs (vertical cavity surface emitting lasers), a deemed value for employment of local citizens, a deemed value for our proprietary process technology, other intellectual property, other intangibles and additional items of value. There is no timeline or deadline by which this must be accomplished, rather it is a good faith covenant entered into between AXT and the Dingxing local government.  Further, there is no specific penalty contemplated if either party breaches the agreement. However, the agreement does state that each party has a right to seek from the other party compensation for losses. Under certain conditions, the Dingxing local government may purchase the land and building at the appraised value. We believe that such cooperation agreements are normal, customary and usual in China and that the future valuation is flexible. We have a similar agreement with the city of Kazuo, China, although on a smaller scale. The total investment targeted by AXT in Kazuo is approximately $15 million in value, assets and capital. In addition, BoYu has a similar agreement with the city of Kazuo. The total investment targeted by BoYu in Kazuo is approximately $8 million in value, assets and capital.
v3.25.0.1
Unaudited Quarterly Consolidated Financial Data
 12 Months Ended
Dec. 31, 2024
Unaudited Quarterly Consolidated Financial Data  
Unaudited Quarterly Consolidated Financial Data

Note 17. Unaudited Quarterly Consolidated Financial Data

Not applicable.

​
v3.25.0.1
Redeemable Noncontrolling Interests
 12 Months Ended
Dec. 31, 2024
Redeemable Noncontrolling Interests  
Redeemable Noncontrolling Interests

Note 18. Redeemable Noncontrolling Interests

As discussed in Note 1, during the quarter ended December 31, 2020, Tongmei entered into the Capital Investment Agreements with Investors that invested approximately $48.1 million in the form of redeemable noncontrolling interests representing 7.06% of the outstanding shares of Tongmei. An additional investment of approximately $1.5 million of new capital was funded in early January 2021. Under China regulations these investments must be formally approved by the appropriate government agency and are not deemed to be dilutive until such approval is granted. The government approved the entire approximately $49 million investment on January 25, 2021, at which time the Investors owned a redeemable noncontrolling interest in Tongmei of 7.28%. The initial carrying amount of the redeemable noncontrolling interest was recorded at fair value on the date of issuance of Tongmei’s common stock, net of issuance costs and presented in temporary equity on the consolidated balance sheets. This classification is due to the existence of certain contingencies that could result in potential redemption at the fixed purchase price as described below. We currently do not believe that this is probable thus no amortization of the issuance costs has been recorded.

Pursuant to the Capital Investment Agreements with the Investors, each Investor has the right to require AXT to redeem any or all Tongmei shares held by such Investor at the original purchase price paid by such Investor, without interest, in the event the IPO fails to pass the audit of the Shanghai Stock Exchange, is not approved by the Chinese Securities Regulatory Commission (“CSRC”) or Tongmei cancels the IPO application. The aggregate redemption amount is approximately $49 million, subject to the foreign exchange rate variable at time of redemption.

Tongmei submitted its IPO application to the Shanghai Stock Exchange in December 2021 and it was formally accepted for review on January 10, 2022. The Shanghai Stock Exchange approved the IPO application on July 12, 2022. On August 1, 2022, the CSRC accepted for review Tongmei’s IPO application. The STAR Market IPO remains subject to review and approval by the CSRC and other authorities. The process of going public on the STAR Market includes several periods of review and, therefore, is a lengthy process. Subject to review and approval by the CSRC and other authorities, Tongmei hopes to accomplish this goal in the coming months. The listing of Tongmei on the STAR Market will not change the status of AXT as a U.S. public company.

The components of the change in redeemable noncontrolling interests for the years ended December 31, 2024 and 2023 are presented in the following table (in thousands):

​

​

​

Balance as of January 1, 2023

$

44,846

Investment in subsidiary with redeemable noncontrolling interest

​

155

Equity issuance costs incurred

​

(880)

Stock-based compensation attributable to redeemable noncontrolling interests

​

52

Net income attributable to redeemable noncontrolling interests

​

(920)

Effect of foreign currency translation on redeemable noncontrolling interests

​

(1,260)

Effect of foreign currency translation attributable to redeemable noncontrolling interests

​

(330)

Balance as of December 31, 2023

​

41,663

Equity issuance costs incurred

​

(992)

Stock-based compensation attributable to redeemable noncontrolling interests

​

34

Net loss attributable to redeemable noncontrolling interests

​

(509)

Effect of foreign currency translation on redeemable noncontrolling interests

​

(1,311)

Effect of foreign currency translation attributable to redeemable noncontrolling interests

​

(308)

Balance as of December 31, 2024

$

38,577

​
v3.25.0.1
Subsequent Events
 12 Months Ended
Dec. 31, 2024
Subsequent Events  
Subsequent Events

Note 19. Subsequent Events

In January, February and March 2025, the Company obtained a total of $8.4 million in new one-year bank loans with interest rates ranging from 2.5% to 3.9%. Of the $8.4 million, $6.0 million is unsecured, while the remaining $2.4 million is collateralized by real estate. In February 2025, the Company secured a fourteen-month unsecured bank loan in an amount of $2.7 million with an interest rate of 3.2%. The Company repaid $7.4 million of existing loans in January and February 2025.

v3.25.0.1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Pay vs Performance Disclosure      
Net Income (Loss) $ (11,624) $ (17,881) $ 15,811
v3.25.0.1
Insider Trading Arrangements
 3 Months Ended
Dec. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.25.0.1
Insider Trading Policies and Procedures
 12 Months Ended
Dec. 31, 2024
Insider Trading Policies and Procedures [Line Items]  
Insider Trading Policies and Procedures Adopted true
v3.25.0.1
Cybersecurity Risk Management and Strategy Disclosure
 12 Months Ended
Dec. 31, 2024
Cybersecurity Risk Management, Strategy, and Governance [Line Items]  
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]

We have established policies and processes for assessing, identifying, and managing material risks from cybersecurity threats, and have integrated these processes into our overall risk management systems and processes. We routinely assess material risks from cybersecurity threats, including any potential unauthorized occurrence on or conducted through our information systems that may result in adverse effects on the confidentiality, integrity, or availability of our information systems or any information residing therein.

We conduct periodic risk assessments to identify cybersecurity threats, as well as assessments in the event of a material change in our business practices that may affect information systems that are vulnerable to such cybersecurity threats. These risk assessments include identification of reasonably foreseeable internal and external risks, the likelihood and potential damage that could result from such risks, and the sufficiency of existing policies, procedures, systems, and safeguards in place to manage such risks.

Following these risk assessments, we re-design, implement, and maintain reasonable safeguards to minimize identified risks; reasonably address any identified gaps in existing safeguards; and regularly monitor the effectiveness of our safeguards. We devote significant resources and designate high-level personnel, including our Chief Financial Officer, VP of Finance, and Controller to manage the risk assessment and mitigation process.

As part of our overall risk management system, we monitor and test our safeguards and train our employees on these safeguards, in collaboration with finance, IT, and management. Personnel at all levels and departments are made aware of our cybersecurity policies through trainings and email notifications.

We engage assessors, consultants, auditors, or other third parties in connection with our risk assessment processes. These service providers assist us to design and implement our cybersecurity policies and procedures, as well as to monitor and test and audit our safeguards. We maintain policies and processes to assess and manage risks relating to third-party service providers, based on the nature of the engagement with the third party and on the information and systems to which the third party will have access. We maintain policies to conduct due diligence before onboarding new service providers and maintain ongoing evaluations to ensure compliance with our security standards.

For additional information regarding whether any risks from cybersecurity threats have materially affected or are reasonably likely to materially affect the Company, including our business strategy, results of operations, or financial condition, please refer to Item 1A, “Risk Factors,” in this Annual Report on Form 10-K, including the risk factor entitled “Cyber-attacks, system security risks and data protection issues could disrupt our internal operations and cause a reduction in revenue, increase in expenses, negatively impact our results of operation or result in other adverse consequences.”
Cybersecurity Risk Management Processes Integrated [Flag] true
Cybersecurity Risk Management Processes Integrated [Text Block]

We have established policies and processes for assessing, identifying, and managing material risks from cybersecurity threats, and have integrated these processes into our overall risk management systems and processes. We routinely assess material risks from cybersecurity threats, including any potential unauthorized occurrence on or conducted through our information systems that may result in adverse effects on the confidentiality, integrity, or availability of our information systems or any information residing therein.

We conduct periodic risk assessments to identify cybersecurity threats, as well as assessments in the event of a material change in our business practices that may affect information systems that are vulnerable to such cybersecurity threats. These risk assessments include identification of reasonably foreseeable internal and external risks, the likelihood and potential damage that could result from such risks, and the sufficiency of existing policies, procedures, systems, and safeguards in place to manage such risks.

Following these risk assessments, we re-design, implement, and maintain reasonable safeguards to minimize identified risks; reasonably address any identified gaps in existing safeguards; and regularly monitor the effectiveness of our safeguards. We devote significant resources and designate high-level personnel, including our Chief Financial Officer, VP of Finance, and Controller to manage the risk assessment and mitigation process.

As part of our overall risk management system, we monitor and test our safeguards and train our employees on these safeguards, in collaboration with finance, IT, and management. Personnel at all levels and departments are made aware of our cybersecurity policies through trainings and email notifications.

We engage assessors, consultants, auditors, or other third parties in connection with our risk assessment processes. These service providers assist us to design and implement our cybersecurity policies and procedures, as well as to monitor and test and audit our safeguards. We maintain policies and processes to assess and manage risks relating to third-party service providers, based on the nature of the engagement with the third party and on the information and systems to which the third party will have access. We maintain policies to conduct due diligence before onboarding new service providers and maintain ongoing evaluations to ensure compliance with our security standards.
Cybersecurity Risk Management Third Party Engaged [Flag] true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] false
Cybersecurity Risk Board of Directors Oversight [Text Block]

Governance

​

One of the key functions of our Board of Directors is informed oversight of our risk management process, including risks from cybersecurity threats. Our Board of Directors is responsible for monitoring and assessing strategic risk exposure, and our executive officers are responsible for the day-to-day management of the material risks we face. Our Board of Directors administers its cybersecurity risk oversight function directly as a whole, as well as through the Audit Committee. The chair of our Audit Committee has experience in assessing and managing cybersecurity risk.

Our management committee on cybersecurity, which includes our Chief Financial Officer and members from finance and IT, is primarily responsible to assess and manage our material risks from cybersecurity threats. Our Chief Financial Officer has had supervisory responsibilities over IT for over 30 years and personally engages our employees in training for cybersecurity. Our lead IT Senior System Engineer has over 20 years of direct IT employment and is a Microsoft Certified System Engineer, a Cisco Certified Network Associate and a Sun Certified System Administrator. One of our Controllers has over 15 years of Sarbanes Oxley compliance training and auditing, including auditing compliance regarding IT. Our VP Finance and Corporate Controller has over 20 years as an employee of AXT and has a thorough understanding of our specific IT systems.

Our management committee on cybersecurity oversees our cybersecurity policies and processes, including those described in “Risk Management and Strategy” above. The processes by which our management committee on cybersecurity is informed about and monitors the prevention, detection, mitigation, and remediation of cybersecurity incidents include regular communication and reporting from our IT manager, alerts and warnings through the use of technological tools and software and the results of cybersecurity systems testing from a third-party consultant.

​

Our Chief Financial Officer provides briefings to our Board of Directors and the Audit Committee regarding the Company’s cybersecurity risks and activities, including cybersecurity systems testing, activities of third parties, and the like.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Audit Committee
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]

One of the key functions of our Board of Directors is informed oversight of our risk management process, including risks from cybersecurity threats. Our Board of Directors is responsible for monitoring and assessing strategic risk exposure, and our executive officers are responsible for the day-to-day management of the material risks we face. Our Board of Directors administers its cybersecurity risk oversight function directly as a whole, as well as through the Audit Committee. The chair of our Audit Committee has experience in assessing and managing cybersecurity risk.
Cybersecurity Risk Role of Management [Text Block]

Our management committee on cybersecurity, which includes our Chief Financial Officer and members from finance and IT, is primarily responsible to assess and manage our material risks from cybersecurity threats. Our Chief Financial Officer has had supervisory responsibilities over IT for over 30 years and personally engages our employees in training for cybersecurity. Our lead IT Senior System Engineer has over 20 years of direct IT employment and is a Microsoft Certified System Engineer, a Cisco Certified Network Associate and a Sun Certified System Administrator. One of our Controllers has over 15 years of Sarbanes Oxley compliance training and auditing, including auditing compliance regarding IT. Our VP Finance and Corporate Controller has over 20 years as an employee of AXT and has a thorough understanding of our specific IT systems.

Our management committee on cybersecurity oversees our cybersecurity policies and processes, including those described in “Risk Management and Strategy” above. The processes by which our management committee on cybersecurity is informed about and monitors the prevention, detection, mitigation, and remediation of cybersecurity incidents include regular communication and reporting from our IT manager, alerts and warnings through the use of technological tools and software and the results of cybersecurity systems testing from a third-party consultant.
Cybersecurity Risk Management Positions or Committees Responsible [Flag] true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block] Chief Financial Officer
Cybersecurity Risk Management Expertise of Management Responsible [Text Block] Our Chief Financial Officer has had supervisory responsibilities over IT for over 30 years and personally engages our employees in training for cybersecurity. Our lead IT Senior System Engineer has over 20 years of direct IT employment and is a Microsoft Certified System Engineer, a Cisco Certified Network Associate and a Sun Certified System Administrator. One of our Controllers has over 15 years of Sarbanes Oxley compliance training and auditing, including auditing compliance regarding IT. Our VP Finance and Corporate Controller has over 20 years as an employee of AXT and has a thorough understanding of our specific IT systems.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] The processes by which our management committee on cybersecurity is informed about and monitors the prevention, detection, mitigation, and remediation of cybersecurity incidents include regular communication and reporting from our IT manager, alerts and warnings through the use of technological tools and software and the results of cybersecurity systems testing from a third-party consultant.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] true
v3.25.0.1
The Company and Summary of Significant Accounting Policies (Policies)
 12 Months Ended
Dec. 31, 2024
The Company and Summary of Significant Accounting Policies  
Principles of Consolidation

Principles of Consolidation

The consolidated financial statements include the accounts of AXT, and our consolidated subsidiaries, Beijing Tongmei Xtal Technology Co., Ltd. (“Tongmei”), AXT-Tongmei, Inc. (“AXT-Tongmei”), Baoding Tongmei Xtal Technology Co., Ltd. (“Baoding Tongmei”), ChaoYang Tongmei Xtal Technology Co., Ltd. (“ChaoYang Tongmei”), ChaoYang LiMei Semiconductor Technology Co., Ltd. (“ChaoYang LiMei”), ChaoYang XinMei High Purity Semiconductor Materials Co., Ltd. (“ChaoYang XinMei”), Nanjing JinMei Gallium Co., Ltd. (“JinMei”), ChaoYang JinMei Gallium Ltd. (“ChaoYang JinMei”), ChaoYang ShuoMei High Purity Semiconductor Materials Co., Ltd. (“ChaoYang ShuoMei”), MaAnShan JinMei Gallium Ltd., (“MaAnShan JinMei”) and Beijing BoYu Semiconductor Vessel Craftwork Technology Co., Ltd. (“BoYu”). Baoding Tongmei is located in the city of Dingxing, China. Each of ChaoYang Tongmei and ChaoYang LiMei is located in the city of Kazuo, China. All significant inter-company accounts and transactions have been eliminated. Investments in business entities in which we do not have controlling interests, but have the ability to exercise significant influence over operating and financial policies (generally 20-50% ownership), are accounted for by the equity method. For the years ended 2024 and 2023, we have three companies accounted for by the equity method. For the majority-owned subsidiaries that we consolidate, we reflect the portion we do not own as either noncontrolling interests in stockholder’s equity or as redeemable noncontrolling interests in temporary equity on our consolidated balance sheets and in our consolidated statements of operations.

​

When market conditions are warranted, we intend to construct facilities at the ChaoYang LiMei location to provide us with additional production capacity. For the years ended 2024 and 2023, expenses associated with ChaoYang LiMei had a de minimis impact on our consolidated financial statements.

​

In February 2021, Tongmei signed a joint venture agreement with certain investors to fund a new company, ChaoYang XinMei. The agreement called for a total investment of approximately $3.0 million, of which Tongmei would fund approximately $1.8 million for a 58.5 percent ownership of ChaoYang XinMei. In February 2021, the investors completed the initial funding of approximately $1.5 million. Tongmei’s portion of the investment was approximately $0.9 million. In May 2021, the investors completed the funding of the remaining balance of approximately $1.5 million. Tongmei’s portion of the final investment was approximately $0.9 million, for a total investment of approximately $1.8 million for a 58.5 percent ownership of ChaoYang XinMei. In September 2021 and October 2021, ChaoYang XinMei received funding from a minority investor of $0.9 million and $1.0 million, respectively. In December 2021 and January 2022, ChaoYang XinMei received funding from Tongmei of $1.4 million and $1.4 million, respectively. In January 2022, the China local government certified this additional funding in ChaoYang XinMei as an equity investment. Tongmei’s ownership remained at 58.5% after these equity investments. In April 2022, Tongmei entered into a capital increase agreement (the “Capital Increase Agreement”) with minority investors to further invest $4.5 million in ChaoYang XinMei. Tongmei’s portion of the investment was approximately $2.6 million, of which $1.1 million was invested in April 2022 and $0.8 million was invested in May 2022. The minority investors’ portion of the investment was approximately $1.9 million, of which $0.7 million was invested in April 2022 and $0.6 million was invested in May 2022. As a result, noncontrolling interests increased $1.4 million and redeemable noncontrolling interests increased $0.1 million. Tongmei’s ownership remained at 58.5% after the April 2022 and May 2022 equity investments. In July 2022, Tongmei and the minority investors further invested $0.8 million and $0.6 million in ChaoYang XinMei, respectively. This completed the investment obligations under the Capital Increase Agreement. As a result, noncontrolling interests increased $610,000 and redeemable noncontrolling interests increased $57,000. Tongmei’s ownership remained at 58.5% after the July 2022 equity investment.

​

In April 2022, ChaoYang JinMei signed a joint venture agreement with a certain investor to fund a new company, ChaoYang ShuoMei, our consolidated subsidiary. The agreement calls for a total investment of approximately $4.4 million, of which ChaoYang JinMei will fund approximately $3.3 million for a 75 percent ownership of ChaoYang ShuoMei. In July and August 2022, ChaoYang JinMei completed the initial funding of $1.0 million in ChaoYang ShuoMei. In August 2022, the investor invested $334,000 in ChaoYang ShuoMei. As a result, noncontrolling interests increased $406,000 and redeemable noncontrolling interests increased $73,000. In January 2023, ChaoYang ShuoMei received $0.5 million in funding from ChaoYang JinMei and $0.2 million in funding from one of the minority investors. As a result, noncontrolling interests increased $0.2 million and redeemable noncontrolling interests increased $36,000. In May 2023, ChaoYang ShuoMei received $1.0 million in funding from ChaoYang JinMei and $0.3 million in funding from one of the minority investors. As a result, noncontrolling interests increased $0.4 million and redeemable noncontrolling interests increased $75,000. In August 2023, ChaoYang ShuoMei received $0.6 million in funding from ChaoYang JinMei and $0.2 million in funding from one of the minority investors. As a result, noncontrolling interests increased $0.2 million and redeemable noncontrolling interests increased $44,000. ChaoYang JinMei has completed its investment obligations under the ChaoYang ShuoMei Joint Venture Agreement. ChaoYang JinMei’s ownership of ChaoYang ShuoMei remained at 75% after these equity investments.

​

In April 2022, Tongmei signed a joint venture agreement with certain investors to fund a new company, ChaoYang KaiMei. The agreement called for a total investment of approximately $7.6 million, of which Tongmei would fund approximately $3.0 million for a 40.0 percent ownership of ChaoYang KaiMei. In July 2022, the investors completed the initial funding of approximately $2.2 million. Tongmei’s portion of the investment was approximately $0.9 million. In January 2023, Tongmei made an investment of $0.9 million to ChaoYang KaiMei. In each of July 2023 and August 2023, Tongmei made an investment of approximately $0.6 million in ChaoYang KaiMei. These contributions culminated in the fulfillment of all of Tongmei’s financial obligations under the April 2022 ChaoYang KaiMei Joint Venture Agreement. In September 2023, Tongmei entered into another joint venture agreement with the same group of investors. This new agreement called for additional investment of approximately $5.6 million, with Tongmei committing to fund approximately $2.3 million. In December 2023, Tongmei made its initial additional investment of approximately $0.6 million in ChaoYang KaiMei, followed by additional investments of approximately $0.3 million each in June, July and November 2024. Tongmei’s ownership of ChaoYang KaiMei remained at 40% after these equity investments.

​

All activities for MaAnShan JinMei ceased during the first half of 2022 and the subsidiary was subsequently dissolved in May 2022. The dissolution of MaAnShan JinMei had a de minimis impact on the consolidated results.

​

During the quarter ended December 31, 2020, Tongmei entered into two sets of definitive transaction documents, each consisting of a capital increase agreement along with certain supplemental agreements in substantially the same form (collectively, the “Capital Increase Agreements”), with several private equity investors in China.

​

In preparation for Tongmei’s application for a listing of shares in an initial public offering (the “IPO”) on the Shanghai Stock Exchange’s Sci-Tech innovAtion boaRd (the “STAR Market”), in late December 2020, we reorganized our entity structures in China. JinMei and BoYu and its subsidiaries were assigned to Tongmei and effectively merged with Tongmei although they retained their own respective legal entity status and are wholly owned subsidiaries of Tongmei. The 33% minority interest stakeholders of BoYu converted their ownership to a 7.59% minority interest in Tongmei. The 8.5% minority interest stakeholders, employees of JinMei, converted their ownership to a 0.38% minority interest in Tongmei. Further, a number of employees, key managers and contributors purchased a 0.4% minority interest in Tongmei. Additionally, Baoding Tongmei and ChaoYang Tongmei, were assigned to Tongmei as wholly owned subsidiaries. In 2020, the private equity funds (the “Investors”) had transferred approximately $48.1 million of new capital to Tongmei. An additional investment of approximately $1.5 million of new capital was funded in January 2021. Under China regulations these investments must be formally approved by the appropriate government agency and are not deemed to be dilutive until such approval is granted. The government approved the approximately $49 million investment in its entirety on January 25, 2021, at which time the Investors owned a redeemable noncontrolling interest in Tongmei of 7.28%. As of September 30, 2022, Tongmei’s noncontrolling interests and redeemable noncontrolling interests totaled approximately 14.5%. AXT remains the controlling stakeholder of Tongmei and holds a majority of the board of director positions of Tongmei. In June 2021, AXT sold AXT-Tongmei to Tongmei for $1. Since Tongmei is 85.5% owned by AXT, and the transaction was between common interest holders, the transaction was accounted for at net book value and resulted in an increase of $1.2 million to noncontrolling interests and $1.2 million to redeemable noncontrolling interests.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates, judgments and assumptions. We believe that the estimates, judgments, and assumptions upon which management relies are reasonable based on information available at the time that these estimates, judgments, and assumptions are made. These estimates, judgments, and assumptions can affect the reported amounts of assets and liabilities as of the date of the consolidated financial statements as well as the reported amounts of revenues and expenses during the periods presented. To the extent there are material differences between these estimates and actual results, our consolidated financial statements would be affected.
Fair Value of Financial Instruments

Fair Value of Financial Instruments

The carrying amounts of certain of our financial instruments including cash and cash equivalents, restricted cash, short-term investments and long-term investments, accounts receivable, accounts payable, accrued liabilities and bank loans approximate fair value due to their short maturities. Certain cash equivalents and investments are required to be adjusted to fair value on a recurring basis. See Note 2.
Fair Value of Investments

Fair Value of Investments

ASC Topic 820, Fair value measurement (“ASC 820”) establishes three levels of inputs that may be used to measure fair value.

Level 1 instruments represent quoted prices in active markets. Therefore, determining fair value for Level 1 instruments does not require significant management judgment, and the estimation is not difficult.

Level 2 instruments include observable inputs other than Level 1 prices, such as quoted prices for similar instruments in markets with insufficient volume or infrequent transactions (less active markets), issuer bank statements, credit ratings, non-binding market consensus prices that can be corroborated with observable market data, model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated with observable market data for substantially the full term of the assets or liabilities, or quoted prices for similar assets or liabilities. These Level 2 instruments require more management judgment and subjectivity compared to Level 1 instruments, including:

●Determining which instruments are most comparable to the instrument being priced requires management to identify a sample of similar securities based on the coupon rates, maturity, issuer, credit rating, and instrument type, and subjectively select an individual security or multiple securities that are deemed most similar to the security being priced.
●Determining which model-derived valuations to use in determining fair value requires management judgment. When observable market prices for similar securities or comparable securities are not available, we price our marketable debt instruments using non-binding market consensus prices that are corroborated with observable market data or pricing models, such as discounted cash flow models, with all significant inputs derived from or corroborated with observable market data.

Level 3 instruments include unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities. The determination of fair value for Level 3 instruments requires the most management judgment and subjectivity.

We place short-term foreign currency hedges that are intended to offset the potential cash exposure related to fluctuations in the exchange rate between the United States dollar and Japanese yen. We measure the fair value of these foreign currency hedges at each month end and quarter end using current exchange rates and in accordance with generally accepted accounting principles. At quarter end any foreign currency hedges not settled are netted in “Accrued liabilities” on the consolidated balance sheets and classified as Level 3 assets and liabilities. As of December 31, 2024 and 2023, the net change in fair value from the placement of the hedge to settlement had a de minimis impact to the consolidated results.
Foreign Currency Translation

Foreign Currency Translation

The functional currency of our Chinese subsidiaries is the renminbi, the local currency of China. Transaction gains and losses resulting from transactions denominated in currencies other than the U.S. dollar or in the functional currencies of our subsidiaries are included in “Other income, net” for the years presented. The transaction gain totaled $0.1 million, $0.2 million and $1.6 million for the years ended December 31, 2024, 2023 and 2022, respectively. The assets and liabilities of the subsidiaries are translated at the rates of exchange on the balance sheet date. Revenue and expense items are translated at the average rate of exchange for the period. Gains and losses from foreign currency translation are included in “Other comprehensive income (loss)”, net of tax in the consolidated statements of comprehensive income (loss).
Revenue Recognition

Revenue Recognition

We manufacture and sell high-performance compound semiconductor substrates including indium phosphide, gallium arsenide and germanium wafers, and our consolidated subsidiaries sell certain raw materials, including high purity gallium (6N and 7N Ga), pyrolytic boron nitride (pBN) crucibles and boron oxide (B2O3). After we ship our products, there are no remaining obligations or customer acceptance requirements that would preclude revenue recognition. Our products are typically sold pursuant to purchase orders placed by our customers, and our terms and conditions of sale do not require customer acceptance. We account for a contract with a customer when there is a legally enforceable contract, which could be the customer’s purchase order, the rights of the parties are identified, the contract has commercial terms, and collectibility of the contract consideration is probable. The majority of our contracts have a single performance obligation to transfer products and are short term in nature, usually less than six months. Our revenue is measured based on the consideration specified in the contract with each customer in exchange for transferring products that are generally based upon a negotiated formula, list or fixed price. Revenue is recognized when control of the promised goods is transferred to our customer, which is either upon shipment from our dock, receipt at the customer’s dock, or removal from consignment inventory at the customer’s location, in an amount that reflects the consideration we expect to be entitled to receive in exchange for those goods.

​

We have elected to account for shipping and handling as activities to fulfill the promise to transfer the goods. Shipping and handling fees billed to customers in a sales transaction are recorded as an offset to shipping and handling expenses. Sales taxes and value added taxes in foreign jurisdictions that are collected from customers and remitted to governmental authorities are accounted for on a net basis and, therefore, are excluded from revenue.

​

We do not provide training, installation or commissioning services. We provide for future returns based on historical data, prior experience, current economic trends and changes in customer demand at the time revenue is recognized. We do not recognize any asset associated with the incremental cost of obtaining revenue generating customer contracts. As such, sales commissions are expensed as incurred, given that the expected period of benefit is less than one year.

 

Contract Balances

 

We receive payments from customers based on a billing schedule as established in our contracts. Contract assets are recorded when we have a conditional right to consideration for our completed performance under the contracts. Accounts receivables are recorded when the right to this consideration becomes unconditional. We do not have any material contract assets as of December 31, 2024, or 2023.

​

​

​

​

​

​

​

​

​

​

​

December 31, 

​

December 31,

​

​

​

2024

​

2023

​

Contract liabilities

​

$

1,590

​

$

305

​

During the three and twelve months ended December 31, 2024, the Company recognized $0 and $156,000, respectively, of revenue that was included in the contract balances as of December 31, 2023. During the three and twelve months ended December 31, 2023, the Company recognized $9,000 and $278,000, respectively, of revenue that was included in the contract balances as of December 31, 2022.

​

​

​

​

​

​

​

​

Disaggregated Revenue

 

In general, revenue disaggregated by product types and geography (See Note 14) is aligned according to the nature and economic characteristics of our business and provides meaningful disaggregation of our results of operations. Since we operate in one segment, all financial segment and product line information can be found in the consolidated financial statements.

 

Practical Expedients and Exemptions

 

We elected to use the following practical expedients: (i) not to adjust the promised amount of consideration for the effects of a significant financing component when we expect, at contract inception, that the period between our transfer of a promised product or service to a customer and when the customer pays for that product or service will be one year or less; (ii) to expense costs as incurred for costs to obtain a contract when the amortization period would have been one year or less; (iii) not to assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer.

 

In addition, we do not disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less.
Accounting for Sales and Use Taxes

Accounting for Sales and Use Taxes

We record sales taxes collected on sales of our products and for amounts not yet remitted to tax authorities as accrued liabilities on our consolidated balance sheets.

Risks and Concentration of Credit Risk

Risks and Concentration of Credit Risk

Our business is very dependent on the semiconductor, lasers and optical industries which can be highly cyclical and experience downturns as a result of economic changes, overcapacity, and technological advancements. Significant technological changes in the industry or customer requirements, or the emergence of competitive products with new capabilities or technologies, could adversely affect our operating results. In addition, a significant portion of our revenues and net income is derived from international sales. Fluctuations of the United States dollar against foreign currencies and changes in local regulatory or economic conditions, particularly in an emerging market such as China, could adversely affect operating results.

We depend on a limited number of suppliers for certain raw materials, components and equipment used in manufacturing our products, including quartz tubing and polishing solutions. We generally purchase these materials through standard purchase orders and not pursuant to long-term supply contracts.

Financial instruments that potentially subject us to concentration of credit risk consist primarily of cash, restricted cash, cash equivalents, investments, and accounts receivable. We invest primarily in money market accounts, certificates of deposit and corporate bonds. The composition and maturities are regularly monitored by management. Such deposits are in excess of the amount of the insurance provided by the federal government on such deposits. We are exposed to credit risks in the event of default by the issuers to the extent of the amount recorded on the consolidated balance sheets.

​

We perform ongoing credit evaluations of our customers’ financial condition, and limit the amount of credit extended when deemed necessary, but generally do not require collateral. The credit risk in our accounts receivable is mitigated by our credit evaluation process and the geographical dispersion of sales transactions. One customer accounted for more than 10% of our accounts receivable as of December 31, 2024 and no customer accounted for more than 10% of our accounts receivable as of December 31, 2023.

No customer represented 10% of our revenue for the year ended December 31, 2024 and 2023. One customer represented 15% of our revenue for the year ended December 31, 2022. Our top five customers, although not the same five customers for each period, represented 30% of our revenue for the year 2024, 25% of our revenue for the year 2023, and 34% of our revenue for the year 2022.

For the years ended December 31, 2024 and 2023, two third-party customers for the raw materials products from our consolidated subsidiaries accounted for over 10% of the revenue from raw materials sales. For the year ended December 31, 2022, one third-party customer for the raw materials products from our consolidated subsidiaries accounted for over 10% of the revenue from raw materials sales. Our subsidiaries and raw material joint ventures are a key strategic benefit for us as they further diversify our sources of revenue.
Cash and Cash Equivalents

Cash and Cash Equivalents

We consider investments in highly liquid instruments purchased with an original maturity of three months or less to be cash equivalents. Cash equivalents consist primarily of certificate of deposits. Cash and cash equivalents are stated at cost, which approximates fair value.

Restricted Cash

Restricted Cash

​

We maintain restricted cash in connection with cash balances temporarily restricted for regular business operations. These balances have been excluded from the Company’s cash and cash equivalents balance. As of December 31, 2024, $11.0 million was included in restricted cash in our consolidated balance sheets.
Short-Term and Long-Term Investments

Short-Term and Long-Term Investments

We classify our investments in marketable securities as available-for-sale debt securities. Short-term and long-term investments are comprised of available-for-sale marketable securities, which consist primarily of certificates of deposit and corporate bonds. These investments are reported at fair value as of the respective balance sheet dates with unrealized gains and losses included in accumulated other comprehensive income (loss) within stockholders’ equity on the consolidated balance sheets. The amortized cost of securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization is included in “Other income, net” in the consolidated statements of operations. Realized gains and losses and declines in value judged to be other than temporary on available-for-sale securities are also included in “Other income, net” in the consolidated statements of operations. The cost of securities sold is based upon the specific identification method.
Accounts Receivable and Allowance for Credit Losses and Sales Returns

Accounts Receivable and Allowance for Credit Losses and Sales Returns

Accounts receivable are recorded at the invoiced amount and are not interest bearing. We review at least quarterly, or when there are changes in credit risks, the likelihood of collection on our accounts receivable balances and provide an allowance for credit losses. We measure the expected credit losses on a collective (pool) basis when similar delinquency status exist. We evaluate receivables from U.S. customers with an emphasis on balances in excess of 90

days and for receivables from customers located outside the U.S. with an emphasis on balances in excess of 120 days and establish a reserve allowance on the receivable balances if needed. The reason for the difference in the evaluation of receivables between foreign and U.S. customers is that U.S. customers have historically made payments in a shorter period of time than foreign customers. Foreign business practices generally require us to allow customer payment terms that are longer than those accepted in the United States.

In accordance with ASC Topic 326, Financial Instruments – Credit Losses current expected credit loss impairment model, we exercise judgment when determining the adequacy of these reserves as we evaluate historical bad debt trends, general economic conditions in the United States and internationally, and reasonable and supportable forecasts of future economic conditions. Uncollectible receivables are recorded as provision for credit losses when a credit loss is expected through the establishment of an allowance, which would then be written off when all efforts to collect have been exhausted and recoveries are recognized when they are received. As of December 31, 2024 and 2023, our accounts receivable, net balance was $25.6 million and $19.3 million, respectively, which was net of an allowance of $147,000 and $579,000, respectively. During 2024, we decreased the allowance by $432,000. During 2023, we increased the allowance by $272,000. If actual uncollectible accounts differ substantially from our estimates, revisions to the estimated allowance for credit losses would be required, which could have a material impact on our financial results for the future periods.

As of December 31, 2024 and 2023, the sales returns reserve (included in accrued liabilities) balance was $28,000 and $39,000, respectively. During 2024, we utilized $28,000 and reserved an additional $17,000 and during 2023, we utilized $39,000 and reduced an additional $34,000.

Warranty Reserve

Warranty Reserve

We maintain a warranty reserve based upon our claims experience during the prior twelve months and any pending claims and returns of which we are aware. Warranty costs are accrued at the time revenue is recognized. As of December 31, 2024 and 2023, accrued product warranties totaled $451,000 and $703,000, respectively. The increase in accrued product warranties is primarily attributable to increased claims for quality issues experienced by some of our customers. If actual warranty costs or pending new claims differ substantially from our estimates, revisions to the estimated warranty liability would be required, which could have a material impact on our financial condition and results of operations for future periods.
Inventories

Inventories

Inventories are stated at the lower of cost (approximated by standard cost) or net realizable value. Cost is determined using the weighted average cost method. Our inventory consists of raw materials as well as finished goods and work-in-process that include material, labor and manufacturing overhead costs. We routinely evaluate the levels of our inventory in light of current market conditions in order to identify excess and obsolete inventory, and we provide a reserve for certain inventories to their estimated net realizable value based upon the age and quality of the product and the projections for sale of the completed products. When a reserve is recorded, a new lower cost basis for that inventory is established and subsequent changes in facts and circumstances do not result in the restoration or increase in the new cost basis.

Property, Plant and Equipment

Property, Plant and Equipment

Property, plant and equipment are stated at cost less accumulated depreciation computed using the straight-line method over the estimated economic lives of the assets, which vary from 1 to 39.5 years. Leasehold improvements are amortized using the straight-line method over the shorter of the estimated useful life or the term of the lease. We generally depreciate computer, software, office equipment, furniture and fixtures over 3 to 5 years, machinery and equipment over 1 to 20 years, automobiles over 5 to 10 years, leasehold and building improvements over 10 years, or the lease term if shorter, and buildings over 39.5 years. Repairs and maintenance costs are expensed as incurred.
Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

We evaluate property, plant and equipment and intangible assets for impairment. When events and circumstances indicate that long-lived assets may be impaired, we compare the carrying value of the long-lived assets to the projection of future undiscounted cash flows attributable to these assets. In the event that the carrying value exceeds the future undiscounted cash flows, we record an impairment charge against income equal to the excess of the carrying value over the assets’ fair value. Fair values are determined based on quoted market values, discounted cash flows or internal and external appraisals, as applicable. We did not recognize any impairment charges of long-lived assets in 2024, 2023 and 2022.
Impairment of Investments

Impairment of Investments

All available-for-sale debt securities are periodically reviewed for impairment. An investment is considered to be impaired when its fair value is less than its amortized cost basis and it is more likely than not that we will be required to sell the impaired security before recovery of its amortized cost basis. Factors considered in determining whether a loss is temporary include the magnitude of the decline in market value, the length of time the market value has been below cost (or adjusted cost), credit quality, and our ability and intent to hold the securities for a period of time sufficient to allow for any anticipated recovery in market value.

We also invest in equity instruments of privately held companies in China for business and strategic purposes. Investments in our unconsolidated joint venture companies are classified as other assets and accounted for under either the equity or fair value method, depending on whether we have the ability to exercise significant influence over their operations or financial decisions. We monitor our investments for impairment and record reductions in carrying value when events or changes in circumstances indicate that the carrying value may not be recoverable. Determination of impairment is highly subjective and is based on a number of factors, including an assessment of the strength of each company’s management, the length of time and extent to which the fair value has been less than our cost basis, the financial condition and near-term prospects of the subsidiary, fundamental changes to the business prospects of the Company, share prices of subsequent offerings, and our intent and ability to hold the investment for a period of time sufficient to allow for any anticipated recovery in our carrying value. We estimate fair value of our fair value method investments considering available information such as pricing in recent rounds of financing, current cash positions, earnings (loss) and cash flow forecasts, recent operational performance, and any other readily available market data.

For the year ended December 31, 2023, one of our PRC joint ventures assessed one of its equity investments was fully impaired. For the year ended December 31, 2023, we divested our equity investment in a PRC joint venture. The impairment and divestiture resulted in a total of $1.9 million in impairment charges in our consolidated financial results. There were no impairment charges during the year ended December 31, 2022 and 2024.
Segment Reporting

Segment Reporting

We operate in one segment for the design, development, manufacture and distribution of high-performance compound and single element semiconductor substrates and sale of raw materials integral to these substrates. Our chief operating decision-maker (“CODM”) has been identified as our Chief Executive Officer, who reviews operating results to make decisions about allocating resources and assessing our performance for the Company. We discuss revenue and capacity for both AXT and our joint ventures collectively, when determining capacity constraints and need for raw materials in our business, and consider their capacity when determining our strategic and product marketing and advertising strategies. While we consolidate our majority-owned or significantly controlled joint ventures, we do not allocate any portion of overhead, interest and other income, interest expense or taxes to them. We therefore have determined that our joint venture operations do not constitute an operating segment. Since we operate in one segment, all financial segment and product line information can be found in the consolidated financial statements. The CODM regularly evaluates consolidated net income (loss) and functional expenses, including cost of revenue, selling, general and administrative and research and development, to manage Company operations.
Stock-Based Compensation

Stock-Based Compensation

We have employee stock option plans, which are described more fully in Note 10-“Employee Benefit Plans and Stock-based Compensation”. We account for stock-based compensation in accordance with the provisions of ASC Topic 718, Compensation-Stock Compensation (“ASC 718”). We utilize the Black-Scholes option pricing model to estimate the grant date fair value of stock options, which requires the input of highly subjective assumptions, including estimating stock price volatility and expected term. Stock-based compensation cost is measured at each grant date, based on the fair value of the award, and is recognized as expense and as an increase in additional paid-in capital over the requisite service period of the award.

Research and Development

Research and Development

Research and development costs consist primarily of salaries, including stock-based compensation expense and related personnel costs, depreciation, materials and product testing which are expensed as incurred. Tangible assets acquired for research and development purposes are capitalized if they have alternative future use.

​
Advertising Costs

Advertising Costs

Advertising costs, included in selling, general and administrative expenses, are expensed as incurred. Advertising costs for the years ended December 31, 2024, 2023 and 2022 were insignificant.
Income Taxes

Income Taxes

We account for income taxes in accordance with ASC Topic 740, Income Taxes (“ASC 740”), which requires that deferred tax assets and liabilities be recognized using enacted tax rates for the effect of temporary differences between the book and tax bases of recorded assets and liabilities. ASC 740 also requires that deferred tax assets be reduced by a valuation allowance if it is more likely than not that a portion of the deferred tax asset will not be realized. The impact of ASC 740 is more fully described in Note 12.
Comprehensive Income (loss)

Comprehensive Income (loss)

The components of other comprehensive income (loss) include unrealized gains and losses on marketable securities and foreign currency translation adjustments. Comprehensive income (loss) is presented in the consolidated statements of comprehensive income (loss). The balance of accumulated other comprehensive income (loss) is as follows (in thousands):

​

​

​

​

​

​

​

​

​

​

As of December 31, 

​

    

2024

​

2023

Accumulated other comprehensive loss:

​

​

​

​

​

​

Unrealized loss on investments, net

​

$

—

​

$

(20)

Cumulative translation adjustment

​

 

(9,514)

​

​

(6,530)

​

​

 

(9,514)

​

​

(6,550)

Less: Cumulative translation adjustment attributable to noncontrolling interests and redeemable noncontrolling interests

​

​

(857)

​

​

(551)

Accumulated other comprehensive loss attributable to AXT, Inc.

​

$

(8,657)

​

$

(5,999)
Net Income (Loss) Per Share

Net Income (Loss) Per Share

Basic net income (loss) per share is computed using the weighted-average number of common shares outstanding during the periods less shares of common stock subject to repurchase and non-vested stock awards. Diluted net income (loss) per share is computed using the weighted-average number of common shares outstanding and potentially dilutive common shares outstanding during the periods. The dilutive effect of outstanding stock options and restricted stock awards is reflected in diluted earnings per share by application of the treasury stock method. Potentially dilutive common shares consist of common shares issuable upon the exercise of stock options and vesting of restricted

stock awards. Potentially dilutive common shares are excluded from the computation of weighted-average number of common shares outstanding in net loss years, as their effect would be anti-dilutive to the computation.
Recent Accounting Pronouncements

Recent Accounting Pronouncements

In November 2023, the Financial Accounting Standards Board (“FASB”) released ASU 2023-07— Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, aiming to enhance the transparency and relevance of segment information provided in financial statements. The amendments in this Update require that a public entity disclose significant segment expenses, profit or loss and assets, etc. for each reportable segment, on an annual and interim basis. The Update is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Adoption of the new standard had an immaterial effect on our consolidated financial statements.

In December 2023, FASB issued ASU 2023-09— Income Taxes (Topic 740): Improvements to Income Tax Disclosures, to help investors better understand an entity’s exposure to potential changes in jurisdictional tax legislation and the ensuing risks and opportunities. Furthermore, the Update improves to assess income tax information that affects cash flow forecasts and capital allocation decisions. The Update is effective for public business entities for annual periods beginning after December 15, 2024, on a prospective basis. Adoption of the new standard will have an immaterial effect on our consolidated financial statements.

In March 2024, FASB released ASU 2024-01— Compensation—Stock Compensation (Topic 718). The update adds an illustrative example aimed at clarifying the scope application of a profit interest award in accordance with Topic 718. The update is effective for annual periods beginning after December 15, 2024, and interim periods within those annual periods. Adoption of the new standard will have an immaterial effect on our consolidated financial statements.

In November 2024, FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40), which requires public business entities to disclose additional information on specific expense categories in the notes to the financial statements. The Update is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Adoption is expected to have an immaterial effect on our consolidated financial statements.
v3.25.0.1
The Company and Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2024
The Company and Summary of Significant Accounting Policies  
Schedule of amounts recorded in accrued liabilities

​

​

​

​

​

​

​

​

​

​

​

December 31, 

​

December 31,

​

​

​

2024

​

2023

​

Contract liabilities

​

$

1,590

​

$

305

​

During the three and twelve months ended December 31, 2024, the Company recognized $0 and $156,000, respectively, of revenue that was included in the contract balances as of December 31, 2023. During the three and twelve months ended December 31, 2023, the Company recognized $9,000 and $278,000, respectively, of revenue that was included in the contract balances as of December 31, 2022.

​

​

​

​

​

​

​
Schedule of accumulated other comprehensive income (loss) The balance of accumulated other comprehensive income (loss) is as follows (in thousands):

​

​

​

​

​

​

​

​

​

​

As of December 31, 

​

    

2024

​

2023

Accumulated other comprehensive loss:

​

​

​

​

​

​

Unrealized loss on investments, net

​

$

—

​

$

(20)

Cumulative translation adjustment

​

 

(9,514)

​

​

(6,530)

​

​

 

(9,514)

​

​

(6,550)

Less: Cumulative translation adjustment attributable to noncontrolling interests and redeemable noncontrolling interests

​

​

(857)

​

​

(551)

Accumulated other comprehensive loss attributable to AXT, Inc.

​

$

(8,657)

​

$

(5,999)
v3.25.0.1
Cash, Restricted Cash, Cash Equivalents and Investments (Tables)
 12 Months Ended
Dec. 31, 2024
Cash, Restricted Cash, Cash Equivalents and Investments  
Schedule of cash, restricted cash, cash equivalents and debt investments As of December 31, 2024 and 2023, our cash, restricted cash, cash equivalents and debt investments are classified as follows (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

December 31, 2024

​

December 31, 2023

 

​

    

​

​

    

Gross

    

Gross

    

​

​

    

​

​

    

Gross

    

Gross

    

​

​

 

​

​

Amortized

​

Unrealized

​

Unrealized

​

Fair

​

Amortized

​

Unrealized

​

Unrealized

​

Fair

 

​

    

Cost

    

Gain

    

(Loss)

    

Value

    

Cost

    

Gain

    

(Loss)

    

Value

 

Classified as:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Cash, restricted cash and cash equivalents

​

$

33,811

​

$

—

​

$

—

​

$

33,811

​

$

50,114

​

$

—

​

$

—

​

$

50,114

​

Investments (available-for-sale):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Certificates of deposit 1

​

 

—

​

 

—

​

​

—

​

 

—

​

 

2,160

​

 

—

​

​

(20)

​

 

2,140

​

Total cash, restricted cash, cash equivalents and investments

​

$

33,811

​

$

—

​

$

—

​

$

33,811

​

$

52,274

​

$

—

​

$

(20)

​

$

52,254

​

Contractual maturities on investments:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Due within 1 year 2

​

$

—

​

​

​

​

​

​

​

$

—

​

$

2,160

​

​

​

​

​

​

​

$

2,140

​

​

​

$

—

​

​

​

​

​

​

​

$

—

​

$

2,160

​

​

​

​

​

​

​

$

2,140

​

1.Certificate of deposit with original maturities of less than three months.
2.Certificate of deposit with original maturities of more than three months.
3.Classified as “Short-term investments” in our consolidated balance sheets.
4.Classified as “Long-term investments” in our consolidated balance sheets.
Fair value and gross unrealized losses related to available-for-sale securities

The following table summarizes the fair value and gross unrealized losses related to available-for-sale debt securities, aggregated by investment category and length of time that individual debt securities have been in a continuous unrealized loss position as of December 31, 2023 (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

In Loss Position

​

In Loss Position

​

Total In

 

​

​

< 12 months

​

> 12 months

​

Loss Position

 

​

    

    

​

    

Gross

    

    

​

    

Gross

    

    

​

    

Gross

 

​

​

Fair

​

Unrealized

​

Fair

​

Unrealized

​

Fair

​

Unrealized

 

As of December 31, 2023

​

Value

​

(Loss)

​

Value

​

(Loss)

​

Value

​

(Loss)

 

Investments:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Certificates of deposit

​

$

—

​

$

—

​

$

2,140

​

$

(20)

​

$

2,140

​

$

(20)

​

Total in loss position

​

$

—

​

$

—

​

$

2,140

​

$

(20)

​

$

2,140

​

$

(20)

​
Summary of financial assets and liabilities measured at fair value on a recurring basis

The following table summarizes our financial assets and liabilities measured at fair value on a recurring basis in accordance with ASC 820 as of December 31, 2023 (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

​

    

Quoted Prices in

    

​

​

​

Significant

 

​

​

​

​

​

Active Markets of

​

Significant Other

​

Unobservable

 

​

​

Balance as of

​

Identical Assets

​

Observable Inputs

​

Inputs

 

​

    

December 31, 2023

    

(Level 1)

    

(Level 2)

    

(Level 3)

 

Assets:

​

​

​

​

​

​

​

​

​

​

​

​

​

Investments:

​

​

​

​

​

​

​

​

​

​

​

​

​

Certificates of deposit

​

$

2,140

​

$

—

​

$

2,140

​

$

—

​

Total

​

$

2,140

​

$

—

​

$

2,140

​

$

—

​
v3.25.0.1
Inventories (Tables)
 12 Months Ended
Dec. 31, 2024
Inventories  
Summary of components of inventories

The components of inventory are summarized below (in thousands):

​

​

​

​

​

​

​

​

​

​

December 31, 

​

December 31, 

​

​

    

2024

    

2023

 

Inventories:

​

​

​

​

​

​

​

Raw materials

​

$

31,743

​

$

32,910

​

Work in process

​

 

50,779

​

 

50,008

​

Finished goods

​

 

2,555

​

 

3,585

​

​

​

$

85,077

​

$

86,503

​

​
v3.25.0.1
Property, Plant and Equipment, Net (Tables)
 12 Months Ended
Dec. 31, 2024
Property, Plant and Equipment, Net.  
Schedule of components of property, plant and equipment

The components of our property, plant and equipment are summarized below (in thousands):

​

​

​

​

​

​

​

​

​

​

December 31, 

​

December 31, 

​

​

​

2024

​

2023

​

Property, plant and equipment:

​

​

​

​

​

​

​

Machinery and equipment, at cost

​

$

67,917

​

$

65,918

​

Less: accumulated depreciation and amortization

​

​

(44,065)

​

​

(42,112)

​

Building, at cost

​

​

137,420

​

​

125,786

​

Less: accumulated depreciation and amortization

​

​

(26,310)

​

​

(23,339)

​

Leasehold improvements, at cost

​

 

7,575

​

 

7,596

​

Less: accumulated depreciation and amortization

​

​

(6,347)

​

​

(5,984)

​

Construction in progress

​

 

23,531

​

 

38,483

​

​

​

$

159,721

​

$

166,348

​
v3.25.0.1
Investments in Privately Held Raw Material Companies (Tables)
 12 Months Ended
Dec. 31, 2024
Investments in Privately Held Raw Material Companies  
Summary of investments

The investments are summarized below (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Investment Balance as of

​

​

​

​

​

​

​

December 31, 

​

December 31, 

​

Accounting

​

Ownership

*

Company

    

2024

    

2023

    

Method

    

Percentage

​

Nanjing JinMei Gallium Co., Ltd.

​

$

592

​

$

592

 

Consolidated

 

** 85.5

%

ChaoYang JinMei Gallium Co., Ltd.

​

​

1,820

​

​

1,820

​

Consolidated

​

** 85.5

%

Beijing BoYu Semiconductor Vessel Craftwork Technology Co., Ltd.

​

 

1,346

​

 

1,346

 

Consolidated

 

** 85.5

%

ChaoYang ShuoMei High Purity Semiconductor Materials Co., Ltd.

​

​

3,122

​

​

3,122

​

Consolidated

​

**** 75.0

%

ChaoYang XinMei High Purity Semiconductor Materials Co., Ltd.

​

​

7,331

​

​

7,331

​

Consolidated

 

*** 58.5

%

​

​

$

14,211

​

$

14,211

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Beijing JiYa Semiconductor Material Co., Ltd.

​

$

4,867

​

​

3,806

​

Equity

​

39

%

Xiaoyi XingAn Gallium Co., Ltd.

​

​

5,304

​

​

5,516

​

Equity

​

** 25

%

ChaoYang KaiMei Quartz Co., Ltd.

​

​

3,895

​

​

3,154

​

Equity

​

***** 40

%

​

​

$

14,066

​

$

12,476

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Emeishan Jia Mei High Purity Metals Co., Ltd.

​

 

551

​

 

551

 

Fair value

 

****** 10

%

​

​

$

551

​

$

551

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​
Schedule of gain (loss) on sale and re measurement of equity method investments

​

​

​

​

​

​

​

Amount

​

    

(in thousands)

Fair value of the consideration received

​

$

779

Foreign income tax withholding

​

​

48

Carrying value of 15% of Emeishan Jia Mei High Purity Metals Co., Ltd.

​

​

(252)

Gain recognized on sale of 15% of Emeishan Jia Mei High Purity Metals Co., Ltd.

​

$

575

​

​

​

​

​

​

​

​

​

​

Amount

​

​

(in thousands)

Fair value of the retained investment in Emeishan Jia Mei High Purity Metals Co., Ltd.

​

$

551

Carrying value of retained noncontrolling investment (10%)

​

​

(168)

Gain on retained noncontrolling investment due to remeasurement (10%)

​

$

383

​

​

​

​

​

​

​

Amount

​

    

(in thousands)

Fair value of the consideration received

​

$

585

Carrying value of 46% of Donghai County Dongfang High Purity Electronic Materials Co., Ltd.

​

​

(1,710)

Loss recognized on sale of 46% of Donghai County Dongfang High Purity Electronic Materials Co., Ltd.

​

$

(1,125)
Summarized income information

AXT’s minority investment entities are not consolidated and are accounted for under the equity method. The equity entities had the following summarized income information (in thousands) for the years ended December 31, 2024, 2023 and 2022, respectively: (The 2023 income information includes results of Jia Mei for Q1 and Q2.)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Our share for the

 

​

​

​

Year Ended

​

Year Ended

 

​

​

​

December 31, 

​

December 31, 

 

​

    

2024

    

2023

​

2022

    

2024

    

2023

    

2022

 

Net revenue

​

$

37,591

​

$

32,544

​

$

48,139

​

$

11,715

​

$

10,033

​

$

15,031

​

Gross profit

​

 

17,747

​

 

11,698

​

 

27,000

​

 

5,374

​

 

3,365

​

 

8,229

​

Operating income

​

 

13,780

​

 

10,115

​

 

24,987

​

 

3,889

​

 

2,724

​

 

7,532

​

Net income

​

​

11,944

​

​

8,681

​

​

19,104

​

​

3,439

​

​

1,884

​

​

5,957

​
Summarized balance sheet information

These minority investment entities that are not consolidated, but rather are accounted for under the equity method, had the following summarized balance sheet information (in thousands) as of December 31, 2024 and 2023, respectively: (The 2023 balance sheet information excludes Jia Mei.)

​

​

​

​

​

​

​

​

​

​

As of December 31, 

 

​

    

2024

​

2023

 

Current assets

​

$

34,858

    

$

31,636

​

Noncurrent assets

​

 

20,975

​

 

19,751

​

Current liabilities

​

 

5,602

​

 

7,367

​

Noncurrent liabilities

​

 

6,165

​

 

—

​
v3.25.0.1
Balance Sheets Details (Tables)
 12 Months Ended
Dec. 31, 2024
Balance Sheets Details  
Schedule of components of other assets

The components of other assets are summarized below (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

As of December 31, 

​

    

 

2024

    

2023

​

Equity method investments

​

​

$

14,066

​

$

12,476

​

Value added tax receivable, long term

​

​

​

194

​

​

1,291

​

Other intangible assets

​

​

​

1,710

​

​

1,821

​

Deferred tax assets

​

​

​

1,418

​

​

1,683

​

Other assets

​

​

​

1,454

​

​

1,627

​

​

​

​

$

18,842

​

$

18,898

​
Schedule of components of accrued liabilities

The components of accrued liabilities are summarized below (in thousands):

​

​

​

​

​

​

​

​

​

​

As of December 31, 

​

​

 

2024

    

2023

 

Preferred stock dividends payable

​

$

2,901

​

$

2,901

​

Accrued compensation and related charges

​

​

2,832

​

​

3,707

​

Payable in connection with construction in progress

​

​

1,985

​

​

7,249

​

Advances from customers

​

​

1,590

​

​

305

​

Accrued professional services

​

​

1,460

​

​

868

​

Current portion of operating lease liabilities

​

​

536

​

​

458

​

Accrued product warranty

​

​

451

​

​

703

​

Other tax payable

​

​

399

​

​

493

​

Other personnel-related costs

​

​

256

​

​

286

​

Accrued income taxes

​

​

127

​

​

—

​

Accrual for sales returns

​

​

28

​

​

39

​

Other accrued liabilities

​

​

1,991

​

​

2,010

​

​

​

$

14,556

​

$

19,019

​

​

​

​

​

​

​

​

​
v3.25.0.1
Bank Loans and Line of Credit (Tables)
 12 Months Ended
Dec. 31, 2024
Bank Loans and Line of Credit  
Schedule of bank loans and line of credit The following table represents short-term bank loans as of December 31, 2024 and 2023 (in thousands, except interest rate data):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Loan

Interest

​

​

​

​

​

December 31, 

​

December 31, 

Subsidiary

Bank

​

Detail

Rate

​

Start Date

​

Due Date

​

2024

​

2023

Tongmei

Bank of China (1)

$

1,848

3.5

%  

January-23

​

January-24

$

-

$

1,795

​

​

​

2,184

2.8

%  

March-23

​

March-24

​

-

​

2,118

​

​

​

376

2.7

%  

September-23

​

September-24

​

-

​

386

​

​

​

876

3.5

%  

November-23

​

November-24

​

-

​

876

​

​

​

1,003

3.5

%  

November-23

​

November-24

​

-

​

1,003

​

Bank of China (2)

​

2,911

3.5

%  

January-23

​

January-24

​

-

​

2,825

​

Bank of China (5)

​

1,426

2.4

%  

September-24

​

September-25

​

1,370

​

-

​

​

​

1,370

2.4

%  

November-24

​

November-25

​

1,370

​

-

​

​

​

685

2.7

%  

November-24

​

November-25

​

685

​

-

​

Bank of Communications (1)

​

1,455

3.3

%  

January-23

​

January-24

​

-

​

1,414

​

​

​

1,380

3.8

%  

May-23

​

May-24

​

-

​

1,414

​

​

​

1,373

3.8

%  

July-23

​

May-24

​

-

​

1,414

​

​

​

1,376

3.0

%  

May-24

​

May-25

​

1,370

​

-

​

​

​

2,480

3.0

%  

June-24

​

May-25

​

2,466

​

-

​

China Merchants Bank (1)

​

4,367

3.7

%  

January-23

​

January-24

​

-

​

4,235

​

​

​

1,386

3.5

%  

January-24

​

January-25

​

1,370

​

-

​

​

​

692

3.5

%  

February-24

​

February-25

​

685

​

-

​

​

​

692

3.5

%  

April-24

​

April-25

​

685

​

-

​

Bank of Beijing (3)

​

2,290

4.2

%  

January-23

​

January-24

​

-

​

2,220

​

​

​

3,541

3.2

%  

June-23

​

May-24

​

-

​

3,626

​

​

​

1,380

3.2

%  

June-23

​

February-24

​

-

​

1,414

​

​

​

1,414

3.0

%  

December-23

​

December-24

​

-

​

1,414

​

​

​

3,600

3.0

%  

March-24

​

February-25

​

3,565

​

-

​

​

​

3,580

3.0

%  

June-24

​

June-25

​

3,565

​

-

​

Industrial Bank (1)

​

2,757

4.3

%  

June-23

​

June-24

​

-

​

2,825

​

​

​

2,744

4.3

%  

July-23

​

July-24

​

-

​

2,825

​

​

​

2,744

4.3

%  

September-23

​

September-24

​

-

​

2,825

​

​

​

2,851

3.9

%  

September-24

​

September-25

​

2,740

​

-

​

​

​

2,679

3.9

%  

October-24

​

October-25

​

2,679

​

-

​

​

​

1,440

3.2

%  

November-24

​

November-25

​

1,440

​

-

​

NingBo Bank (1)

​

2,744

4.2

%  

August-23

​

September-24

​

-

​

2,820

​

​

​

1,271

4.3

%  

November-23

​

November-24

​

-

​

1,271

​

​

​

2,825

4.3

%  

December-23

​

December-24

​

-

​

2,825

​

​

​

1,647

4.3

%  

January-24

​

January-25

​

1,630

​

-

​

​

​

1,258

4.3

%  

May-24

​

March-25

​

1,255

​

-

​

​

​

1,822

3.9

%  

November-24

​

November-25

​

1,822

​

-

​

​

​

550

3.9

%  

December-24

​

December-25

​

550

​

-

​

Industrial and Commercial Bank of China (1)

​

2,744

3.3

%  

September-23

​

September-24

​

-

​

2,825

​

​

​

2,851

3.3

%  

September-24

​

September-25

​

2,740

​

-

​

NanJing Bank (1)

​

2,752

3.8

%  

October-23

​

October-24

​

-

​

2,752

​

China Citic Bank (1)

​

2,752

2.9

%  

June-24

​

June-25

​

2,740

​

-

​

​

​

2,851

2.9

%  

July-24

​

July-25

​

2,740

​

-

​

​

​

1,426

2.9

%  

September-24

​

September-25

​

1,370

​

-

​

Agricultural Bank of China (1)

​

1,235

2.6

%  

November-24

​

November-25

​

1,235

​

-

​

​

​

137

2.6

%  

December-24

​

December-25

​

137

​

-

BoYu

Industrial and Commercial Bank of China (4)

​

1,414

2.7

%  

December-23

​

December-24

​

-

​

1,414

​

Industrial and Commercial Bank of China (1)

​

1,426

2.8

%  

September-24

​

September-25

​

1,370

​

-

​

Bank of China (1)

​

1,204

2.4

%  

January-23

​

January-24

​

-

​

849

​

​

​

1,145

2.3

%  

September-24

​

September-25

​

1,096

​

-

​

​

​

274

2.4

%  

December-24

​

December-25

​

274

​

-

​

NingBo Bank (1)

​

1,414

3.3

%  

November-23

​

May-24

​

-

​

1,414

​

Industrial Bank (1)

​

688

3.6

%  

September-23

​

September-24

​

-

​

708

​

​

​

1,370

2.7

%  

November-24

​

November-25

​

1,370

​

-

​

Bank of Communications (1)

​

1,414

3.0

%  

November-23

​

May-24

​

-

​

1,414

​

​

​

274

3.0

%  

May-24

​

May-25

​

274

​

-

​

NanJing Bank (1)

​

1,370

2.8

%  

December-24

​

December-25

​

1,370

​

-

​

Loan Balance

​

​

​

​

​

​

​

$

45,963

$

52,921

Collateral for the above bank loans and line of credit

(1)Not collateralized.
(2)ChaoYang LiMei time deposit.
(3)AXT time deposit.
(4)BoYu’s land use rights and its building located at its facility in Tianjin, China. In addition, the December 2023 loan attracts a guarantee fee amounting to 0.7% of the loan amount.
(5)Baoding Tongmei’s land use rights and its building located at its facility in Dingxing, China. In addition, the loan attracts a guarantee fee amounting to 1.0% of the loan amount.
Schedule of maturities of long-term loan

As of December 31, 2024, the maturities of our long-term loan liabilities in five years (including current portion) are as follows (in thousands):

​

​

​

​

Maturity of long-term loans

    

​

2025

$

1,301

2026

​

1,301

2027

​

959

2028

​

1,233

2029

​

2,347
v3.25.0.1
Stockholders' Equity and Stock Repurchase Program (Tables)
 12 Months Ended
Dec. 31, 2024
Stockholders' Equity and Stock Repurchase Program  
Schedule of changes in ownership interest in consolidated subsidiaries

​

​

​

​

​

​

​

​

​

​

As of December 31, 

​

    

2024

​

2023

Net loss attributable to AXT, Inc.

​

$

(11,624)

    

$

(17,881)

Decrease in additional paid-in capital for:

​

 

​

​

 

​

Investment in subsidiary with noncontrolling interest

​

 

—

​

 

(308)

Change from net loss attributable to AXT, Inc., net of transfers to noncontrolling interests

​

$

(11,624)

​

$

(18,189)
v3.25.0.1
Employee Benefit Plans and Stock-based Compensation (Tables)
 12 Months Ended
Dec. 31, 2024
Employee Benefit Plans and Stock-based Compensation  
Summary of stock option activity

The following table summarizes the stock option transactions for each of the years ended December 31, 2022, 2023 and 2024 (in thousands, except per share data):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted-

​

​

​

​

​

    

​

    

​

​

    

average

    

​

​

 

​

​

​

​

Weighted-

​

Remaining

​

​

​

 

​

​

Number of

​

average

​

Contractual

​

Aggregate

 

​

​

Options

​

Exercise

​

Life

​

Intrinsic

 

Stock Options

    

Outstanding

    

Price

    

(in years)

    

Value

 

​

​

​

​

​

​

 

​

​

​

​

​

Balance as of January 1, 2022

 

1,378

​

$

4.83

 

5.60

​

$

5,573

​

Granted

 

—

​

 

—

​

​

​

​

​

​

Exercised

 

(172)

​

 

3.02

​

​

​

​

​

​

Canceled and expired

 

—

​

 

—

​

​

​

​

​

​

Balance as of December 31, 2022

 

1,206

​

$

5.09

 

5.08

​

$

630

​

Granted

 

—

​

 

—

​

​

​

​

​

​

Exercised

 

(4)

​

 

2.30

​

​

​

​

​

​

Canceled and expired

 

(4)

​

 

4.12

​

​

​

​

​

​

Balance as of December 31, 2023

​

1,198

​

$

5.10

 

4.09

​

$

14

​

Granted

 

—

​

 

—

​

​

​

​

​

​

Exercised

 

(12)

​

​

2.24

​

​

​

​

​

​

Canceled and expired

 

(11)

​

​

2.47

​

​

​

​

​

​

Balance as of December 31, 2024

 

1,175

​

$

5.16

 

3.16

​

$

—

​

Options exercisable as of December 31, 2024

 

1,175

​

$

5.16

 

3.16

​

$

—

​

​
Summary of options outstanding and exercisable by exercise price ranges

The options outstanding and exercisable as of December 31, 2024 were in the following exercise price ranges (in thousands, except per share data):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Options Vested and

 

​

​

​

​

​

​

Options Outstanding as of

​

Exercisable as of

 

​

​

​

​

​

​

December 31, 2024

​

December 31, 2024

 

​

​

​

​

​

​

​

    

​

​

    

Weighted‑average

    

​

    

​

​

 

Range of

​

​

​

Weighted‑average

    

Remaining

​

​

​

Weighted‑Average

 

Exercise Price

​

Shares

​

Exercise Price

    

Contractual Life

​

Shares

​

Exercise Price

 

$

2.18

-

$

2.18

​

53

​

$

2.18

 

0.84

 

53

​

$

2.18

​

$

2.56

-

$

2.56

​

11

​

$

2.56

 

1.01

 

11

​

$

2.56

​

$

3.06

-

$

3.06

​

330

​

$

3.06

 

4.85

 

330

​

$

3.06

​

$

5.21

-

$

5.21

​

352

​

$

5.21

 

1.82

 

352

​

$

5.21

​

$

5.77

-

$

5.77

​

245

​

$

5.77

 

3.85

 

245

​

$

5.77

​

$

7.95

-

$

7.95

​

60

​

$

7.95

 

2.08

 

60

​

$

7.95

​

$

9.50

-

$

9.50

​

124

​

$

9.50

 

2.82

 

124

​

$

9.50

​

​

​

​

​

​

​

1,175

​

$

5.16

 

3.16

 

1,175

​

$

5.16

​

​
Summary of restricted stock awards activity

A summary of activity related to restricted stock awards for the years ended December 31, 2022, 2023 and 2024 is presented below (in thousands, except per share data):

​

​

​

​

​

​

​

​

    

​

    

Weighted-Average

 

​

​

​

​

Grant Date

 

Stock Awards

    

Shares

    

Share Value

 

Non-vested as of January 1, 2022

 

875

​

$

6.26

​

Granted

 

513

​

$

4.67

​

Vested

 

(387)

​

$

6.01

​

Forfeited

 

(17)

​

$

5.34

​

Non-vested as of December 31, 2022

 

984

​

$

5.55

​

Granted

 

692

​

$

2.20

​

Vested

 

(446)

​

$

5.25

​

Forfeited

 

(10)

​

$

6.37

​

Non-vested as of December 31, 2023

​

1,220

​

$

3.75

​

Granted

 

811

​

$

2.40

​

Vested

 

(485)

​

$

4.39

​

Forfeited

​

(5)

​

$

2.99

​

Non-vested as of December 31, 2024

 

1,541

​

$

2.84

​
Summary of unvested at-risk performance shares

A summary of the status of our unvested at-risk, performance shares as of December 31, 2024 is presented below (in thousands, except per share data):

​

​

​

​

​

​

​

    

​

    

Weighted-Average

​

​

​

​

Grant Date

Stock Awards

    

Shares

    

Share Value

Non-vested as of January 1, 2023

 

76

*

$

15.37

Granted

 

13

​

$

3.71

Vested

 

(38)

​

$

15.37

Forfeited

 

(13)

​

$

3.71

Non-vested as of December 31, 2023

​

38

​

$

15.37

Granted

 

301

**

$

2.28

Vested

 

(38)

​

$

15.37

Forfeited

​

—

​

$

—

Non-vested as of December 31, 2024

 

301

​

$

2.28

*The number of share presented is based on achieving 150% of the targeted financial performance metric as defined in the at-risk, performance shares agreement.

Summary of common stock reserved for future issuance

The following number of shares of common stock were reserved and available for future issuance as of December 31, 2024 (in thousands, except per share data):

​

​

​

​

Options outstanding

    

1,175

​

Restricted stock awards outstanding

 

1,842

​

Stock available for future grant: 2015 Equity Incentive Plan

 

3,733

​

Total

 

6,750

​
Summary of compensation costs related to stock-based awards

​

​

​

​

​

​

​

​

​

​

​

​

​

Year Ended

​

​

​

December 31, 

​

​

    

2024

    

2023

​

2022

 

Cost of revenue

​

$

322

​

$

414

​

$

379

​

Selling, general and administrative

​

 

2,295

​

 

2,502

​

 

2,947

​

Research and development

​

 

480

​

 

624

​

 

680

​

Net effect on net loss

​

$

3,097

​

$

3,540

​

$

4,006

​

Shares used in computing basic net income (loss) per share

​

 

43,154

​

 

42,643

​

 

42,104

​

Shares used in computing diluted net income (loss) per share

​

 

43,154

​

 

42,643

​

 

42,715

​

Effect on basic net income (loss) per share

​

$

0.07

​

$

0.08

​

$

0.10

​

Effect on diluted net income (loss) per share

​

$

0.07

​

$

0.08

​

$

0.09

​

​
v3.25.0.1
Guarantees (Tables)
 12 Months Ended
Dec. 31, 2024
Guarantees  
Schedule of product warranty liability

​

​

​

​

​

​

​

​

​

​

Year Ended

 

​

​

December 31, 

 

​

    

2024

    

2023

 

Beginning accrued product warranty

​

$

703

​

$

669

​

Accruals for warranties issued

​

 

353

​

 

794

​

Adjustments related to pre-existing warranties including expirations and changes in estimates

​

 

(22)

​

 

(159)

​

Cost of warranty repair

​

 

(583)

​

 

(601)

​

Ending accrued product warranty

​

$

451

​

$

703

​

​
v3.25.0.1
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2024
Income Taxes  
Schedule of components of the provision (benefits) for income taxes

​

​

​

​

​

​

​

​

​

​

​

​

​

Year Ended December 31, 

 

​

    

2024

    

2023

    

2022

 

Current:

​

​

​

​

​

​

​

​

​

​

Federal

​

$

3

​

$

(317)

​

$

848

​

State

​

 

18

​

 

41

​

 

34

​

Foreign

​

 

910

​

 

(62)

​

 

918

​

Total current

​

 

931

​

 

(338)

​

 

1,800

​

Deferred:

​

​

​

​

​

​

​

​

​

​

Federal

​

 

144

​

 

(9)

​

 

(591)

​

State

​

​

6

​

​

(7)

​

​

(4)

​

Foreign

​

 

53

​

 

514

​

 

980

​

Total deferred

​

 

203

​

 

498

​

 

385

​

Total provision for income taxes

​

$

1,134

​

$

160

​

$

2,185

​
Schedule of reconciliation of the effective income tax rates and the U.S. statutory federal income tax rate

​

​

​

​

​

​

​

​

​

​

​

Year Ended December 31, 

 

​

    

2024

    

2023

    

2022

 

Statutory federal income tax rate

 

21.0

%  

21.0

%  

21.0

%  

State income taxes, net of federal tax benefits

 

(0.2)

​

1.6

​

0.1

​

Valuation allowance

 

(32.3)

​

(25.7)

​

(19.3)

​

Stock-based compensation

 

(2.4)

​

(1.7)

​

0.7

​

Foreign tax rate differential

​

(1.5)

​

6.1

​

(2.6)

​

Foreign tax incentives

​

1.9

​

0.1

​

(3.5)

​

Foreign income inclusion

​

—

​

—

​

18.9

​

Tax effect in equity method loss or gain from unconsolidated affiliates

​

2.8

​

0.4

​

(3.0)

​

Other

​

0.1

​

(2.6)

​

(1.8)

​

Effective tax rate

 

(10.6)

%  

(0.8)

%  

10.5

%  
Schedule of deferred tax assets and liabilities

Deferred tax assets and liabilities are summarized below (in thousands):

​

​

​

​

​

​

​

​

​

​

As of December 31, 

 

​

    

2024

    

2023

 

Deferred tax assets:

​

​

​

​

​

​

​

Net operating loss carryforwards

​

$

17,220

​

$

14,362

​

Accruals, reserves and other

​

 

4,542

​

 

4,349

​

Credit carryforwards

​

 

207

​

 

206

​

Operating lease liability

​

 

268

​

 

325

​

Gross deferred tax assets

​

​

22,237

​

​

19,242

​

Valuation allowance

​

 

(20,722)

​

 

(17,462)

​

Total deferred tax assets

​

 

1,515

​

 

1,780

​

Deferred tax liabilities:

​

 

​

​

 

​

​

Operating lease right-of-use assets

​

 

(261)

​

 

(323)

​

Total net deferred tax assets (included in other assets)

​

$

1,254

​

$

1,457

​
v3.25.0.1
Net Income (Loss) per Share (Tables)
 12 Months Ended
Dec. 31, 2024
Net Income (Loss) per Share  
Reconciliation of numerators and denominators of basic and diluted net income per share

A reconciliation of the numerators and denominators of the basic and diluted net income per share calculations is as follows (in thousands, except per share data):

​

​

​

​

​

​

​

​

​

​

​

​

​

Year ended

​

​

​

December 31, 

​

​

    

2024

    

2023

    

2022

 

Numerator:

​

​

​

​

​

​

​

​

​

​

Net income (loss) attributable to AXT, Inc.

​

$

(11,624)

​

$

(17,881)

​

$

15,811

​

Less: Preferred stock dividends

​

 

(177)

​

 

(177)

​

 

(177)

​

Net income (loss) available to common stockholders

​

$

(11,801)

​

$

(18,058)

​

$

15,634

​

Denominator:

​

​

​

​

​

​

​

​

​

​

Denominator for basic net income (loss) per share - weighted-average common shares

​

 

43,154

​

 

42,643

​

 

42,104

​

Effect of dilutive securities:

​

​

​

​

​

​

​

​

​

​

Common stock options

​

 

—

​

 

—

​

 

333

​

Restricted stock awards

​

 

—

​

 

—

​

 

278

​

Denominator for dilutive net income (loss) per common shares

​

 

43,154

​

 

42,643

​

 

42,715

​

Net income (loss) attributable to AXT, Inc. per common share:

​

​

​

​

​

​

​

​

​

​

Basic

​

$

(0.27)

​

$

(0.42)

​

$

0.37

​

Diluted

​

$

(0.27)

​

$

(0.42)

​

$

0.37

​

​

​

​

​

​

​

​

​

​

​

​

Options excluded from diluted net income (loss) per share as the impact is anti-dilutive

​

 

1,175

​

 

1,198

​

 

220

​

Restricted stock excluded from diluted net income (loss) per share as the impact is anti-dilutive

​

 

1,842

​

 

1,258

​

 

291

​

​
v3.25.0.1
Segment Information and Foreign Operations (Tables)
 12 Months Ended
Dec. 31, 2024
Segment Information and Foreign Operations  
Revenues reported by product type

The following table represents revenue amounts (in thousands) by product type:

​

​

​

​

​

​

​

​

​

​

​

​

​

Year Ended

​

​

​

December 31, 

​

 

​

2024

    

2023

    

2022

 

​

Product Type:

​

​

​

​

​

​

​

​

​

​

Substrates

$

67,748

​

$

47,466

​

$

111,094

​

​

Raw materials and others

 

31,613

​

 

28,329

​

 

30,024

​

​

Total

$

99,361

​

$

75,795

​

$

141,118

​
Revenue reported for products shipped to customers in the corresponding geographic region

The following table represents revenue amounts (in thousands) reported for products shipped to customers in the corresponding geographic region:

​

​

​

​

​

​

​

​

​

​

​

​

​

Year Ended

​

​

​

December 31, 

​

 

​

2024

    

2023

    

2022

 

​

Geographical region:

​

​

​

​

​

​

​

​

​

​

China

$

56,119

​

$

39,778

​

$

55,414

​

​

Taiwan

​

14,098

​

​

8,651

​

​

28,780

​

​

Japan

​

4,979

​

​

4,641

​

​

11,724

​

​

Asia Pacific (excluding China, Taiwan and Japan)

​

2,818

​

​

3,814

​

​

4,188

​

​

Europe (primarily Germany)

​

13,766

​

​

12,315

​

​

20,592

​

​

North America (primarily the United States)

 

7,581

​

 

6,596

​

 

20,420

​

​

Total

$

99,361

​

$

75,795

​

$

141,118

​
Long-lived assets by geographic region

Long-lived assets consist primarily of property, plant and equipment, and operating lease right-of-use assets are attributed to the geographic location in which they are located. Long-lived assets, net of depreciation, by geographic region were as follows (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

As of December 31, 

​

​

 

2024

    

2023

 

Long-lived assets by geographic region, net of depreciation:

​

​

​

​

​

​

​

North America

​

$

1,353

​

$

1,631

​

China

​

 

160,847

​

 

167,516

​

​

​

$

162,200

​

$

169,147

​

​
v3.25.0.1
Other income (expense), net (Tables)
 12 Months Ended
Dec. 31, 2024
Other income (expense), net  
Schedule of components of other income (expense), net

The components of other income (expense), net are summarized below (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

Year Ended

​

​

December 31, 

​

​

2024

    

2023

    

2022

Foreign exchange gain (loss)

​

$

91

​

$

169

​

$

1,573

Income from local China government subsidy

​

​

2,239

​

​

2,557

​

​

1,710

Other income (expense)

​

​

(283)

​

​

(547)

​

​

204

​

​

$

2,047

​

$

2,179

​

$

3,487

​

​

​

​

​

​

​

​

​

​

​
v3.25.0.1
Commitments and Contingencies (Tables)
 12 Months Ended
Dec. 31, 2024
Commitments and Contingencies  
Summary of maturities of our operating lease liabilities

As of December 31, 2024, the maturities of our operating lease liabilities (excluding short-term leases) are as follows (in thousands):

​

​

​

Maturity of Lease Liabilities

    

​

2025

$

630

2026

​

653

2027

​

670

2028

​

651

2029

​

191

Thereafter

​

-

Total minimum lease payments

​

2,795

Less: Interest

​

(282)

Present value of lease obligations

​

2,513

Less: Current portion, included in accrued liabilities

​

(536)

Long-term portion of lease obligations

$

1,977
Schedule of weighted-average remaining lease term and the weighted-average discount rate of operating leases

​

​

​

​

​

​

​

​

​

December 31, 

​

December 31, 

​

​

​

2024

​

2023

​

Weighted-average remaining lease term (years)

​

4.27

​

5.22

​

Weighted-average discount rate

​

5.02

%

5.14

%
Schedule of supplemental cash flow information related to leases

Supplemental cash flow information related to leases where we are the lessee is as follows (in thousands):

​

​

​

​

​

​

​

​

​

​

Year Ended

​

​

​

December 31, 

​

​

​

2024

​

2023

​

Cash paid for amounts included in the measurement of lease liabilities:

​

​

​

​

​

​

​

Operating cash flows from operating leases

​

$

603

​

$

578

​
Summary of components of lease expense

The components of lease expense are as follows (in thousands) within our consolidated statements of operations:

​

​

​

​

​

​

​

Year Ended

​

December 31, 

​

2024

​

2023

Operating lease

$

615

​

$

548

Short-term lease expense

​

170

​

​

143

Total

$

785

​

$

691
v3.25.0.1
Redeemable Noncontrolling Interests (Tables)
 12 Months Ended
Dec. 31, 2024
Redeemable Noncontrolling Interests  
Components of the change in redeemable noncontrolling interests

The components of the change in redeemable noncontrolling interests for the years ended December 31, 2024 and 2023 are presented in the following table (in thousands):

​

​

​

Balance as of January 1, 2023

$

44,846

Investment in subsidiary with redeemable noncontrolling interest

​

155

Equity issuance costs incurred

​

(880)

Stock-based compensation attributable to redeemable noncontrolling interests

​

52

Net income attributable to redeemable noncontrolling interests

​

(920)

Effect of foreign currency translation on redeemable noncontrolling interests

​

(1,260)

Effect of foreign currency translation attributable to redeemable noncontrolling interests

​

(330)

Balance as of December 31, 2023

​

41,663

Equity issuance costs incurred

​

(992)

Stock-based compensation attributable to redeemable noncontrolling interests

​

34

Net loss attributable to redeemable noncontrolling interests

​

(509)

Effect of foreign currency translation on redeemable noncontrolling interests

​

(1,311)

Effect of foreign currency translation attributable to redeemable noncontrolling interests

​

(308)

Balance as of December 31, 2024

$

38,577

​
v3.25.0.1
The Company and Summary of Significant Accounting Policies - The Company (Details)
 12 Months Ended
Dec. 31, 2024
segment
item
The Company and Summary of Significant Accounting Policies  
Number of product lines | segment 2
Minimum  
The Company and Summary of Significant Accounting Policies  
Temperature in C 500
Maximum  
The Company and Summary of Significant Accounting Policies  
Temperature in C 1,500
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Specialty Material Substrates  
The Company and Summary of Significant Accounting Policies  
Revenue by product line (as a percent) 68.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Raw Materials  
The Company and Summary of Significant Accounting Policies  
Revenue by product line (as a percent) 32.00%
v3.25.0.1
The Company and Summary of Significant Accounting Policies- Principles of Consolidation (Details)
 1 Months Ended 2 Months Ended 3 Months Ended 12 Months Ended
Jan. 25, 2021
USD ($)
Nov. 30, 2024
USD ($)
Jul. 31, 2024
USD ($)
Jun. 30, 2024
USD ($)
Dec. 31, 2023
USD ($)
Aug. 31, 2023
USD ($)
May 31, 2023
USD ($)
Jan. 31, 2023
USD ($)
Aug. 31, 2022
USD ($)
Jul. 31, 2022
USD ($)
May 31, 2022
USD ($)
Apr. 30, 2022
USD ($)
Jan. 31, 2022
USD ($)
Jun. 30, 2021
USD ($)
May 31, 2021
USD ($)
Feb. 28, 2021
USD ($)
Jan. 31, 2021
USD ($)
Aug. 31, 2022
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2024
USD ($)
company
Dec. 31, 2023
USD ($)
company
Dec. 31, 2022
Dec. 31, 2020
USD ($)
Sep. 30, 2023
USD ($)
Jul. 31, 2023
USD ($)
Sep. 30, 2022
Dec. 31, 2021
USD ($)
Oct. 31, 2021
USD ($)
Sep. 30, 2021
USD ($)
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                                                          
Number of equity method investments | company                                       3 3                
Investments, equity method         $ 12,476,000                             $ 14,066,000 $ 12,476,000                
Payment for investment                                       $ 834,000 2,538,000                
AXT-Tongmei, Inc | Disposal Group, Disposed of by Sale, Not Discontinued Operations                                                          
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                                                          
Cash consideration                           $ 1,000,000                              
Minority investors                                                          
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                                                          
Loan amount           $ 200,000 $ 300,000 $ 200,000                                          
Chao Yang XinMei High Purity Semiconductor Materials Co. Ltd. | Loan from related party                                                          
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                                                          
Increase in redeemable noncontrolling interests                     $ 100,000                                    
Chao Yang XinMei High Purity Semiconductor Materials Co. Ltd. | Loan from related party | ChaoYang Xinshuo                                                          
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                                                          
Loan amount                                                       $ 1,000,000 $ 900,000
Sale of subsidiary shares to noncontrolling interests                       $ 1,900,000                                  
Amount paid to subsidiary                     600,000 700,000                                  
Chao Yang XinMei High Purity Semiconductor Materials Co. Ltd. | Loan from related party | Beijing Tongmei Xtal Technology                                                          
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                                                          
Sale of subsidiary shares to noncontrolling interests                       2,600,000                                  
Amount paid to subsidiary                     800,000 1,100,000                                  
Increase in noncontrolling interest                     $ 1,400,000   $ 2,200,000                                
Increase in redeemable noncontrolling interests                         $ 200,000                                
Chao Yang XinMei High Purity Semiconductor Materials Co. Ltd.                                                          
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                                                          
Ownership (as a percent)                   58.50% 58.50%   58.50%   58.50% 58.50%                          
Investment value, agreement amount                             $ 1,800,000 $ 3,000,000                          
Investments, equity method                               1,800,000                          
Initial funding                             1,500,000 1,500,000                          
Increase in noncontrolling interest                   $ 610,000                                      
Further investment                   600,000                                      
Redeemable noncontrolling interest increased                   57,000                                      
Chao Yang XinMei High Purity Semiconductor Materials Co. Ltd. | Loan from related party                                                          
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                                                          
Sale of subsidiary shares to noncontrolling interests                       $ 4,500,000                                  
ChaoYang ShuoMei High Purity Semiconductor Materials Co., Ltd.                                                          
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                                                          
Ownership (as a percent)           75.00%           75.00%                                  
Investment value, agreement amount                       $ 4,400,000                                  
Investments, equity method                       $ 3,300,000                                  
Initial funding                 $ 334,000                                        
Increase in noncontrolling interest           $ 200,000     406,000                                        
Increase in redeemable noncontrolling interests           44,000                                              
Redeemable noncontrolling interest increased                 $ 73,000                                        
ChaoYang KaiMei Quartz Co., Ltd                                                          
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                                                          
Ownership (as a percent)   40.00%                   40.00%               40.00%                  
Investment value, agreement amount                       $ 7,600,000                                  
Investments, equity method         3,154,000 600,000   900,000       $ 3,000,000               $ 3,895,000 $ 3,154,000     $ 2,300,000 $ 600,000        
Initial funding                   2,200,000                                      
Investment amount                   900,000                                      
Additional investment                                               $ 5,600,000          
Payment for investment   $ 300,000 $ 300,000 $ 300,000 $ 600,000                                                
ChaoYang ShuoMei High Purity Semiconductor Materials Co., Ltd.                                                          
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                                                          
Increase in noncontrolling interest             400,000 200,000                                          
Increase in redeemable noncontrolling interests             75,000 36,000                                          
Beijing BoYu Semiconductor Vessel Craftwork Technology Co., Ltd Investment                                                          
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                                                          
Percentage of outstanding shares                                     33.00%       33.00%            
Beijing BoYu Semiconductor Vessel Craftwork Technology Co., Ltd Investment | Beijing Boyu Semiconductor Vessel Craftwork Technology Co Ltd                                                          
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                                                          
Private equity ownership percentage                                             7.59%            
Beijing Tongmei Xtal Technology                                                          
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                                                          
Increase in redeemable noncontrolling interests                                 $ 1,500,000   $ 48,100,000       $ 48,100,000            
Percentage of outstanding shares 7.28%                                                 14.50%      
Private equity ownership percentage 7.28%                                         14.50%              
Percentage of key managers and contributors purchased                                             0.40%            
Investment in new facility $ 49,000,000                                   $ 48,100,000       $ 48,100,000            
Raised additional capital                                 $ 1,500,000                        
Percentage of ownership                           85.50%                              
Transaction results in increase to noncontrolling interests                           $ 1,200,000                              
Transaction results in increase to redeemable noncontrolling interests                           $ 1,200,000                              
Beijing Tongmei Xtal Technology | Beijing Boyu Semiconductor Vessel Craftwork Technology Co Ltd                                                          
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                                                          
Investment amount                               $ 900,000                          
Private equity ownership percentage                                             7.59%            
Beijing Tongmei Xtal Technology | Nanjing JinMei Gallium Co., Ltd                                                          
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                                                          
Private equity ownership percentage                                             0.0038%            
Beijing Tongmei Xtal Technology | Chao Yang XinMei High Purity Semiconductor Materials Co. Ltd.                                                          
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                                                          
Loan amount                         $ 1,400,000                           $ 1,400,000    
Beijing Tongmei Xtal Technology | Chao Yang XinMei High Purity Semiconductor Materials Co. Ltd. | Loan from related party                                                          
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                                                          
Increase in noncontrolling interest                     $ 1,400,000                                    
Beijing Tongmei Xtal Technology | Chao Yang XinMei High Purity Semiconductor Materials Co. Ltd.                                                          
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                                                          
Initial funding                   800,000                                      
Investment amount                             $ 900,000                            
Further investment                   $ 800,000                                      
Nanjing JinMei Gallium Co., Ltd Investment                                                          
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                                                          
Percentage of outstanding shares                                     8.50%       8.50%            
Nanjing JinMei Gallium Co., Ltd Investment | Nanjing JinMei Gallium Co., Ltd                                                          
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                                                          
Private equity ownership percentage                                             0.38%            
Chao Yang XinMei High Purity Semiconductor Materials Co. Ltd. | ChaoYang ShuoMei High Purity Semiconductor Materials Co., Ltd.                                                          
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                                                          
Initial funding                                   $ 1,000,000                      
ChaoYang JinMei Gallium Ltd. | ChaoYang ShuoMei High Purity Semiconductor Materials Co., Ltd.                                                          
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                                                          
Loan amount               $ 500,000                                          
ChaoYang JinMei Gallium Ltd. | ChaoYang ShuoMei High Purity Semiconductor Materials Co., Ltd. | ChaoYang ShuoMei High Purity Semiconductor Materials Co., Ltd.                                                          
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                                                          
Loan amount           $ 600,000 $ 1,000,000                                            
v3.25.0.1
The Company and Summary of Significant Accounting Policies - Foreign Currency Translation (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Foreign Exchange Transaction Gains/Lossess      
Foreign exchange gain (loss) $ 91 $ 169 $ 1,573
v3.25.0.1
The Company and Summary of Significant Accounting Policies - Revenue Recognition (Details)
 3 Months Ended 12 Months Ended
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2024
USD ($)
segment
Dec. 31, 2023
USD ($)
Revenue from Contract with Customer [Abstract]        
Contract liabilities $ 1,590,000 $ 305,000 $ 1,590,000 $ 305,000
Amounts included in contract balances $ 0 $ 9,000 $ 156,000 $ 278,000
Number of Operating Segments | segment     1  
Revenue, Practical Expedient, Incremental Cost of Obtaining Contract     true  
Revenue, Practical Expedient, Financing Component     true  
Revenue, Practical Expedient, Remaining Performance Obligation     true  
Maximum        
Revenue Recognition        
Sales commissions benefit period     1 year  
v3.25.0.1
The Company and Summary of Significant Accounting Policies - Risks and Concentration of Credit Risk (Details) - customer
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Customer Concentration Risk [Member]      
The Company and Summary of Significant Accounting Policies      
Number of customers representing significant share 0 0  
Accounts Receivable [Member]      
The Company and Summary of Significant Accounting Policies      
Number of customers representing significant share 1 0  
Raw Materials | Sales [Member]      
The Company and Summary of Significant Accounting Policies      
Number of customers representing significant share 2 2 1
Major Customer One [Member] | Sales [Member] | Customer Concentration Risk [Member]      
The Company and Summary of Significant Accounting Policies      
Number of customers representing significant share     1
Percentage share generated by major customers 10.00% 10.00% 15.00%
Top Five Major Customers [Member] | Sales [Member]      
The Company and Summary of Significant Accounting Policies      
Number of customers representing significant share 5 5 5
Top Five Major Customers [Member] | Sales [Member] | Customer Concentration Risk [Member]      
The Company and Summary of Significant Accounting Policies      
Percentage share generated by major customers 30.00% 25.00% 34.00%
v3.25.0.1
The Company and Summary of Significant Accounting Policies - Restricted Cash (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Restricted Cash and Cash Equivalents [Abstract]    
Restricted cash $ 10,978 $ 12,362
v3.25.0.1
The Company and Summary of Significant Accounting Policies - Accounts Receivable and Allowance for Doubtful Accounts and Sales Returns (Details) - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
The Company and Summary of Significant Accounting Policies    
Accounts receivable $ 25,640,000 $ 19,256,000
Allowance for Doubtful Accounts    
The Company and Summary of Significant Accounting Policies    
Valuation allowance balance 147,000 579,000
Increase/ (decrease) in allowance for doubtful accounts (432,000) 272,000
Allowance for Sales Returns    
The Company and Summary of Significant Accounting Policies    
Valuation allowance balance 28,000 39,000
Allowance utilized 28,000 39,000
Additional reduction $ 17,000 $ 34,000
v3.25.0.1
The Company and Summary of Significant Accounting Policies - Warranty Reserve (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Warranty Reserve      
Accrued product warranties $ 451,000 $ 703,000 $ 669,000
v3.25.0.1
The Company and Summary of Significant Accounting Policies - Property, Plant and Equipment (Details)
Dec. 31, 2024
Minimum  
Property, Plant and Equipment  
Property, plant and equipment, estimated economic life 1 year
Maximum  
Property, Plant and Equipment  
Property, plant and equipment, estimated economic life 39 years 6 months
Computers | Minimum  
Property, Plant and Equipment  
Property, plant and equipment, estimated economic life 3 years
Computers | Maximum  
Property, Plant and Equipment  
Property, plant and equipment, estimated economic life 5 years
Office equipment | Minimum  
Property, Plant and Equipment  
Property, plant and equipment, estimated economic life 3 years
Office equipment | Maximum  
Property, Plant and Equipment  
Property, plant and equipment, estimated economic life 5 years
Software | Minimum  
Property, Plant and Equipment  
Property, plant and equipment, estimated economic life 3 years
Software | Maximum  
Property, Plant and Equipment  
Property, plant and equipment, estimated economic life 5 years
Furniture and fixtures | Minimum  
Property, Plant and Equipment  
Property, plant and equipment, estimated economic life 3 years
Furniture and fixtures | Maximum  
Property, Plant and Equipment  
Property, plant and equipment, estimated economic life 5 years
Automobiles | Minimum  
Property, Plant and Equipment  
Property, plant and equipment, estimated economic life 5 years
Automobiles | Maximum  
Property, Plant and Equipment  
Property, plant and equipment, estimated economic life 10 years
Leasehold improvements  
Property, Plant and Equipment  
Property, plant and equipment, estimated economic life 10 years
Building improvements  
Property, Plant and Equipment  
Property, plant and equipment, estimated economic life 10 years
Machinery and equipment | Minimum  
Property, Plant and Equipment  
Property, plant and equipment, estimated economic life 1 year
Machinery and equipment | Maximum  
Property, Plant and Equipment  
Property, plant and equipment, estimated economic life 20 years
Building  
Property, Plant and Equipment  
Property, plant and equipment, estimated economic life 39 years 6 months
v3.25.0.1
The Company and Summary of Significant Accounting Policies - Impairment of Investments (Details) - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
The Company and Summary of Significant Accounting Policies      
Impairment charge $ 0 $ 1,900,000 $ 0
v3.25.0.1
The Company and Summary of Significant Accounting Policies - Segment Reporting (Details)
 12 Months Ended
Dec. 31, 2024
segment
The Company and Summary of Significant Accounting Policies  
Number of operating segments 1
v3.25.0.1
The Company and Summary of Significant Accounting Policies - Comprehensive Income (loss) (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Accumulated other comprehensive loss:        
Accumulated other comprehensive loss $ 216,331 $ 227,483 $ 244,900 $ 229,846
AOCI unrealized loss on investments, net        
Accumulated other comprehensive loss:        
Accumulated other comprehensive loss   (20)    
AOCI cumulative translation adjustment        
Accumulated other comprehensive loss:        
Accumulated other comprehensive loss (9,514) (6,530)    
AOCI Including portion attributable to noncontrolling interest        
Accumulated other comprehensive loss:        
Accumulated other comprehensive loss (9,514) (6,550)    
AOCI attributable to noncontrolling interest        
Accumulated other comprehensive loss:        
Accumulated other comprehensive loss (857) (551)    
Accumulated Other Comprehensive Income (Loss)        
Accumulated other comprehensive loss:        
Accumulated other comprehensive loss $ (8,657) $ (5,999) $ (3,118) $ 6,302
v3.25.0.1
Cash, Restricted Cash, Cash Equivalents and Investments (Details) - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash Equivalents, at Carrying Value        
Cash, restricted cash and cash equivalents $ 33,811,000 $ 50,114,000 $ 41,348,000 $ 36,763,000
Amortized Cost   2,160,000    
Total cash, restricted cash, cash equivalents and investments, amortized cost 33,811,000 52,274,000    
Gross Unrealized (Loss)   (20,000)    
Fair Value   2,140,000    
Total cash, restricted cash, cash equivalents and investments, fair value 33,811,000 52,254,000    
Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity        
Due within 1 year   2,160,000    
Investments, amortized cost   2,160,000    
Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity        
Due within 1 year   2,140,000    
Investments, fair value   2,140,000    
Debt Securities, Available-for-Sale, Unrealized Loss   20,000    
Impairment charge $ 0 1,900,000 $ 0  
Certificates of Deposit        
Cash Equivalents, at Carrying Value        
Amortized Cost   2,160,000    
Gross Unrealized (Loss)   (20,000)    
Fair Value   2,140,000    
Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity        
Investments, amortized cost   2,160,000    
Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity        
Investments, fair value   $ 2,140,000    
v3.25.0.1
Cash, Restricted Cash, Cash Equivalents and Investments - Investment Category and Length (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
USD ($)
company
Dec. 31, 2023
USD ($)
company
Available-for-Sale Securities, Continuous Unrealized Loss Position, Qualitative Disclosure    
Fair value, in loss position greater than twelve months   $ 2,140
Gross unrealized (loss), in loss position greater than twelve months   (20)
Fair value, total in loss position   2,140
Gross unrealized (loss), total in loss position   (20)
Investments in Privately Held Raw Material Companies    
Investments, equity method $ 14,066 $ 12,476
Number of equity method investments | company 3 3
Certificates of Deposit    
Available-for-Sale Securities, Continuous Unrealized Loss Position, Qualitative Disclosure    
Fair value, in loss position greater than twelve months   $ 2,140
Gross unrealized (loss), in loss position greater than twelve months   (20)
Fair value, total in loss position   2,140
Gross unrealized (loss), total in loss position   (20)
Other Assets    
Investments in Privately Held Raw Material Companies    
Investments, equity method $ 14,100 $ 12,500
v3.25.0.1
Cash, Restricted Cash, Cash Equivalents and Investments - Recurring Basis (Details) - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Assets, Fair Value Disclosure    
Investments, amortized cost   $ 2,140,000
Fair Value, Transfer Between Level 1 and Level 2, Description and Policy    
Transfer from Level 1 to Level 2 , assets $ 0 0
Transfers into Level 3, assets 0 0
Transfer out of Level 3, assets $ 0 0
Recurring    
Assets, Fair Value Disclosure    
Total   2,140,000
Recurring | Certificates of Deposit    
Assets, Fair Value Disclosure    
Cash and cash equivalents, fair value disclosure   2,140,000
Recurring | Significant Other Observable Inputs (Level 2)    
Assets, Fair Value Disclosure    
Total   2,140,000
Recurring | Significant Other Observable Inputs (Level 2) | Certificates of Deposit    
Assets, Fair Value Disclosure    
Cash and cash equivalents, fair value disclosure   $ 2,140,000
v3.25.0.1
Inventories (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Inventories    
Raw materials $ 31,743,000 $ 32,910,000
Work in process 50,779,000 50,008,000
Finished goods 2,555,000 3,585,000
Inventories, Total 85,077,000 86,503,000
Inventory reserve 24,100,000 21,900,000
Excess and obsolete inventory $ 73,000 $ 78,000
v3.25.0.1
Related Party Transactions (Details) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Jan. 31, 2023
Sep. 30, 2022
Jul. 31, 2022
May 31, 2022
Apr. 30, 2022
Jan. 31, 2022
Dec. 31, 2021
Oct. 31, 2021
Sep. 30, 2021
Jan. 31, 2021
Dec. 31, 2020
Dec. 31, 2020
Dec. 31, 2024
Dec. 31, 2023
May 31, 2021
Feb. 28, 2021
Related Party Transactions                                
Amount payable to related party                         $ 12,356,000 $ 9,617,000    
Beijing Tongmei Xtal Technology                                
Related Party Transactions                                
Increase in redeemable noncontrolling interests                   $ 1,500,000 $ 48,100,000 $ 48,100,000        
Loan from related party | Chao Yang XinMei High Purity Semiconductor Materials Co. Ltd.                                
Related Party Transactions                                
Increase in redeemable noncontrolling interests       $ 100,000                        
Loan from related party | Chao Yang XinMei High Purity Semiconductor Materials Co. Ltd. | Beijing Tongmei Xtal Technology                                
Related Party Transactions                                
Increase in noncontrolling interest       1,400,000                        
ChaoYang XinMei                                
Related Party Transactions                                
Sale of subsidiary shares to noncontrolling interests         $ 4,500,000                      
Donghai County Dongfang High Purity Electronic Materials Co., Ltd | Raw materials purchases from related party | Accounts payable | Chao Yang Tongmei Xtal Technology Co., Ltd.                                
Related Party Transactions                                
Amount payable to related party                         0 $ 0    
ChaoYang Xinshuo | Loan from related party | Chao Yang XinMei High Purity Semiconductor Materials Co. Ltd.                                
Related Party Transactions                                
Amount of transaction               $ 1,000,000 $ 900,000              
Short-term loan from noncontrolling interest             $ 1,900,000                  
Sale of subsidiary shares to noncontrolling interests         1,900,000                      
Amount paid to subsidiary       600,000 700,000                      
Beijing Tongmei Xtal Technology | Related party loan | Chao Yang XinMei High Purity Semiconductor Materials Co. Ltd.                                
Related Party Transactions                                
Amount of transaction             $ 1,400,000                  
Beijing Tongmei Xtal Technology | Loan from related party | Chao Yang XinMei High Purity Semiconductor Materials Co. Ltd.                                
Related Party Transactions                                
Amount of transaction           $ 1,400,000                    
Short-term loan from noncontrolling interest           0                    
Increase in noncontrolling interest       1,400,000   2,200,000                    
Increase in redeemable noncontrolling interests           $ 200,000                    
Sale of subsidiary shares to noncontrolling interests         2,600,000                      
Amount paid to subsidiary       $ 800,000 1,100,000                      
Chao Yang XinMei High Purity Semiconductor Materials Co. Ltd.                                
Related Party Transactions                                
Increase in noncontrolling interest     $ 610,000                          
Further investment     600,000                          
Redeemable noncontrolling interest increased     $ 57,000                          
Ownership (as a percent)     58.50% 58.50%   58.50%                 58.50% 58.50%
Chao Yang XinMei High Purity Semiconductor Materials Co. Ltd. | Beijing Tongmei Xtal Technology                                
Related Party Transactions                                
Further investment     $ 800,000                          
Chao Yang XinMei High Purity Semiconductor Materials Co. Ltd. | ChaoYang KaiMei Quartz Co., Ltd                                
Related Party Transactions                                
Amount of transaction   $ 1,500,000                            
Proceeds from related party $ 1,500,000                              
Chao Yang XinMei High Purity Semiconductor Materials Co. Ltd. | Prepaid expenses and other current assets | ChaoYang KaiMei Quartz Co., Ltd                                
Related Party Transactions                                
Other receivables                         $ 0      
Chao Yang XinMei High Purity Semiconductor Materials Co. Ltd. | Loan from related party                                
Related Party Transactions                                
Sale of subsidiary shares to noncontrolling interests         $ 4,500,000                      
v3.25.0.1
Property, Plant and Equipment, Net (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Property, plant and equipment      
Property, plant and equipment, net $ 159,721 $ 166,348  
Depreciation and amortization 8,979 8,722 $ 8,119
Machinery and equipment      
Property, plant and equipment      
Property, plant and equipment, gross 67,917 65,918  
Less: accumulated depreciation and amortization (44,065) (42,112)  
Building      
Property, plant and equipment      
Property, plant and equipment, gross 137,420 125,786  
Less: accumulated depreciation and amortization (26,310) (23,339)  
Leasehold improvements      
Property, plant and equipment      
Property, plant and equipment, gross 7,575 7,596  
Less: accumulated depreciation and amortization (6,347) (5,984)  
Construction in progress      
Property, plant and equipment      
Property, plant and equipment, gross 23,531 38,483  
Construction in progress Dingxin and Kazuo locations      
Property, plant and equipment      
Property, plant and equipment, gross 17,900 31,200  
Construction in progress manufacturing equipment purchases      
Property, plant and equipment      
Property, plant and equipment, gross 1,400 3,100  
Construction in progress other consolidated subsidiaries      
Property, plant and equipment      
Property, plant and equipment, gross $ 4,300 $ 4,200  
v3.25.0.1
Investments in Privately Held Raw Material Companies (Details) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
May 31, 2023
Jan. 25, 2021
Nov. 30, 2024
May 31, 2024
Nov. 30, 2023
May 31, 2023
Apr. 30, 2023
Jan. 31, 2023
Aug. 31, 2022
Jul. 31, 2022
Jun. 30, 2022
Jan. 31, 2021
Dec. 31, 2020
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2020
Sep. 30, 2023
Aug. 31, 2023
Jul. 31, 2023
Sep. 30, 2022
Apr. 30, 2022
Jun. 30, 2021
Summary of investments                                              
Investments, equity method                           $ 14,066,000 $ 12,476,000                
Investments, cost method                           $ 551,000 551,000                
Percentage of equity interest sold                           15.00%                  
Proceeds from sale of equity method investments                             827,000                
Dividend received                           $ 2,396,000 4,316,000 $ 1,608,000              
Other Assets                                              
Summary of investments                                              
Investments, equity method                           14,100,000 12,500,000                
Beijing JiYa Semiconductor Material Co., Ltd Investment                                              
Summary of investments                                              
Dividends received     $ 300,000                                        
Xilingol Tongli Germanium Co. Ltd Investment                                              
Summary of investments                                              
Dividends received       $ 2,100,000                                      
Emeishan Jia Mei High Purity Metals Co., Ltd Investment                                              
Summary of investments                                              
Investments, cost method                           $ 551,000 551,000                
Percentage of ownership, equity method 25.00%         25.00%               10.00%                  
Percentage of ownership, cost method 10.00%         10.00%               10.00%                  
Percentage of equity interest sold 15.00%                         15.00%                  
Proceeds from sale of equity method investments $ 10         $ 827,000                                  
Beijing BoYu Semiconductor Vessel Craftwork Technology Co., Ltd Investment                                              
Summary of investments                                              
Dividends received                     $ 1,300,000                        
Beijing JiYa Semiconductor Material Co., Ltd Investment                                              
Summary of investments                                              
Investments, equity method                           $ 4,867,000 3,806,000                
Percentage of ownership, equity method                           39.00%                  
Dividends received         $ 500,000   $ 2,000,000   $ 100,000                            
Xiaoyi XingAn Gallium Co., Ltd.                                              
Summary of investments                                              
Investments, equity method                           $ 5,304,000 5,516,000                
Percentage of ownership, equity method                           25.00%                  
Dividends received             $ 1,800,000     $ 1,500,000                          
ChaoYang KaiMei Quartz Co., Ltd                                              
Summary of investments                                              
Investments, equity method               $ 900,000           $ 3,895,000 3,154,000     $ 2,300,000 $ 600,000 $ 600,000   $ 3,000,000  
Percentage of ownership, equity method     40.00%                     40.00%               40.00%  
Donghai County Dongfang High Purity Electronic Materials Co., Ltd Investment                                              
Summary of investments                                              
Percentage of ownership, equity method         46.00%                                    
Percentage of ownership, cost method         0.00%                                    
Percentage of equity interest sold         46.00%                 46.00%                  
PRC subsidiaries and PRC raw material joint ventures                                              
Summary of investments                                              
Dividends received                           $ 2,400,000 4,300,000 $ 2,900,000              
Dividends paid                           $ 0 0                
Nanjing JinMei Gallium Co., Ltd Investment                                              
Summary of investments                                              
Percentage of outstanding shares                         8.50%       8.50%            
Nanjing JinMei Gallium Co., Ltd Investment | Beijing JiYa Semiconductor Material Co., Ltd Investment                                              
Summary of investments                                              
Percentage of ownership, equity method                           39.00%                  
Beijing BoYu Semiconductor Vessel Craftwork Technology Co., Ltd Investment                                              
Summary of investments                                              
Percentage of outstanding shares                         33.00%       33.00%            
Beijing Tongmei Xtal Technology                                              
Summary of investments                                              
Percentage of ownership, consolidated method                                             85.50%
Percentage of outstanding shares   7.28%                                     14.50%    
Private equity ownership percentage   7.28%                           14.50%              
Percentage of key managers and contributors purchased                                 0.40%            
Increase in redeemable noncontrolling interests                       $ 1,500,000 $ 48,100,000       $ 48,100,000            
Investments, government approved   $ 49,000,000                                          
Nanjing JinMei Gallium Co., Ltd | Nanjing JinMei Gallium Co., Ltd Investment                                              
Summary of investments                                              
Private equity ownership percentage                                 0.38%            
Nanjing JinMei Gallium Co., Ltd | Beijing Tongmei Xtal Technology                                              
Summary of investments                                              
Private equity ownership percentage                                 0.0038%            
Beijing Boyu Semiconductor Vessel Craftwork Technology Co Ltd | Beijing BoYu Semiconductor Vessel Craftwork Technology Co., Ltd Investment                                              
Summary of investments                                              
Private equity ownership percentage                                 7.59%            
Beijing Boyu Semiconductor Vessel Craftwork Technology Co Ltd | Beijing Tongmei Xtal Technology                                              
Summary of investments                                              
Private equity ownership percentage                                 7.59%            
Majority-Owned Subsidiaries                                              
Summary of investments                                              
Investments, consolidated method                           $ 14,211,000 14,211,000                
Nanjing JinMei Gallium Co., Ltd Investment                                              
Summary of investments                                              
Investments, consolidated method                           $ 592,000 592,000                
Nanjing JinMei Gallium Co., Ltd Investment | Nanjing JinMei Gallium Co., Ltd Investment                                              
Summary of investments                                              
Percentage of ownership, consolidated method                           85.50%                  
ChaoYang JinMei Gallium Co., Ltd.                                              
Summary of investments                                              
Investments, consolidated method                           $ 1,820,000 1,820,000                
ChaoYang JinMei Gallium Co., Ltd. | ChaoYang JinMei Gallium Co., Ltd.                                              
Summary of investments                                              
Percentage of ownership, consolidated method                           85.50%                  
Beijing BoYu Semiconductor Vessel Craftwork Technology Co., Ltd Investment                                              
Summary of investments                                              
Investments, consolidated method                           $ 1,346,000 1,346,000                
Beijing BoYu Semiconductor Vessel Craftwork Technology Co., Ltd Investment | Beijing BoYu Semiconductor Vessel Craftwork Technology Co., Ltd Investment                                              
Summary of investments                                              
Percentage of ownership, consolidated method                           85.50%                  
ChaoYang ShuoMei High Purity Semiconductor Materials Co., Ltd.                                              
Summary of investments                                              
Investments, consolidated method                           $ 3,122,000 3,122,000                
Increase in redeemable noncontrolling interests           $ 75,000   $ 36,000                              
ChaoYang ShuoMei High Purity Semiconductor Materials Co., Ltd. | ChaoYang ShuoMei High Purity Semiconductor Materials Co., Ltd.                                              
Summary of investments                                              
Percentage of ownership, consolidated method                           75.00%                  
Chao Yang XinMei High Purity Semiconductor Materials Co. Ltd.                                              
Summary of investments                                              
Investments, consolidated method                           $ 7,331,000 $ 7,331,000                
Chao Yang XinMei High Purity Semiconductor Materials Co. Ltd. | Chao Yang XinMei High Purity Semiconductor Materials Co. Ltd.                                              
Summary of investments                                              
Percentage of ownership, consolidated method                           58.50%                  
v3.25.0.1
Investments in Privately Held Raw Material Companies - Gain (Loss) on Sale and Remeasurement of Equity Method Investments (Details) - USD ($)
 1 Months Ended 12 Months Ended
May 31, 2023
Nov. 30, 2023
May 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Investments in Privately-Held Raw Material Companies          
Fair value of the consideration received         $ 779,000
Gain (loss) recognized on sale         (166,000)
Fair value of the retained investment in Emeishan Jia Mei High Purity Metals Co., Ltd.       $ 551,000 551,000
Percentage of equity interest sold       15.00%  
Emeishan Jia Mei High Purity Metals Co., Ltd Investment          
Investments in Privately-Held Raw Material Companies          
Foreign income tax withholding         48,000
Carrying value         (252,000)
Gain (loss) recognized on sale     $ 575,000   575,000
Fair value of the retained investment in Emeishan Jia Mei High Purity Metals Co., Ltd.       $ 551,000 551,000
Carrying value of retained noncontrolling investment (10%)       (168,000)  
Gain on retained noncontrolling investment due to remeasurement (10%)       $ 383,000  
Percentage of equity interest sold 15.00%     15.00%  
Percentage of ownership, cost method 10.00%   10.00% 10.00%  
Percentage of ownership, equity method 25.00%   25.00% 10.00%  
Donghai County Dongfang High Purity Electronic Materials Co., Ltd Investment          
Investments in Privately-Held Raw Material Companies          
Fair value of the consideration received   $ 600,000     585,000
Carrying value         (1,710,000)
Gain (loss) recognized on sale         $ (1,125,000)
Percentage of equity interest sold   46.00%   46.00%  
Percentage of ownership, cost method   0.00%      
Percentage of ownership, equity method   46.00%      
v3.25.0.1
Investments in Privately Held Raw Material Companies - Minority Investment Entities (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest      
Net revenue $ 99,361 $ 75,795 $ 141,118
Gross profit 23,836 13,318 52,121
Net income (11,791) (19,193) 18,742
Gross Profit      
Current assets 158,272 170,656  
Current liabilities 74,176 81,557  
Undistributed Earnings, Basic 9,200 8,100  
Five Minority Investments      
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest      
Net revenue 37,591 32,544 48,139
Gross profit 17,747 11,698 27,000
Operating income 13,780 10,115 24,987
Net income 11,944 8,681 19,104
Gross Profit      
Current assets 34,858 31,636  
Noncurrent assets 20,975 19,751  
Noncurrent liabilities 6,165    
Current liabilities 5,602 7,367  
Five Minority Investments      
Gross Profit      
Entity income (loss) excluding impairment 3,400 1,900 6,000
Parent [Member]      
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest      
Net revenue 11,715 10,033 15,031
Gross profit 5,374 3,365 8,229
Operating income 3,889 2,724 7,532
Net income $ 3,439 $ 1,884 $ 5,957
v3.25.0.1
Balance Sheets Details - Other Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Components of other assets    
Equity method investments $ 14,066 $ 12,476
Value added tax receivable, long term 194 1,291
Other intangible assets 1,710 1,821
Deferred tax assets 1,418 1,683
Other assets 1,454 1,627
Other assets, Total $ 18,842 $ 18,898
v3.25.0.1
Balance Sheets Details - Accrued Liabilities (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Accrued Liabilities, Current [Abstract]      
Preferred stock dividends payable $ 2,901,000 $ 2,901,000  
Accrued compensation and related charges 2,832,000 3,707,000  
Payable in connection with construction in progress 1,985,000 7,249,000  
Advances from customers 1,590,000 305,000  
Accrued professional services 1,460,000 868,000  
Current portion of operating lease liabilities 536,000 458,000  
Accrued product warranty 451,000 703,000 $ 669,000
Other tax payable 399,000 493,000  
Other personnel-related costs 256,000 286,000  
Accrued income taxes 127,000    
Accrual for sales returns 28,000 39,000  
Other accrued liabilities 1,991,000 2,010,000  
Accrued liabilities, Total $ 14,556,000 $ 19,019,000  
v3.25.0.1
Bank Loans and Line of Credit - Schedule of Bank Loans (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Bank Loans and Line of Credit    
Loan Balance $ 45,963 $ 52,921
Beijing Tongmei Xtal Technology | Bank of China | Bank Loan with 3.5 Percent, January 2024 Due Date One    
Bank Loans and Line of Credit    
Loan Detail $ 1,848  
Interest rate 3.50%  
Loan Balance   1,795
Beijing Tongmei Xtal Technology | Bank of China | Bank Loan with 2.8 Percent, March 2024 Due Date One    
Bank Loans and Line of Credit    
Loan Detail $ 2,184  
Interest rate 2.80%  
Loan Balance   2,118
Beijing Tongmei Xtal Technology | Bank of China | Bank Loan with 2.7 Percent, September 2024 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 376  
Interest rate 2.70%  
Loan Balance   386
Beijing Tongmei Xtal Technology | Bank of China | Bank Loan with 3.5 Percent, November 2024 Due Date One    
Bank Loans and Line of Credit    
Loan Detail $ 876  
Interest rate 3.50%  
Loan Balance   876
Beijing Tongmei Xtal Technology | Bank of China | Bank Loan with 3.5 Percent, November 2024 Due Date Two    
Bank Loans and Line of Credit    
Loan Detail $ 1,003  
Interest rate 3.50%  
Loan Balance   1,003
Beijing Tongmei Xtal Technology | Bank of China | Bank Loan with 3.5 Percent, January 2024 Due Date Two    
Bank Loans and Line of Credit    
Loan Detail $ 2,911  
Interest rate 3.50%  
Loan Balance   2,825
Beijing Tongmei Xtal Technology | Bank of China | Bank Loan with 2.4 Percent, September 2025 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 1,426  
Interest rate 2.40%  
Loan Balance $ 1,370  
Beijing Tongmei Xtal Technology | Bank of China | Bank Loan with 2.4 Percent, November 2025 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 1,370  
Interest rate 2.40%  
Loan Balance $ 1,370  
Beijing Tongmei Xtal Technology | Bank of China | Bank Loan With 2.7 Percent, November 2025 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 685  
Interest rate 2.70%  
Loan Balance $ 685  
Beijing Tongmei Xtal Technology | Bank of Communications | Bank Loan with 3.3 Percent, January 2024 Due Date Two    
Bank Loans and Line of Credit    
Loan Detail $ 1,455  
Interest rate 3.30%  
Loan Balance   1,414
Beijing Tongmei Xtal Technology | Bank of Communications | Bank Loan with 3.8 Percent, May 2024 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 1,380  
Interest rate 3.80%  
Loan Balance   1,414
Beijing Tongmei Xtal Technology | Bank of Communications | Bank Loan with 3.8 Percent, May 2024 Due Date One    
Bank Loans and Line of Credit    
Loan Detail $ 1,373  
Interest rate 3.80%  
Loan Balance   1,414
Beijing Tongmei Xtal Technology | Bank of Communications | Bank Loan with 3.0 Percent, May 2025 Due Date One    
Bank Loans and Line of Credit    
Loan Detail $ 1,376  
Interest rate 3.00%  
Loan Balance $ 1,370  
Beijing Tongmei Xtal Technology | Bank of Communications | Bank Loan with 3.0 Percent, May 2025 Due Date Two    
Bank Loans and Line of Credit    
Loan Detail $ 2,480  
Interest rate 3.00%  
Loan Balance $ 2,466  
Beijing Tongmei Xtal Technology | Agricultural Bank of China | Bank Loan With 2.6 Percent, November 2025 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 1,235  
Interest rate 2.60%  
Loan Balance $ 1,235  
Beijing Tongmei Xtal Technology | Agricultural Bank of China | Bank Loan With 2.6 Percent, December 2025 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 137  
Interest rate 2.60%  
Loan Balance $ 137  
Beijing Tongmei Xtal Technology | China Merchants Bank | Bank Loan with 3.7 Percent, January 2024 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 4,367  
Interest rate 3.70%  
Loan Balance   4,235
Beijing Tongmei Xtal Technology | China Merchants Bank | Bank Loan with 3.5 Percent, January 2025 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 1,386  
Interest rate 3.50%  
Loan Balance $ 1,370  
Beijing Tongmei Xtal Technology | China Merchants Bank | Bank Loan with 3.5 Percent, February 2025 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 692  
Interest rate 3.50%  
Loan Balance $ 685  
Beijing Tongmei Xtal Technology | China Merchants Bank | Bank Loan with 3.5 Percent, April 2025 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 692  
Interest rate 3.50%  
Loan Balance $ 685  
Beijing Tongmei Xtal Technology | Bank of Beijing | Bank Loan with 4.2 Percent One, January 2024 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 2,290  
Interest rate 4.20%  
Loan Balance   2,220
Beijing Tongmei Xtal Technology | Bank of Beijing | Bank Loan with 3.2 Percent, May 2024 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 3,541  
Interest rate 3.20%  
Loan Balance   3,626
Beijing Tongmei Xtal Technology | Bank of Beijing | Bank Loan with 3.2 Percent, February 2024 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 1,380  
Interest rate 3.20%  
Loan Balance   1,414
Beijing Tongmei Xtal Technology | Bank of Beijing | Bank Loan with 3.0 Percent, December 2024 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 1,414  
Interest rate 3.00%  
Loan Balance   1,414
Beijing Tongmei Xtal Technology | Bank of Beijing | Bank Loan with 3.0 Percent, February 2025 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 3,600  
Interest rate 3.00%  
Loan Balance $ 3,565  
Beijing Tongmei Xtal Technology | Bank of Beijing | Bank Loan with 3.0 Percent, June 2025 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 3,580  
Interest rate 3.00%  
Loan Balance $ 3,565  
Beijing Tongmei Xtal Technology | Industrial Bank    
Bank Loans and Line of Credit    
Guarantee fee (as a percent) 1.00%  
Beijing Tongmei Xtal Technology | Industrial Bank | Bank Loan with 4.3 Percent, June 2024 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 2,757  
Interest rate 4.30%  
Loan Balance   2,825
Beijing Tongmei Xtal Technology | Industrial Bank | Bank Loan with 4.3 Percent, July 2024 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 2,744  
Interest rate 4.30%  
Loan Balance   2,825
Beijing Tongmei Xtal Technology | Industrial Bank | Bank Loan with 4.3 Percent, September 2024 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 2,744  
Interest rate 4.30%  
Loan Balance   2,825
Beijing Tongmei Xtal Technology | Industrial Bank | Bank Loan with 3.9 Percent, September 2025 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 2,851  
Interest rate 3.90%  
Loan Balance $ 2,740  
Beijing Tongmei Xtal Technology | Industrial Bank | Bank Loan With 3.9 Percent, October 2025 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 2,679  
Interest rate 3.90%  
Loan Balance $ 2,679  
Beijing Tongmei Xtal Technology | Industrial Bank | Bank Loan With 3.2 Percent, November 2025 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 1,440  
Interest rate 3.20%  
Loan Balance $ 1,440  
Beijing Tongmei Xtal Technology | NingBo Bank | Bank Loan with 4.2 Percent, September 2024 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 2,744  
Interest rate 4.20%  
Loan Balance   2,820
Beijing Tongmei Xtal Technology | NingBo Bank | Bank Loan with 4.3 Percent, November 2024 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 1,271  
Interest rate 4.30%  
Loan Balance   1,271
Beijing Tongmei Xtal Technology | NingBo Bank | Bank Loan with 4.3 Percent, December 2024 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 2,825  
Interest rate 4.30%  
Loan Balance   2,825
Beijing Tongmei Xtal Technology | NingBo Bank | Bank Loan with 4.3 Percent, January 2025 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 1,647  
Interest rate 4.30%  
Loan Balance $ 1,630  
Beijing Tongmei Xtal Technology | NingBo Bank | Bank Loan with 4.3 Percent, March 2025 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 1,258  
Interest rate 4.30%  
Loan Balance $ 1,255  
Beijing Tongmei Xtal Technology | NingBo Bank | Bank Loan With 3.9 Percent, November 2025 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 1,822  
Interest rate 3.90%  
Loan Balance $ 1,822  
Beijing Tongmei Xtal Technology | NingBo Bank | Bank Loan With 3.9 Percent, December 2025 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 550  
Interest rate 3.90%  
Loan Balance $ 550  
Beijing Tongmei Xtal Technology | China Citic Bank | Bank Loan With 2.9 Percent, June 2025 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 2,752  
Interest rate 2.90%  
Loan Balance $ 2,740  
Beijing Tongmei Xtal Technology | China Citic Bank | Bank Loan with 2.9 Percent, July 2025 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 2,851  
Interest rate 2.90%  
Loan Balance $ 2,740  
Beijing Tongmei Xtal Technology | China Citic Bank | Bank Loan with 2.9 Percent, September 2025 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 1,426  
Interest rate 2.90%  
Loan Balance $ 1,370  
Beijing Tongmei Xtal Technology | Industrial and Commercial Bank of China | Bank Loan with 3.3 Percent, September 2024 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 2,744  
Interest rate 3.30%  
Loan Balance   2,825
Beijing Tongmei Xtal Technology | Industrial and Commercial Bank of China | Bank Loan with 3.3 Percent, September 2025 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 2,851  
Interest rate 3.30%  
Loan Balance $ 2,740  
Beijing Tongmei Xtal Technology | NanJing Bank | Bank Loan with 3.8 Percent, October 2024 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 2,752  
Interest rate 3.80%  
Loan Balance   2,752
Beijing BoYu Semiconductor Vessel Craftwork Technology Co | Bank of China | Bank Loan with 2.4 Percent, January 2024 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 1,204  
Interest rate 2.40%  
Loan Balance   849
Beijing BoYu Semiconductor Vessel Craftwork Technology Co | Bank of China | Bank Loan with 2.3 Percent, September 2025 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 1,145  
Interest rate 2.30%  
Loan Balance $ 1,096  
Beijing BoYu Semiconductor Vessel Craftwork Technology Co | Bank of China | Bank Loan With 2.4 Percent, December 2025 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 274  
Interest rate 2.40%  
Loan Balance $ 274  
Beijing BoYu Semiconductor Vessel Craftwork Technology Co | Bank of Communications | Bank Loan with 3.0 Percent, May 2024 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 1,414  
Interest rate 3.00%  
Loan Balance   $ 1,414
Beijing BoYu Semiconductor Vessel Craftwork Technology Co | Bank of Communications | Bank Loan with 3.0 Percent, May 2025 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 274  
Interest rate 3.00%  
Loan Balance $ 274  
Beijing BoYu Semiconductor Vessel Craftwork Technology Co | Industrial Bank    
Bank Loans and Line of Credit    
Guarantee fee (as a percent)   0.70%
Beijing BoYu Semiconductor Vessel Craftwork Technology Co | Industrial Bank | Bank Loan With 3.6 Percent September 2024 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 688  
Interest rate 3.60%  
Loan Balance   $ 708
Beijing BoYu Semiconductor Vessel Craftwork Technology Co | Industrial Bank | Bank Loan With 2.7 Percent, November 2025 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 1,370  
Interest rate 2.70%  
Loan Balance $ 1,370  
Beijing BoYu Semiconductor Vessel Craftwork Technology Co | NingBo Bank | Bank Loan with 3.3 Percent, May 2024 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 1,414  
Interest rate 3.30%  
Loan Balance   1,414
Beijing BoYu Semiconductor Vessel Craftwork Technology Co | Industrial and Commercial Bank of China | Bank Loan with 2.7 Percent, December 2024 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 1,414  
Interest rate 2.70%  
Loan Balance   $ 1,414
Beijing BoYu Semiconductor Vessel Craftwork Technology Co | Industrial and Commercial Bank of China | Bank Loan with 2.8 Percent, September 2025 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 1,426  
Interest rate 2.80%  
Loan Balance $ 1,370  
Beijing BoYu Semiconductor Vessel Craftwork Technology Co | NanJing Bank | Bank Loan With 2.8 Percent, December 2025 Due Date    
Bank Loans and Line of Credit    
Loan Detail $ 1,370  
Interest rate 2.80%  
Loan Balance $ 1,370  
v3.25.0.1
Bank Loans and Line of Credit - Long-Term Loans (Details) - USD ($)
 1 Months Ended
Jan. 31, 2024
Dec. 31, 2024
Jan. 30, 2024
Dec. 31, 2023
Long-term Loans        
Maximum borrowing capacity     $ 9,700,000  
Term of loan     5 years  
Interest rate     6.50%  
Line of credit, Non Current   $ 5,800,000    
Line of credit, Current   47,300,000    
Loan Balance   $ 45,963,000   $ 52,921,000
Chaoyang Xinmei High Purity Semiconductor MaterialsCo. Ltd        
Long-term Loans        
Term of loan   5 years    
Loan amount       2,100,000
Value of option to repurchase production line       $ 14
Long term loan   $ 600,000    
Chaoyang Xinmei High Purity Semiconductor MaterialsCo. Ltd | Other long-term liabilities        
Long-term Loans        
Long term loan   619,000    
Chaoyang Xinmei High Purity Semiconductor MaterialsCo. Ltd | Short-term loans        
Long-term Loans        
Loan Balance   890,000    
Chao Yang Tongmei High Purity Semiconductor Materials Co. Ltd [Member]        
Long-term Loans        
Proceeds from bank loan $ 5,800,000      
Long term loan   5,200,000    
Chao Yang Tongmei High Purity Semiconductor Materials Co. Ltd [Member] | Other long-term liabilities        
Long-term Loans        
Line of credit, Non Current   5,200,000    
Chao Yang Tongmei High Purity Semiconductor Materials Co. Ltd [Member] | Short-term loans        
Long-term Loans        
Line of credit, Current   $ 411,000    
v3.25.0.1
Bank Loans and Line of Credit - Maturities of Long-Term Liabilities (Details)
$ in Thousands
Dec. 31, 2024
USD ($)
Maturities of long-term liabilities  
2025 $ 1,301
2026 1,301
2027 959
2028 1,233
2029 $ 2,347
v3.25.0.1
Bank Loans and Line of Credit - Balances (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Jan. 30, 2024
Dec. 31, 2023
Long-term Loans      
Line of credit, Current $ 47,300    
Loan Balance 45,963   $ 52,921
Current portion of long term dent 1,300    
Line of credit, Non Current 5,800    
Term of loan   5 years  
Chaoyang Xinmei High Purity Semiconductor MaterialsCo. Ltd      
Long-term Loans      
Long term loan $ 600    
Term of loan 5 years    
Chao Yang Tongmei High Purity Semiconductor Materials Co. Ltd      
Long-term Loans      
Long term loan $ 5,200    
v3.25.0.1
Stockholders' Equity and Stock Repurchase Program (Details) - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2015
Oct. 27, 2014
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Preferred stock, shares issued (in shares) 883,000 883,000      
Cumulative annual dividend rate (as a percent) 5.00% 5.00%      
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001      
Preferred stock, shares outstanding (in shares) 883,000 883,000      
Preferred stock, value $ 3,532,000 $ 3,532,000      
Liquidation preference over common stock (in dollars per share) $ 4 $ 4      
Stock repurchase program, authorized amount         $ 5,000,000
Shares repurchased (in shares) 0 0 0 908,000  
Average price of shares repurchased (in dollars per share)       $ 2.52  
Total purchase price       $ 2,300,000  
Stock repurchase program remaining authorized repurchase amount $ 2,700,000        
Preferred stock dividends payable $ 2,901,000 $ 2,901,000      
Series A Preferred Stock [Member]          
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Preferred stock dividends payable       $ 2,900,000  
v3.25.0.1
Stockholders' Equity and Stock Repurchase Program - Ownership Interest in Consolidated Subsidiaries (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Stockholders' Equity and Stock Repurchase Program      
Net income attributable to AXT, Inc. $ (11,624) $ (17,881) $ 15,811
Decrease in additional paid-in capital for:      
Investment in subsidiary with noncontrolling interest   (308)  
Change from net loss attributable to AXT, Inc., net of transfers to noncontrolling interests $ (11,624) $ (18,189)  
v3.25.0.1
Employee Benefit Plans and Stock-based Compensation (Details) - USD ($)
 1 Months Ended 12 Months Ended
May 31, 2024
May 31, 2021
May 31, 2019
May 31, 2015
May 31, 2013
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Employee Stock Option [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Exercised (in shares)           12,000 4,000 172,000
Intrinsic value of options exercised           $ 29,000 $ 7,000 $ 800,000
1997 Stock Option Plan                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Number of shares available for grant (in shares)           1,928,994    
2007 Equity Incentive Plan                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Number of shares authorized for issuance (in shares)           1,300,000    
Number of additional shares authorized for issuance (in shares)         2,000,000      
2007 Equity Incentive Plan | Employee Stock Option [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Vesting period           3 years    
2007 Equity Incentive Plan | Restricted Stock [Member] | Time based vesting                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Vesting period           3 years    
2007 Equity Incentive Plan | Restricted Stock [Member] | Performance Based Vesting                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Vesting period           12 months    
2007 Equity Incentive Plan | Maximum | Employee Stock Option [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Expected term           10 years    
2015 Equity Incentive Plan                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Number of shares authorized for issuance (in shares)       399,562        
Number of additional shares authorized for issuance (in shares) 3,600,000 3,600,000 1,600,000 3,000,000        
Number of shares available for grant (in shares)           3,700,000    
2015 Equity Incentive Plan | Consultant                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Vesting period           1 year    
2015 Equity Incentive Plan | Employee Stock Option [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Vesting period           4 years    
2015 Equity Incentive Plan | Restricted Stock [Member] | Time based vesting                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Vesting period           3 years    
2015 Equity Incentive Plan | Restricted Stock [Member] | Performance Based Vesting                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Vesting period           12 months    
2015 Equity Incentive Plan | Maximum | Employee Stock Option [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Expected term           10 years    
v3.25.0.1
Employee Benefit Plans and Stock-based Compensation - Options (Details) - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Employee Stock Option        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Stock options grants in period 0 0 0  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding        
Options outstanding, beginning of period (in shares) 1,198,000 1,206,000 1,378,000  
Exercised (in shares) (12,000) (4,000) (172,000)  
Canceled and expired (in shares) (11,000) (4,000)    
Options outstanding, end of period (in shares) 1,175,000 1,198,000 1,206,000 1,378,000
Options exercisable, end of period (in shares) 1,175,000      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price        
Options outstanding, beginning of period (in dollars per share) $ 5.1 $ 5.09 $ 4.83  
Exercised (in dollars per share) 2.24 2.3 3.02  
Canceled and expired (in dollars per share) 2.47 4.12    
Options outstanding, end of period (in dollars per share) 5.16 $ 5.1 $ 5.09 $ 4.83
Options exercisable, end of period (in dollars per share) $ 5.16      
Weighted average Remaining Contractual Life        
Options outstanding 3 years 1 month 28 days 4 years 1 month 2 days 5 years 29 days 5 years 7 months 6 days
Option exercisable, end of period 3 years 1 month 28 days      
Aggregate Intrinsic Value        
Options outstanding, beginning of period $ 14,000 $ 630,000 $ 5,573,000  
Options outstanding, end of period   $ 14,000 $ 630,000 $ 5,573,000
2015 Equity Incentive Plan        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Value of estimated forfeitures $ 0      
v3.25.0.1
Employee Benefit Plans and Stock-based Compensation - Options Exercise Prices (Details)
shares in Thousands
 12 Months Ended
Dec. 31, 2024
$ / shares
shares
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options outstanding, shares (in shares) | shares 1,175
Weighted-average Exercise Price (in dollars per share) $ 5.16
Weighted-average Remaining Contractual Life 3 years 1 month 28 days
Options Vested and Exercisable, Shares (in shares) | shares 1,175
Options Vested and Exercisable, Weighted-Average Exercise Price (in dollars per share) $ 5.16
$ 2.18 - $ 2.18  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price, minimum (in dollars per share) 2.18
Range of exercise price, maximum (in dollars per share) $ 2.18
Options outstanding, shares (in shares) | shares 53
Weighted-average Exercise Price (in dollars per share) $ 2.18
Weighted-average Remaining Contractual Life 10 months 2 days
Options Vested and Exercisable, Shares (in shares) | shares 53
Options Vested and Exercisable, Weighted-Average Exercise Price (in dollars per share) $ 2.18
$ 2.56 - $ 2.56  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price, minimum (in dollars per share) 2.56
Range of exercise price, maximum (in dollars per share) $ 2.56
Options outstanding, shares (in shares) | shares 11
Weighted-average Exercise Price (in dollars per share) $ 2.56
Weighted-average Remaining Contractual Life 1 year 3 days
Options Vested and Exercisable, Shares (in shares) | shares 11
Options Vested and Exercisable, Weighted-Average Exercise Price (in dollars per share) $ 2.56
$ 3.06 - $ 3.06  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price, minimum (in dollars per share) 3.06
Range of exercise price, maximum (in dollars per share) $ 3.06
Options outstanding, shares (in shares) | shares 330
Weighted-average Exercise Price (in dollars per share) $ 3.06
Weighted-average Remaining Contractual Life 4 years 10 months 6 days
Options Vested and Exercisable, Shares (in shares) | shares 330
Options Vested and Exercisable, Weighted-Average Exercise Price (in dollars per share) $ 3.06
$ 5.21 - $ 5.21  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price, minimum (in dollars per share) 5.21
Range of exercise price, maximum (in dollars per share) $ 5.21
Options outstanding, shares (in shares) | shares 352
Weighted-average Exercise Price (in dollars per share) $ 5.21
Weighted-average Remaining Contractual Life 1 year 9 months 25 days
Options Vested and Exercisable, Shares (in shares) | shares 352
Options Vested and Exercisable, Weighted-Average Exercise Price (in dollars per share) $ 5.21
$ 5.77 - $ 5.77  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price, minimum (in dollars per share) 5.77
Range of exercise price, maximum (in dollars per share) $ 5.77
Options outstanding, shares (in shares) | shares 245
Weighted-average Exercise Price (in dollars per share) $ 5.77
Weighted-average Remaining Contractual Life 3 years 10 months 6 days
Options Vested and Exercisable, Shares (in shares) | shares 245
Options Vested and Exercisable, Weighted-Average Exercise Price (in dollars per share) $ 5.77
$ 7.95 - $ 7.95  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price, minimum (in dollars per share) 7.95
Range of exercise price, maximum (in dollars per share) $ 7.95
Options outstanding, shares (in shares) | shares 60
Weighted-average Exercise Price (in dollars per share) $ 7.95
Weighted-average Remaining Contractual Life 2 years 29 days
Options Vested and Exercisable, Shares (in shares) | shares 60
Options Vested and Exercisable, Weighted-Average Exercise Price (in dollars per share) $ 7.95
$ 9.50 - $ 9.50  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price, minimum (in dollars per share) 9.5
Range of exercise price, maximum (in dollars per share) $ 9.5
Options outstanding, shares (in shares) | shares 124
Weighted-average Exercise Price (in dollars per share) $ 9.5
Weighted-average Remaining Contractual Life 2 years 9 months 25 days
Options Vested and Exercisable, Shares (in shares) | shares 124
Options Vested and Exercisable, Weighted-Average Exercise Price (in dollars per share) $ 9.5
v3.25.0.1
Employee Benefit Plans and Stock-based Compensation - Restricted stock awards (Details) - Restricted Stock Awards - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Total fair value of restricted stock awards vested $ 2.1 $ 2.3 $ 2.3
Unamortized compensation cost related to restricted stock awards $ 3.8    
Weighted-average remaining contractual terms 1 year 6 months    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Non-vested, beginning of period (in shares) 1,220 984 875
Granted (in shares) 811 692 513
Vested (in shares) (485) (446) (387)
Forfeited (in shares) (5) (10) (17)
Non-vested, end of period (in shares) 1,541 1,220 984
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value      
Non-vested, beginning of period (in dollars per share) $ 3.75 $ 5.55 $ 6.26
Granted (in dollars per share) 2.4 2.2 4.67
Vested (in dollars per share) 4.39 5.25 6.01
Forfeited (in dollars per share) 2.99 6.37 5.34
Non-vested, end of period (in dollars per share) $ 2.84 $ 3.75 $ 5.55
v3.25.0.1
Employee Benefit Plans and Stock-based Compensation - Performance Shares (Details) - USD ($)
$ / shares in Units, $ in Millions
 1 Months Ended 12 Months Ended
Feb. 18, 2025
Feb. 20, 2024
Mar. 15, 2023
Feb. 14, 2023
Mar. 14, 2022
Feb. 15, 2022
Feb. 17, 2021
Mar. 31, 2023
Feb. 28, 2022
Feb. 28, 2021
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Performance Shares                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares                          
Non-vested, beginning of period (in shares)                     38,000 76,000  
Granted (in shares)                     301,000 13,000  
Vested (in shares)                     (38,000) (38,000)  
Forfeited (in shares)                       (13,000)  
Non-vested, end of period (in shares)                     301,000 38,000 76,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Non-vested, beginning of period (in dollars per share)                     $ 15.37 $ 15.37  
Granted (in dollars per share)                     2.28 3.71  
Vested (in dollars per share)                     15.37 15.37  
Forfeited (in dollars per share)                       3.71  
Non-vested, end of period (in dollars per share)                     $ 2.28 $ 15.37 $ 15.37
Weighted-average grant date fair value of stock options granted (in dollars per share)               $ 3.71 $ 7.83 $ 15.37      
Percentage of performance target cap of award   100.00% 100.00%                    
Percentage of year-over-year annual revenue growth rate       2.70% 44.00%                
Shares eligible to vest   0   0                  
Percentage of targeted financial performance                     200.00%   150.00%
Unrecognized compensation expense related to restricted stock awards                     $ 0.3    
Weighted-average remaining contractual terms                     1 year 10 months 24 days    
Performance Shares | Subsequent Event                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Percentage of year-over-year annual revenue growth rate 200.00%                        
Performance Shares | Minimum | Scenario Performance Financial Metric Less Than 50%                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Percentage of targeted financial performance           50.00%              
Performance Shares | Minimum | Scenario Performance Financial Metric is Between 50% to 200%                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Percentage of targeted financial performance           50.00%              
Performance Shares | Maximum | Scenario Performance Financial Metric is Between 50% to 200%                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Percentage of targeted financial performance           200.00%              
Performance Shares | Maximum | Scenario Performance Financial Metric Greater Than 200%                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Percentage of targeted financial performance           200.00%              
Performance Shares | Share-Based Payment Arrangement, Tranche One                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares                          
Vested (in shares)                     0    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Vesting period                     4 years    
Performance Shares | Chief Executive Officer                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Stock options grants in period   223,590 223,590       113,130            
Performance Shares | Chief Executive Officer | Scenario Performance Minimum Financial Metric                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Share options vested in period   223,590 223,590                    
Performance Shares | Chief Executive Officer | Scenario Performance Financial Metric Less Than 50%                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Stock options grants in period           114,320              
Performance Shares | Chief Executive Officer | Scenario Performance Financial Metric is Between 50% to 200%                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Stock options grants in period           114,320              
Performance Shares | Chief Executive Officer | Scenario Performance Financial Metric Greater Than 200%                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Stock options grants in period           114,320              
Performance Shares | Chief Financial Officer                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Stock options grants in period   77,600 77,600       38,475            
Performance Shares | Chief Financial Officer | Scenario Performance Minimum Financial Metric                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Share options vested in period   77,600 77,600                    
Performance Shares | Chief Financial Officer | Scenario Performance Financial Metric Less Than 50%                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Stock options grants in period           32,100              
Performance Shares | Chief Financial Officer | Scenario Performance Financial Metric is Between 50% to 200%                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Stock options grants in period           32,100              
Performance Shares | Chief Financial Officer | Scenario Performance Financial Metric Greater Than 200%                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Stock options grants in period           32,100              
Employee Stock Option                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Stock options grants in period                     0 0 0
v3.25.0.1
Employee Benefit Plans and Stock-based Compensation - Common Stock (Details)
shares in Thousands
Dec. 31, 2024
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Common stock reserved for future issuance 6,750
2015 Equity Incentive Plan  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Common stock reserved for future issuance 3,733
Employee Stock Option [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Common stock reserved for future issuance 1,175
Restricted Stock [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Common stock reserved for future issuance 1,842
v3.25.0.1
Employee Benefit Plans and Stock-based Compensation - Stock-Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Net effect on net loss $ 3,097 $ 3,540 $ 4,006
Effect on basic net income (loss) per share $ 0.07 $ 0.08 $ 0.1
Effect on diluted net income (loss) per share $ 0.07 $ 0.08 $ 0.09
Cost of revenue      
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Net effect on net loss $ 322 $ 414 $ 379
Selling, general and administrative      
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Net effect on net loss 2,295 2,502 2,947
Research and development      
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Net effect on net loss $ 480 $ 624 $ 680
v3.25.0.1
Employee Benefit Plans and Stock-based Compensation - Assumptions (Details) - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Expected dividend (in hundredths) 0.00% 0.00% 0.00%
Retirement Benefits [Abstract]      
Period after which all full time employees are eligible to participate in the savings plan 90 days    
Contributions to the Savings Plan $ 188,000 $ 186,000 $ 191,000
Maximum      
Retirement Benefits [Abstract]      
Maximum percentage of employer matching contribution if employees contribute at least 6% of base pay (in hundredths) 4.00%    
Minimum      
Retirement Benefits [Abstract]      
Minimum percentage of employee contribution to get 4% of employer's contribution (in hundredths) 6.00%    
v3.25.0.1
Guarantees (Details) - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Product Warranty    
Period of warranty 12 months  
Change in warranty accrual    
Beginning accrued product warranty $ 703,000 $ 669,000
Accruals for warranties issued 353,000 794,000
Adjustments related to pre-existing warranties including expirations and changes in estimates (22,000) (159,000)
Cost of warranty repair (583,000) (601,000)
Ending accrued product warranty $ 451,000 $ 703,000
v3.25.0.1
Income Taxes (Details) - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Operating Loss Carryforwards      
Income (loss) before provision for income taxes $ (10,657,000) $ (19,033,000) $ 20,927,000
Current:      
Federal 3,000 (317,000) 848,000
State 18,000 41,000 34,000
Foreign 910,000 (62,000) 918,000
Total current 931,000 (338,000) 1,800,000
Deferred:      
Federal 144,000 (9,000) (591,000)
State 6,000 (7,000) (4,000)
Foreign 53,000 514,000 980,000
Total deferred 203,000 498,000 385,000
Total provision for income taxes $ 1,134,000 $ 160,000 $ 2,185,000
Reconciliation of effective income tax rates and the U.S. statutory federal income tax rate      
Statutory federal income tax rate (as a percent) 21.00% 21.00% 21.00%
State income taxes, net of federal tax benefits (as a percent) (0.20%) 1.60% 0.10%
Valuation allowance (as a percent) (32.30%) (25.70%) (19.30%)
Stock-based compensation (as a percent) (2.40%) (1.70%) 0.70%
Foreign tax rate differential (as a percent) (1.50%) 6.10% (2.60%)
Foreign tax incentives (as a percent) 1.90% 0.10% (3.50%)
Foreign income inclusion (as a percent)     18.90%
Tax effect in equity method loss or gain from unconsolidated affiliates (as a percent) 2.80% 0.40% (3.00%)
Other (as a percent) 0.10% (2.60%) (1.80%)
Effective tax rate (as a percent) (10.60%) (0.80%) 10.50%
Deferred tax assets:      
Net operating loss carryforwards $ 17,220,000 $ 14,362,000  
Accruals, reserves and other 4,542,000 4,349,000  
Credit carryforwards 207,000 206,000  
Operating lease liability 268,000 325,000  
Gross deferred tax assets 22,237,000 19,242,000  
Valuation allowance (20,722,000) (17,462,000)  
Total deferred tax assets 1,515,000 1,780,000  
Deferred tax liabilities:      
Operating lease right-of-use assets (261,000) (323,000)  
Total net deferred tax assets (included in other assets) 1,254,000 1,457,000  
Increase (decrease) in valuation allowance $ 3,300,000 5,600,000  
Realized benefits of tax rate reduction (as a percent) 10.00%    
Unrecognized tax benefit would favorably impact the effective tax rate in future periods if recognized $ 1,100,000 1,100,000  
Domestic Tax Authority      
Deferred tax liabilities:      
Operating loss carryforwards 46,400,000    
State      
Deferred tax liabilities:      
Operating loss carryforwards $ 108,000    
Foreign Tax Authority      
Deferred tax liabilities:      
EIT income tax rate (as a percent) 25.00%    
Preferential tax rate (as a percent) 15.00%    
Benefit from foreign tax rate $ 348,000 $ 47,000 $ 900,000
v3.25.0.1
Net Income (Loss) per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Numerator:      
Net income (loss) attributable to AXT, Inc. $ (11,624) $ (17,881) $ 15,811
Less: Preferred stock dividends (177) (177) (177)
Net income (loss) available to common stockholders $ (11,801) $ (18,058) $ 15,634
Denominator:      
Denominator for basic net income (loss) per share - weighted-average common shares 43,154 42,643 42,104
Effect of dilutive securities:      
Denominator for dilutive net income (loss) per common shares 43,154 42,643 42,715
Net income (loss) attributable to AXT, Inc. per common share:      
Basic $ (0.27) $ (0.42) $ 0.37
Diluted $ (0.27) $ (0.42) $ 0.37
Common stock options      
Effect of dilutive securities:      
Effect of dilutive securities (in shares)     333
Net income (loss) attributable to AXT, Inc. per common share:      
Securities excluded from diluted net income (loss) per share as the impact is anti-dilutive (in shares) 1,175 1,198 220
Restricted Stock Awards      
Effect of dilutive securities:      
Effect of dilutive securities (in shares)     278
Net income (loss) attributable to AXT, Inc. per common share:      
Securities excluded from diluted net income (loss) per share as the impact is anti-dilutive (in shares) 1,842 1,258 291
v3.25.0.1
Segment Information and Foreign Operations - Product Information (Details) - Single reportable segment - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Revenue by product type      
Revenue $ 99,361 $ 75,795 $ 141,118
Substrates      
Revenue by product type      
Revenue 67,748 47,466 111,094
Raw materials and others      
Revenue by product type      
Revenue $ 31,613 $ 28,329 $ 30,024
v3.25.0.1
Segment Information and Foreign Operations - Segment and Geographical Information (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
USD ($)
segment
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Segment Information and Foreign Operations      
Number of operating segments | segment 1    
Single reportable segment      
Geographic Areas, Revenues from External Customers [Abstract]      
Revenue $ 99,361 $ 75,795 $ 141,118
Long-lived assets by geographic region, net of depreciation:      
Long-lived assets 162,200 169,147  
Single reportable segment | CHINA      
Long-lived assets by geographic region, net of depreciation:      
Long-lived assets 160,847 167,516  
Single reportable segment | North America (primarily the United States)      
Long-lived assets by geographic region, net of depreciation:      
Long-lived assets 1,353 1,631  
Single reportable segment | Reportable Geographical Components [Member]      
Geographic Areas, Revenues from External Customers [Abstract]      
Revenue 99,361 75,795 141,118
Single reportable segment | Reportable Geographical Components [Member] | CHINA      
Geographic Areas, Revenues from External Customers [Abstract]      
Revenue 56,119 39,778 55,414
Single reportable segment | Reportable Geographical Components [Member] | TAIWAN      
Geographic Areas, Revenues from External Customers [Abstract]      
Revenue 14,098 8,651 28,780
Single reportable segment | Reportable Geographical Components [Member] | JAPAN      
Geographic Areas, Revenues from External Customers [Abstract]      
Revenue 4,979 4,641 11,724
Single reportable segment | Reportable Geographical Components [Member] | Asia Pacific (excluding China, Taiwan and Japan)      
Geographic Areas, Revenues from External Customers [Abstract]      
Revenue 2,818 3,814 4,188
Single reportable segment | Reportable Geographical Components [Member] | Europe (primarily Germany)      
Geographic Areas, Revenues from External Customers [Abstract]      
Revenue 13,766 12,315 20,592
Single reportable segment | Reportable Geographical Components [Member] | North America (primarily the United States)      
Geographic Areas, Revenues from External Customers [Abstract]      
Revenue $ 7,581 $ 6,596 $ 20,420
v3.25.0.1
Other income (expense), net (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Other income (expense), net      
Foreign exchange gain (loss) $ 91 $ 169 $ 1,573
Income from local China government subsidy 2,239 2,557 1,710
Other income (expense) (283) (547) 204
Total other income (expense), net $ 2,047 $ 2,179 $ 3,487
v3.25.0.1
Commitments and Contingencies (Details)
 12 Months Ended
Dec. 31, 2024
USD ($)
ft²
Sep. 30, 2023
May 31, 2020
Leases      
Area of leased property (in square feet) | ft² 19,467    
Operating lease, extension term   5 years 3 years
Variable lease payments $ 0    
Equipment lease      
Leases      
Variable lease payments $ 0    
Cross License Agreement      
Leases      
Term of agreement 10 years    
Dingxing      
Leases      
Total investment agreement value $ 90,000,000    
Kazuo      
Leases      
Total investment agreement value 15,000,000    
Kazuo | Beijing BoYu Semiconductor Vessel Craftwork Technology Co      
Leases      
Total investment agreement value $ 8,000,000    
v3.25.0.1
Commitments and Contingencies - Maturities of Operating Lease Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Future minimum lease payments    
2025 $ 630  
2026 653  
2027 670  
2028 651  
2029 191  
Total minimum lease payments 2,795  
Less: Interest (282)  
Present value of lease obligations 2,513  
Less: Current portion, included in accrued liabilities (536) $ (458)
Long-term portion of lease obligations $ 1,977 $ 2,351
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Accrued Liabilities, Current Accrued Liabilities, Current
v3.25.0.1
Commitments and Contingencies - Weighted-Average Remaining Lease Term and Discount Rate (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Leases [Abstract]    
Weighted-average remaining lease term (years) 4 years 3 months 7 days 5 years 2 months 19 days
Weighted-average discount rate 5.02% 5.14%
Cash paid for amounts included in the measurement of lease liabilities:    
Operating cash flows from operating leases $ 603 $ 578
v3.25.0.1
Commitments and Contingencies - Components of Lease Expense (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Leases    
Operating lease $ 615 $ 548
Short-term lease expense 170 143
Total $ 785 $ 691
v3.25.0.1
Redeemable Noncontrolling Interests (Details) - Beijing Tongmei Xtal Technology - USD ($)
$ in Millions
 1 Months Ended 3 Months Ended 12 Months Ended
Jan. 25, 2021
Jan. 31, 2021
Dec. 31, 2020
Dec. 31, 2022
Dec. 31, 2020
Dec. 31, 2024
Noncontrolling Interest [Line Items]            
Increase in redeemable noncontrolling interests due to issuance of Tongmei's common stock   $ 1.5 $ 48.1   $ 48.1  
Redeemable noncontrolling interests ownership percentage     7.06%      
Investments, government approved $ 49.0          
Percentage of equity issued on conversion of noncontrolling interests 7.28%     14.50%    
Redemption value           $ 49.0
v3.25.0.1
Redeemable Noncontrolling Interests - Components of the Change in Redeemable Noncontrolling Interests (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Redeemable Noncontrolling Interests    
Redeemable noncontrolling interests beginning balance $ 41,663 $ 44,846
Investment in subsidiary with redeemable noncontrolling interest   155
Equity issuance costs incurred (992) (880)
Stock-based compensation attributable to redeemable noncontrolling interests 34 52
Net income (loss) attributable to redeemable noncontrolling interests (509) (920)
Effect of foreign currency translation on redeemable noncontrolling interests (1,311) (1,260)
Effect of foreign currency translation attributable to redeemable noncontrolling interests (308) (330)
Redeemable noncontrolling interests ending balance $ 38,577 $ 41,663
v3.25.0.1
Subsequent Events (Details) - USD ($)
$ in Thousands
 1 Months Ended 12 Months Ended
Mar. 31, 2025
Feb. 28, 2025
Jan. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Subsequent Events            
Repayment of existing loans       $ 60,092 $ 49,210 $ 17,798
Bank loans with 2.5% to 3.9% interest rate | Subsequent Event            
Subsequent Events            
Loan amount $ 8,400 $ 8,400 $ 8,400      
Line of credit, term 1 year 1 year 1 year      
Repayment of existing loans   $ 7,400 $ 7,400      
Bank loans with 2.5% to 3.9% interest rate | Subsequent Event | Minimum            
Subsequent Events            
Interest rate 2.50% 2.50% 2.50%      
Bank loans with 2.5% to 3.9% interest rate | Subsequent Event | Maximum            
Subsequent Events            
Interest rate 3.90% 3.90% 3.90%      
Bank loans with 2.5% to 3.9% interest rate | Subsequent Event | Unsecured debt            
Subsequent Events            
Loan amount $ 6,000 $ 6,000 $ 6,000      
Bank loans with 2.5% to 3.9% interest rate | Subsequent Event | Secured debt            
Subsequent Events            
Loan amount $ 2,400 2,400 $ 2,400      
Unsecured bank loans with 3.2% interest rate | Subsequent Event            
Subsequent Events            
Loan amount   $ 2,700        
Line of credit, term   14 months        
Interest rate   3.20%